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Abstract 
The provision of care in a hospital includes a series of activities that are often recorded 
in the electronic health record (EHR) systems. Analysing the data in these EHRs has 
the potential to support the understanding of care processes and exploring the 
opportunities for process improvement.  
One of the emerging data analytics approaches for such analyses is process mining, 
and one critical challenge in working with EHR data is that processes might change 
over time. This thesis uses a process mining approach to detect process change over 
time and analyse the impact of those changes on the EHR data. The overall aim is to 
summarise the attributable change in the data due to process so that clinicians can 
better analyse the data.  
Three datasets were used in this study to understand the variability of the EHR 
systems. The first dataset is a publicly available EHR data that was used for 
developing the methods and supporting the reproducibility of the research. The second 
dataset is a de-identified subset of the database of cancer patients from the Leeds 
Cancer Centre. The second dataset was used in the experiments to improve on the 
results of  a previous study using the same dataset. The third dataset was the full Leeds 
Cancer Centre  EHR database after more comprehensive ethics was approved. In the 
third dataset, experiments were done to analyse the impact of a known system change 
on clinical pathways and to explore process change over time without a known system 
change. All three datasets were analysed using process mining. 
Process mining was shown to be useful for analysing clinical pathways and exploring 
process changes over time. It can be used to visualise the process before and after a 
known change. When the system change is unknown, process mining can be used to 
explore the process execution over time and identify the potential period where the 
system was changed. This thesis explores some aspects of the complex inter-
relatedness of process and user interface (UI) of the EHR system.  
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Chapter 1  
Introduction 
1.1 Overview 
The provision of care in a hospital is delivered through healthcare processes. 
Healthcare processes can be described as a series of activities in the diagnosis, 
treatment, and follow-up of any disease aimed at improving patient health [1]. In 
modern healthcare, these activities are often recorded in a structured way using 
computerised information systems within the hospital. The information systems 
collect, store and manage data about these healthcare processes [2]. Analysing these 
data could be beneficial to build an understanding of healthcare processes, differences 
in processes, what results in the best outcome, and opportunities for improvement. As 
data volume grows, data analysis needs to improve to keep pace. This is especially 
important when considering that a large amount of data is collected during healthcare 
transactions every day. In the last few decades, many advancements in data analytics 
approaches have been introduced. Process mining is one of the emerging approaches 
that has the potential to offer new and interesting insights that help improve healthcare 
[3, 4].   
The most common type of computerised information systems in a hospital is the 
Electronic Health Record (EHR) system [5, 6]. Clinicians use EHR systems to record 
the activities that they do in relation to the care they provide. Examples of activities 
in a treatment process within a hospital are screening, admission, investigation, 
pathological test, surgery, chemotherapy, and radiotherapy. The flow from one 
activity to the others for a patient in a clinical setting is known as a care pathway [7] 
or clinical pathway [8]. Analysis of the recorded data in the EHR system is potentially 
useful to assess the quality of the care pathways. 
Process mining is an analytic approach to discover, monitor, and improve a process 
by analysing the data about that process [3, 4]. The input of process mining is an event 
log, which contains data about the process of interest. Process mining proposes a 
systematic approach to use that event log to create process models. A process model 
is a representation of the process from a specific perspective [4]. The discovered 
process model can then be used to check the conformance of the individual cases, and 
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to improve the process. Process mining has been used in many case studies and 
various organisations, such as education [9], insurance [10], and healthcare [11]. In a 
healthcare setting, a care pathway is a process to be analysed with process mining. 
One critical challenge in process mining is that the process might change over time 
[3]. Process mining is most useful when analysing a large volume of data, which is 
not easily analysed with manual approaches. Such data may be collected over a long 
period. A common approach in analysing these data in process mining is to assume 
that the process has not changed during the period of the study. In reality, processes 
are frequently changed over time. There are many reasons for that, for example, the 
organisation needs to align with a new procedure, the staff find an alternative way to 
do a process, a software upgrade, or the User Interface (UI) of the information system 
might need to be improved by introducing a new feature. 
This thesis explores the opportunity for accessing EHR data and using a process 
mining approach to analyse care pathways, considering the possibility of process 
changes over time. The motivation of this thesis is to help make the healthcare process 
mining community more aware of the impact of process changes in process mining 
projects. The aims are: (1) to develop methods based on process mining to analyse the 
impact of changes in UI of EHR systems on clinical pathways, (2) to examine the 
applicability of process mining on different EHR datasets, and (3) to analyse EHR 
data to retrospectively examine the treatment process on Leeds patients diagnosed 
with cancer. This thesis focuses on the changes in the UI of EHR systems as a starting 
point of the analyses and discussed related aspects of system changes over time. Three 
datasets were used in this study to investigate the variability of EHR data. The 
challenges of this study need to draw on the insights from computer science and 
medical science. 
 
1.2 Understanding the problem domain 
To illustrate the range of challenges the thesis will explore, this section describes an 
example of a patient journey in a hospital. This example is based on a fictitious person 
entirely based on the discussions with clinical experts. The example is explored from 
the health service, process mining and information system perspectives. 
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1.2.1 An illustrative example 
An illustrative example is provided by following the journey of Jane, a patient in a 
hospital. Jane was referred by her General Practitioner (GP) on an urgent basis to a 
gynaecologist in a hospital. The gynaecologist met her in an outpatient consultation. 
After checking on the detailed history and examination, the gynaecologist requested 
a range of tests (investigations) including an ultrasound scan, blood test, and 
hysteroscopy. Hysteroscopy is a procedure where a fibre optic camera is used to 
directly visualise the internal anatomy of the womb and obtain biopsy samples if 
required. The results of the investigations were then discussed in a multi-disciplinary 
team (MDT) review. The MDT review is held to get a consensus view of the 
gynaecologist, oncologist, radiologist, pathologist, and other healthcare professionals. 
Jane’s pathology sample confirmed a diagnosis of cancer. The outcome of the MDT 
review was a recommendation to proceed to surgical treatment. 
A few days later, Jane brought back to the hospital to meet with a gynaecological 
oncologist. During the appointment, the test results and cancer diagnosis were 
explained to Jane. They discussed the recommended course of surgery as the first and 
definitive treatment. Jane agreed and was formally consented for surgical treatment. 
Jane attended the hospital two weeks later where she was admitted for her surgical 
procedure. The operation successfully removed all of the visible tumours and she was 
discharged awaiting results of the surgical histology. At the follow up appointment, 
the surgeon met Jane explaining that the operation was successful and that the 
pathology showed healthy tissue and clear margins from her surgical resection. Jane 
was then followed up with annual outpatient visits for five years after which she was 
discharged with no signs of recurrent disease. 
Jane’s case is used as an example to illustrate one possible pathway for cancer 
treatment in a typical NHS hospital providing specialised cancer services. This 
example will now be further discussed from the health service perspective, the process 
mining perspective, and the information system perspective. 
1.2.2 Health service perspective 
The important stakeholders from the health service perspective are the patients, the 
clinicians, and the health service managers. Most obviously, the patient is the main 
stakeholder, along with their family who cares about the sequence of patient 
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treatment. Jane’s journey can be seen as one example of an individual care pathway 
from the patient perspective. For Jane, the patient, it is important to know the details 
of each activity, who will deliver the treatment, when and how long it will last, and 
what are the results of the treatment. It is upsetting for the patient to be diagnosed 
with cancer, so the more detail given and the clearer their understanding about the 
individual pathway the better. When the gynaecologist did some tests, for example, 
Jane needs to know what will be tested, how will it be done and what to expect. When 
Jane and the oncologist discuss the course of treatment, Jane needs to know her 
options and risks of each option. The gynaecologist needs to explain this based on his 
or her understanding of previous care pathways that he or she is aware of. 
Another important stakeholder is the clinician who executes the activities within the 
process. This refers to a clinician with specific expertise, but also as part of a 
Multidisciplinary Team (MDT) within a hospital. The clinician is interested in the 
treatment given to a patient under their care. In Jane’s example, when the 
gynaecologist sees Jane in a consultation, the gynaecologist needs to know what has 
been done to the patient, what her current condition is, and what should be done as 
the next step in the pathway. When the clinicians meet in an MDT meeting, they need 
to discuss Jane’s care pathway from different perspectives. Process mining can be 
used to analyse durations, variants, and pathways from different perspectives needed 
by clinicians. 
Within a hospital, a health service manager is also a stakeholder who cares about 
patient treatments in the hospital. The health service manager is responsible for 
directing, coordinating, and administering medical and non-medical resources, 
facilities and services. Health service managers would be interested in Jane’s journey 
to see how the medical and non-medical resources within the hospital provide health 
services for patients. Health service managers need to plan, direct, and coordinate 
health services. From Jane’s example, the health service managers manage the 
medical resources, facilities, and services in the oncology unit, the pathology unit, and 
the surgery unit to support Jane’s treatment. They need to plan the services, analyse 
how the services have been used, how clinicians work from time to time, and what 
can be done to improve overall performance. They might need to see the sequence of 
Jane’s treatment and to know if the sequence conforms to the standard guidelines of 
the treatment process. They might be interested to know the duration of each event in 
Jane’s journey and how those durations conform to the guidelines of the services. 
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They might need to detect possible delays in Jane’s journey and to know the cause of 
the delay. They might also need to identify ways to improve the outcome of Jane’s 
treatment. 
Those might be easily done for one patient journey, but a health service manager 
needs to analyse the journeys of all patients within a hospital. Those patients might 
have various sequences of events in their treatment, depending on many conditions, 
such as their symptoms, age group, and other characteristics. The hospital might also 
apply various treatment approaches for different patients that might later result in a 
different sequence of events or different durations from the same sequence of events. 
The health service managers need some approaches to analyse those variations. 
Process mining is one of the promising approaches to analyse durations, sequence of 
events, variants, and other related analysis. 
1.2.3 Process mining perspective 
Jane’s journey can be represented as a sequence of discrete events: referral, outpatient 
consultation, investigation, test result consultation, diagnosis, admission, surgery, 
after-surgery consultation, and discharge. The clinicians who undertook these events 
included the gynaecologist, the oncologist, the pathologist, and the surgeon. In each 
of those activities, the clinicians entered the details of the events in the EHR system. 
The EHR system added some extra information about the events, for example, the 
exact timestamp when the event was performed. 
A typical EHR system records clinical information in a complex database structure. 
That includes the details of the event in a specific data format. The event names are 
stored along with the clinician’s login information, and the timestamp when the event 
happened. Those recorded details are the minimum components of an event log, which 
can later be analysed to understand the recorded events that have happened within the 
hospital. The structure of the EHR system is generally more complex than what is 
needed for process mining. Thus, the first challenge is to extract and transform the 
details of the events in the suitable format for process mining. 
A process mining approach is used in this study to analyse such data. In Jane’s 
example, the treatment process is described in a series of events as actions to achieve 
the outcome of being cancer free. A systematic approach can be used to select and 
find the information needed in analysing clinical pathway using process mining 
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approaches. The recorded event name, clinician name, and timestamp of each event 
can be used to discover the sequence of events that happened to any particular patient. 
Jane’s journey, for example, can be represented in the following sequence: GP 
referral à outpatient consultation à investigation à pathology test à MDT review 
à diagnosis à test results consultation à admission à surgery à after-surgery 
consultation à discharge. The sequence of events of many patients might create 
splitting pathways depending on what is found and what actions are taken. 
From the sequence of the events of many patients, a process mining approach can be 
used to analyse the patient pathways within a hospital. The sequence of events can be 
compared to the guidelines related to cancer treatment. One example of the guidelines 
in the NHS is cancer waiting time target, for example, the 62-days wait pathway. This 
guideline requires the pathways from referral to treatment to be completed in no more 
than 62 days (two months) [12]. 
This representation omits things, of course, and this might be worth noting. For 
example, when Jane and the oncologist discussed and agreed the course of treatment, 
there might have been a long discussion on how the diagnosis has upset the patient, 
what options had been given by the clinician, and other considerations. This 
discussion is not represented in the sequence of events. Some details are possibly 
recorded in in free text and can be built in to increase the completeness of the analysis 
in process mining. In this example, process mining only takes account of the sequence 
itself and not any free text which might, for example contain the reason why the 
sequence occurred. This would remain as a limitation of this study, as the analysis is 
carried out based only on the recorded data. 
1.2.4 Information system perspective  
The EHR system can be seen as a type of information systems where the main users 
are the clinicians and other healthcare professionals including surgeons and 
pharmacists. They interact with the information system through the UI. As users work 
with the system, they input data, do some actions, and get outputs through the UI 
designed in the system. The UI through which the users interact with the information 
system plays an important part in the success of the information system. A good UI 
design can play a key role in the success of the systems, including EHR systems [13]. 
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This can be related to Jane’s journey as the example. When Jane came to the hospital, 
her journey was recorded as data in the EHR system. Some details were typed in 
manually by clinicians in the hospital or recorded automatically by the EHR system. 
For example, the admission staff who admitted Jane for surgery would enter Jane’s 
medical information, including the date of the GP referral. The oncologist in Jane’s 
oncology consultation entered more details in Jane’s medical information, including 
the scheduled date for the pathology test. When the oncologist submitted the 
information, the EHR system would automatically record the time when the oncology 
consultation took place. The pathologist might have added medical information 
before/after the pathology test, while the pathology system automatically recorded 
pathology test results and the time when the pathology test was conducted. 
The users of the EHR system in Jane’s example were the admission staff, the 
oncologist, the pathologist, and the surgeon. Those users worked to input data, do 
some actions, and get outputs through the UI of the EHR system. For example, the 
admission staff who admitted Jane checked if Jane had already been registered in the 
system, checked some personal details to make sure that the data are valid, inputted 
some medical information, and received confirmation from the EHR system that the 
data had been updated. 
Looking back at Jane’s journey, all of Jane’s treatment was facilitated by the 
information systems. The admission system was used to record Jane’s information on 
hospital admission and discharge. The oncology system was used by the oncologist 
to record details of the consultations. The pathology system was used by the 
pathologist to record pathology test results. The surgery system was used by the 
surgeon and the surgery team to record information regarding Jane’s surgery. In fact, 
Jane’s journey is actually  recorded in greater detail than outlined above, for example 
including when the referral is received, the system makes the appointment, generated 
the letter, was updated if Jane called to change the appointment, probably resulted in 
requested per-appointment details, scheduled the time of the appointment, recorded 
the time that the patient enters the consultation room and the time of the next 
appointment, etc. Whenever the information system was used, the UI had an important 
part to play in the success of the EHR system. 
For example, when Jane visited the hospital to get admitted, the admission staff 
needed to check if Jane had already been registered. The UI required the staff to type 
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in a National Health Service (NHS) number, last name, or date of birth to correctly 
identify Jane. When the data produced a match, the staff were then required to see and 
verify Jane’s personal information. The UI needs to be designed in such a way that 
personal information can be presented in a suitable layout to make it easy for the staff 
to see all important information on the screen. The staff might ask Jane some 
questions to see if any information requires to be updated, for example, Jane’s home 
address. The staff then need to enter the date of the GP referral, along with some other 
details such as GP name and/or address. The UI of the EHR system needs to be 
designed such that the date of GP referral can be inputted in a standard format to avoid 
any error. The regular GP name or address might be presented as a list to improve 
efficiency. 
1.2.5 System change 
Over time, the EHR system might change for several reasons. Some users may find 
that a button is missed out most of the time because it is too small, so the developer 
team makes it bigger. Other users may find that a menu is placed in the wrong order 
that does not agree with the order of the care process, so the developer team moves it 
to the correct order. There might also be a change in the guidelines for patient 
treatment that requires changes in the records. Another time, the hospital might decide 
to join an initiative to connect the EHR system to all care records throughout the city, 
so the developer team makes some changes to adjust the EHR system. In an extreme 
example, the hospital might decide to change the EHR system to another system 
completely. All these examples show that the EHR systems have some changes at 
different levels, for various purposes. 
To relate to Jane’s example, the EHR system where Jane’s journey is recorded might 
have faced several changes. Those changes might affect the way Jane’s journey is 
recorded in the database of the EHR system. For example, if five years ago, the 
hospital had a separate pathology system to record all pathology test activities within 
the hospital. The hospital only started to record pathology test results in the last five 
years. Whenever a pathology test is done, the EHR system would record the test result 
and make it available to be updated by the clinicians, as required. If Jane had come 
five years earlier, her records in the EHR system would not include any activities 
related to the pathology tests. In this case, the analysis would reveal that Jane’s 
journey was not complete because she did not have a pathology test. This does not 
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mean, of course, that Jane had been diagnosed without a pathology test but illustrates 
an effect of a system change over time. 
This thesis focused on the changes in the UI of EHR systems. The aim is to build a 
method to examine and analyse different types of UI changes and the effect of those 
changes on the processes. The process change is analysed using a process mining 
approach. Process mining is used in this study because it can be useful in analysing 
and understanding processes through the event log automatically generated in the 
information system. The current literature in process mining has shown promising 
results in the analysis and understanding of the processes. Still, there are limited 
studies discussing the effect of system changes on process changes over time. This 
study demonstrates the suitability of using process mining for process change analysis 
within the healthcare domain, to understand the suitability for using EHR given 
changes over time and how to control for the change over time. The motivation of this 
thesis is to make contributions to the healthcare process mining community [14], 
where one of the main challenges is the complexity due to the changes over time. 
 
1.3 Objective, hypothesis, and research questions 
The objective of this research is to detect and analyse process changes in EHR 
systems. In aiming to meet this objective, the key hypothesis is that process mining 
can be used to analyse process change in the EHR system. The Research Questions 
are developed by breaking down the key hypothesis, as presented in Figure 1.1.  
 
Figure 1.1 Research Question development. The left side shows the primary questions with 
two possible cases connected with solid arrows. The right side shows the measurement 
questions in either one of two cases (2 or 3 on the left), connected with dashed arrows. 
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The first research question is “Is it possible to analyse changes in the care processes 
in an e-health system using process mining?” (RQ-1). This research question can be 
split into two based on the pre-condition whether a process change point is known or 
not: “Is it possible to analyse process change from a given UI change?” (RQ-2) or “Is 
it possible to detect a point in time when a care process changed?” (RQ-3). In a case 
where UI changes have been documented, it may be possible to know the exact point 
in time when the change happened. If this is the case, the analysis focuses on how a 
given UI change affects the care process. Another case is where a care process is 
undertaken over a long period, the process might have been changed over time. In this 
case, the analysis focuses on how to characterise this process change over time. 
Further, Figure 1.1 shows that this research needs to find parameters that can be used 
to characterise process changes (RQ-4). Those parameters can be defined based on 
process characteristics. A process can be characterised from many representations and 
perspectives, for example, based on the sequence of activities, based on the duration, 
or based on the outcomes. Each of those representations and perspectives may change 
over time. To support this question, this research needs to consider how best to 
represent the care pathways (RQ-5). The fundamental question is how to extract an 
event log, a dataset of patient pathways, from the EHR system (RQ-6). The database 
was not developed from a process perspective; hence the initial challenge is to get the 
correct data required to analyse processes.  
 
1.4 Study approach 
The general approach of this study was to explore the dataset of patient pathways as 
extracted from the EHR system, test the hypothesis through some experiments of 
process change analysis, and evaluate the results through discussions with clinical 
experts. The main inputs of this research were the EHR database, the information 
about a UI change, and advice on clinical treatments. The EHR database was explored 
to extract the data related to the process change. Using process mining approaches, 
those data were transformed to represent and characterise the process as needed by 
clinical experts to better understand the process change. Based on those 
representations and characteristics, the analysis was completed by discovering 
process changes over time. The output was presented in many visualisations to 
support understanding of the process. 
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The methodology in this study is adapted from the two well-established process 
mining methods, the L* life-cycle model [3] and the Process Mining Project 
Methodology (PM2) [15], and they are discussed in more detail in Chapter 3. The 
study started with planning and justification to define the scope, research questions, 
and the data of this study. It was followed by Extraction, Transformation, and Loading 
(ETL) of the identified data required for this study. The next stage is the main part of 
this study, where the process mining and process change analysis was done. The 
process change analysis [16] was conducted by partitioning the event log over time 
and by process mining each of them to discover the process models over time. The 
last stage is evaluation, which was conducted through both a statistical evaluation and 
a clinical evaluation. The statistical evaluation was done using hypothesis testing, to 
test if there is a statistically significant change before and after a change point in time. 
The clinical evaluation was done through focused group discussions with clinical 
experts to unravel the real changes happening within the EHR system. 
Based on the study planning and justification, the datasets used in this study were 
chosen from two data sources to understand the variability of the EHR systems. The 
datasets came from two data sources: one from a hospital in the United States of 
America (USA) and one from a hospital in the United Kingdom (UK). The USA 
represents a country with a non-universal healthcare insurance system where 
healthcare services are largely provided by private providers [17]. The UK represents 
a country with a universal government-funded health system, also known as single-
payer healthcare [18]. By analysing datasets from the USA and the UK, this study 
may be extended to an international comparison of healthcare services. The data 
provenance of those two data sources are described in the following section. 
1.4.1 Data sources 
There are two data sources for this study. These are: the Beth Israel Deaconess 
Medical Center (BIDMC), USA, and the St James’s University Hospital (SJUH), UK. 
Those two data sources come from hospitals located in two cities of comparable size. 
Without trying to compare those two hospitals with one another, the following 
sections present the overview of those two data sources. 
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1) The Beth Israel Deaconess Medical Center in Boston, USA 
The first data source was the EHR of the BIDMC hospital in Boston, USA. This 
hospital was formed in 1996 by a merger of Beth Israel Hospital (founded in 1916) 
and New England Deaconess Hospital (founded in 1896). BIDMC is a private hospital 
for Harvard Medical School and is located in Boston [19].  
Boston is the capital and the most populous city of Massachusetts in the US. The city 
covers 89.63 square miles (232.14 km2) with an estimated population of 694,583 in 
2018. In addition, there are hundred thousands of people who travel to Boston for 
work, education, healthcare, and special events. The population rises to 1.2 million 
during working hours and 2 million during special events. Boston is a home to an 
affluent population and is a wealthy city with one of the highest costs of living in the 
USA[20]. 
In March 2019, the BIDMC joined Beth Israel Lahey Health, a new healthcare system 
in the US, along with 11 other hospitals. Since the merger, the hospital has consisted 
of two campuses, the East (former Beth Israel) and the West (former Deaconess). The 
East Campus houses most of the primary care, outpatient, clinical and administrative 
functions. The West Campus retains the department of human resources, the 
emergency department, inpatient care, and many specialists. The medical center has 
more than 6,000 full-time employees. The BIDMC provides 673 licensed beds, which 
includes 493 beds in medical/surgical department, 77 beds in critical care and 62 beds 
in obstetrics/ gynaecology (OB/GYN) [19]. 
2) The St James’s University Hospital in Leeds, UK 
The second data source for this study was the EHR of the SJUH in Leeds, UK [21]. 
This public hospital was originally the Leeds Moral and Industrial Training School 
built in 1848 and was named as St James’s University Hospital in 1970, which is 
located in Leeds, UK.  
Leeds is a city in West Yorkshire, England, UK. Leeds has one of the most diverse 
economies and the fastest rate of growth in the UK. The city covers 213 square miles 
(551.7 km2) with an estimated population of 789,194 in 2018. Leeds economy is one 
of the most diverse of all the UK main employment centres. Leeds  is one of the largest 
business centres in the UK with around a quarter million people are employed in the 
Leeds City Region in the financial and professional sector [22].  
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Along with five other hospitals, SJUH is managed by the Leeds Teaching Hospitals 
NHS Trust (LTHT). The LTHT is the largest provider of specialised services in 
England [23]. The SJUH provides 997 beds, including the new oncology building, the 
Bexley Wing. The Leeds Cancer Centre is one of Europe’s largest cancer centres with 
350 beds and 1,600 staff [24]. 
1.4.2 Overview of the datasets 
The EHR data from those two data sources were made accessible to the researcher. 
Initially, access was gained to the open accessible dataset from the BIDMC, USA. 
This is called the Medical Information Mart for Intensive Care III (MIMIC-III). The 
second dataset was the de-identified subset of the Patient Pathway Manager (PPM) 
data from the LTHT. This is called the PPM Chemotherapy dataset. Subsequently, the 
third dataset was accessible from the full access of PPM dataset. This is called the 
PPM Cancer dataset. The second and third datasets came from the same data source, 
but were considered as two different datasets due to their data access, anonymisation 
process, and the scope of the datasets.A summary of the datasets in this study is 
presented in Table 1.1. 
Table 1.1 Data summary 








1. Colorectal cancer patients (n=1,600) 










Breast cancer patients receiving EC-
90 adjuvant chemotherapy between 
2003 – 2012 (n=738) 
3) PPM Cancer 
(n>2.5M) 
1. Breast cancer patients receiving 
EC-90 adjuvant chemotherapy 
between 2014-2018 (n=733) 
2. Referral to diagnosis of Leeds 
patients diagnosed with 
endometrial cancer (n=1,664) 
3. Referral to first treatment of Leeds 
patients diagnosed with 
endometrial cancer (n= 949) 
4. Cancer patients  
* n = number of patients 
Those three datasets were carefully chosen to represent variability of EHR data. The 
MIMIC-III dataset includes patients in critical care units only. MIMIC-III was chosen 
because this is publicly available and supporting reproducibility of the research using 
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the same dataset. The PPM Chemotherapy dataset is an extract of patient data 
consisting data of patients receiving chemotherapy in the LTHT. This dataset 
represents a specific cohort of patients following a general pathway of chemotherapy 
treatment. The PPM Cancer dataset is the full dataset of cancer patients in the LTHT. 
This dataset represents a larger cohort of patients with many different pathways 
followed. Analysis of the PPM Cancer dataset was also supported with adirect access 
to representatives of clinicians and PPM developers. For simplicity and consistency 
reasons, the dataset names to be used in this research are the MIMIC-III dataset, the 
PPM Chemotherapy dataset, and the PPM Cancer dataset. Case studies of these 
datasets are described in Section 3.4 and are explored in more detail in Chapters 4–6. 
 
1.5 Thesis structure 
This thesis is structured based on the experiments conducted on the three datasets as 
three separate case studies. The case studies are presented as separate chapters but 
experiments are numbered chronologically based on the order on which they were 
conducted. The structure of this thesis and description of the chapter headings are as 
follow. 
1) Introduction 
This chapter introduces the importance of improving healthcare processes through 
data. An illustrative example of a patient journey is presented to set a problem 
definition which can be seen from different perspectives i.e. the health service 
manager, process mining, and information system perspectives. The UI change is then 
introduced to highlight the main focus of this study. This chapter is concluded with 
the establishment of research objectives, research questions, approaches, and the 
thesis structure. 
2) Background 
This chapter summarises the literature in healthcare and technical areas as the 
background for this thesis. The healthcare background includes a review of healthcare 
systems, electronic health record research, coding standards, process guidelines, and 
cancer. The technical background includes workflow technology and process 
modelling, process modelling notation, process mining, process mining in healthcare, 
process mining to analyse process changes, and statistical approaches. 
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3) Methodology 
This chapter describes the general methodology and the three datasets used in the 
study. The four main steps in the general methodology following the PM2 are: (1) 
Plan and Justify; (2) Extract, Transform, Load; (3) Mine and Analyse, and (4) 
Evaluate. The three datasets used in this study are the MIMIC-III data, the PPM 
Chemotherapy data, and the PPM Cancer data. Each dataset will be treated as a 
separate case study and will be discussed in a dedicated chapter. Chapter 3 describes 
the general methodology, while Chapters 4–6 are organised around the three datasets. 
4) Case study 1: Experiments using the MIMIC-III dataset 
The first part of this chapter explores the MIMIC-III dataset in terms of the data 
characterisation, data provenance, scope, representativeness, data quality, data 
variety, and the limitations. 
The second part of this chapter describes how process mining has been used to analyse 
the data from the MIMIC-III dataset, following the steps in the general methodology. 
It starts with the description of cancer patient treatments in the BIDMC data source; 
followed by introducing a new stage called the Database Reconstruction; ETL; 
process discovery and conformance checking; and comparing processes in CV and 
MV systems. 
5) Case study 2: Experiments using the PPM Chemotherapy dataset 
The first part of this chapter explores the PPM Chemotherapy dataset in terms of the 
data characterisation, data provenance, scope, representativeness, data quality, data 
variety, and the limitations. 
The second part of this chapter describes how process mining has been used to analyse 
the PPM Chemotherapy database, following the steps in the general methodology. It 
starts with the description of PPM Chemotherapy data; followed by ETL; process 
discovery and conformance checking; and the process analytics. The process analytics 
include process mining to reproduce data analysis in chemotherapy process, trace 
clustering for similarity analysis, and the detection of system changes and their effects 
on treatment processes in the PPM EHR system. 
6) Case study 3: Experiments using the PPM Cancer dataset 
This chapter explores the PPM Cancer dataset in terms of the data characterisation, 
data provenance, scope, representativeness, data quality, data variety, and limitations. 
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This chapter describes how process mining has been used to analyse the PPM Cancer 
data, following the steps in the general methodology. It starts with the description of 
PPM Cancer data from the PPM database; followed by ETL; process discovery and 
conformance checking; and the process analytics. The process analytics include the 
windowing methods, process comparison and the detection of system changes and 
their effects on treatment processes in the PPM EHR system. 
7) Discussion 
This chapter explores the challenges on healthcare process mining, the data analytics 
to analyse processes, process change analysis, the effect of system change in 
healthcare processes, and the contributions of this thesis. The challenges on healthcare 
process mining include data access and ethics approval, data quality, data 
understanding, and the data and process visualisation. Contributions of this thesis 
include using the process mining approach on three datasets, exploring the dimensions 
of process change analysis, and time window selection to analyse the process. 
8) Summary 
This chapter concludes the whole study with the findings in terms of the method 
developed and the case studies explored in the study. This chapter also identifies 
future work to be done based on the findings and lessons learned in the study. 
1.6 Summary 
This first chapter has introduced the research undertaken during this PhD, by 
providing an overview and an illustrative example in order to understand the problem 
domain. The example has been explored from the perspectives of health service, 
process mining, and information systems. UI change has been introduced as one main 
challenge to be explored in this study. The aim, research objectives, research 
questions, approaches, and the thesis structure have also been presented. The next 
chapter will review the literature which builds the background for this study. 
There is an opportunity to improve healthcare through the application of process 
mining to EHR data, but there are some challenges as described. The impact of UI 
changes on the data is one of these challenges. The case study method will be adopted 
based on the pragmatic availability of data to test the hypothesis that process mining 
can be used to understand process change over time. 
 
Chapter 2  
Background 
Chapter 1 introduced this thesis as a study that needed both healthcare and technical 
expertise. Here in Chapter 2, the literature within the healthcare and technical 
background is reviewed to develop the context of the study. This chapter includes a 
jointly-authored publication presented in the IEEE International Conference on 
Information Communication and Management (ICICM) entitled “Process mining in 
oncology: a literature review” [25]. This literature review paper is summarised in 
Section 2.2.4.2. 
2.1 Healthcare background 
The relevant background to healthcare is presented in this section. Healthcare is a 
complex domain that includes the prevention, diagnosis, and treatment of disease, 
injury, illness, and other conditions in people [26]. Healthcare is delivered by health 
practitioners or providers i.e. primary care, secondary care, tertiary care, community 
care, and public health. Healthcare professionals include doctors, nurses, therapists, 
pharmacists. The following subsections have been structured to describe the general 
introduction to healthcare systems, how the healthcare data has been used in the EHR 
research, some coding standards and process guidelines related to this study, and a 
description of cancer as a specific domain analysed in this study. 
2.1.1 Healthcare systems 
A healthcare system is the organisation of people, institutions, and resources that 
deliver healthcare services to meet the health needs of the populations. According to 
the World Health Organization (WHO), a healthcare system consists of all 
organisations, people and actions to promote, restore, or maintain health. The goals 
of healthcare systems are good health for the populations, responsiveness to the 
expectations, and fair funding [27].  
Healthcare systems vary across countries [27]. They can be classified based on the 
funding body supporting the healthcare system. Some countries with universal 
government-funded health systems are Australia,  Canada, and UK. Some countries 
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with universal public insurance systems are China, Japan, and United Arab Emirates. 
Some countries with universal public-private insurance system are Austria, Chile, and 
Germany. Some countries with universal private health insurance are Netherlands and 
Switzerland. Some countries with non-universal insurance systems are Egypt, 
Indonesia, and the USA. This thesis analyses healthcare data from the USA and UK 
as two countries with different type of healthcare systems. 
The healthcare system in the USA is a non-universal insurance system, where 
healthcare is operated under a mixed market healthcare system. It is mostly funded by 
private health insurance and a small number are funded by public health coverage 
such as Medicare, Medicaid, and the Veteran Health Administration [28]. Some states 
in the USA are moving towards universal healthcare coverage, including Minnesota 
and Massachusetts. In this study, the USA healthcare system was explored to analyse 
the MIMIC-III data from the Beth Israel Deaconess Medical Center (BIDMC) 
hospital. No additional information was required in order to perform the analysis of 
the dataset.  
The healthcare system in the UK is a single-payer system, where healthcare is 
controlled by the government, funded by leveraging taxes and redistributing across 
the population, and made available to all citizens [29]. In this thesis, the UK healthcare 
system was explored by using  data from the Leeds Teaching Hospitals NHS Trust 
(LTHT) as a secondary/tertiary care provider. Relevant details of the healthcare 
system were discussed with clinical experts during the experiments using the datasets. 
2.1.2 Electronic Health Record research 
Information is one of the main components of a healthcare system. The Electronic 
Health Record (EHR) is the computerised format of healthcare information, which 
stores the health-related data of all patients treated within a healthcare institution, 
which may include records of patients’ referral, symptoms, past medical history, 
physical examination, diagnosis, tests, procedures, treatment, medication, and 
discharge [30]. An EHR contains the clinical histories of patients, which are stored to 
support the clinical care delivery for patients, improve the performance of the clinical 
practice, and facilitate clinical research. In any implementation, an EHR can be fully 
integrated or partially integrated in the healthcare institution. 
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The EHRs in general have been used for many research projects, including 
epidemiology [31], observational research, safety surveillance and regulatory uses, 
and prospective clinical research [32]. The benefits of using EHRs in clinical studies 
include, among others, integrating large amounts of medical information, enabling a 
longitudinal study of diseases, and enabling linkage to other datasets. The actual 
benefits of a study using EHRs compared to other studies are that (1) savings in cost, 
time, and labour are possible because additional data collection is not needed, and (2) 
it supports decision making based on the recorded data in the EHR, which is known 
as evidence-based decision making. The challenges to using EHRs in research are 
related to data quality, complete data capture, and heterogeneity between systems. 
From a pathway point of view, the challenges are that the EHR data recorded for 
clinical purpose might contain much more details that are not needed in the analysis, 
not recorded complete sequence of patient pathway, recorded in different levels of 
detail than needed, or might spread in different systems with different recording 
formats. The first challenge to work with the EHR data is therefore how to find the 
suitable data needed for the analysis. 
One interesting type of observational research in the EHR systems is clinical pathway 
analysis. A clinical pathway is a sequence of events in the patient care with a specific 
clinical problem [8]. The purpose of clinical pathway analysis varies from analysing 
patterns and deviations of the clinical pathway to analysing outcomes. Analysing 
patterns of clinical pathways is important in understanding medical behaviours and 
the order of activities in patient treatment [33]. Analysing outcomes are important to 
recommend procedures and treatments suitable for patients to gain positive health 
outcomes. By observing the recorded data in the EHR systems, pathways analysis can 
be supported by the recorded data as the evidence of any findings.  
Process mining is a promising approach in order to analyse the patterns of clinical 
pathways based on the data recorded in the EHR system. It is particularly interesting 
as a secondary use of routinely collected data in the healthcare settings to understand 
and improve health services [34]. The main input for process mining is an event log, 
which records the events in a pathway as they are undertaken by clinicians in a clinical 
setting. The models discovered by analysing the event log are representatives of the 
pathways being analysed. More details about process mining and how it can be used 
for clinical pathway analysis is presented in Section 2.2.3. 
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2.1.3 Coding standards: the International Classification of Diseases 
There are a range of coding standards used worldwide, but the International 
Classification of Diseases (ICD) is the most widely used for classifying diseases. It is 
mandated by the World Health Organisation (WHO) for the statistical analysis of 
diseases and mortality. ICD is a standard for the diagnostic classification that can be 
used for ensuring coding consistency in clinical and research purposes. [35] 
The first version of this system was introduced in 1893. After several changes, the 
ICD-9 (1978) was introduced to revise the standards and to reflect advances in health 
and medical science over time. The ICD-10 (1994) allowed for significantly more 
codes and permitted the tracking of many new diagnoses and procedures. The ICD-
10 is an extension of the ICD-9 with additional codes. It is possible to map codes from 
ICD-9 to ICD-10. The latest version, ICD-11, was released in June 2018, but it is not 
currently used in practice. [36]  
In this study, the MIMIC-III data used the ICD-9 codes while the PPM data used the 
ICD-10 codes. Understanding of both ICD-9 and ICD-10 codes is important in order 
to support analysis of specific cohorts of patients.  
2.1.4 Process guidelines 
Several guidelines are used in healthcare to standardise processes within the EHR 
system. Some of these are followed internationally, nationally, and locally. The 
process guidelines followed in this study based on the UK healthcare system are the 
National Institute for Health and Care Excellence (NICE) guidelines as national 
guidelines in the UK and the Leeds Health Pathways as local guidelines in the LTHT. 
Process guidelines in the US healthcare system are not discussed because there was 
no direct access to the BIDMC hospital to confirm which ones were followed. 
The NICE pathway guidelines are evidence-based recommendations for health and 
care in England. The NICE is an executive public body in the United Kingdom, a part 
of  the Department of Health that provides national guidance and pathways to conduct 
health and social care in England and Wales. NICE assesses the recommended 
treatment of diseases medically and economically [37]. For example, there is specific 
guidance based on the condition of breast cancer, more specifically in advanced (stage 
4) breast cancer [38]. The pathway is presented as an interactive flowchart, which 
includes information and support, imaging assessment, pathological assessment, and 
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the management of a person with suspected advanced breast cancer. The NICE 
guidance is a high level standard that needs to be broken down into a detailed level 
suitable to specific practices in hospitals.  
The Leeds Health Pathways (LHP) [39] are a set of local guidelines adopted by the 
LTHT and other organisations including the Yorkshire Cancer Network. They were 
adopted from the guidelines from various professional bodies including NICE. The 
LHP is provided as part of the clinical guidelines in the LTHT for patient treatment 
in various diseases. In gynaecology, for example, it provides guidelines for abnormal 
bleeding (post-menopausal/pre-menopausal), management of premenstrual 
syndrome, and lumps and bumps, among others. The guideline includes background 
information or scope of pathway, information resources for patients and carers, 
development and updates to the pathway, and referral forms. More details referring to 
the LHP about specific types of cancer are presented in Sections 2.1.6. 
Understanding the guidelines and ontology of the healthcare domain is a part of this 
study, as a reference in discovery and conformance checking steps. Generally, ICD 
codes are used to code diagnoses and procedures, while the NICE pathways and the 
LHP are useful as guidance of patient treatment. It is important to check if the 
discovered process models are conforming to the guidelines used in the healthcare 
processes to assess the quality of the guidelines and possibly find best practices. 
2.1.5 Cancer  
Cancer is a leading cause of death worldwide. There were an estimated 9.6 million 
deaths caused by cancer in 2018 [40]. The five most common causes of cancer death 
are breast, colorectal, liver, lungs and stomach cancers. In the UK, cancer is the fourth 
leading cause of death [12]. There are around 164,000 cancer deaths every year 
(2014–2016), with the most common being lung, bowel, breast, and prostate cancers 
[41]. 
Cancer is a group of diseases involving abnormal cell growth. Cancer has the potential 
to invade or spread to other parts of the body [42]. Other terms used are malignant 
tumours and neoplasms. Cancer is a genetic disease caused by changes to the genes 
that control how cells grow and divide. A cancer that spreads from the original place 
to another place in the body is called metastatic cancer [43]. Most cancers are 
recognised through the presenting symptoms or through screening. The definitive 
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diagnoses would require the examination of a tissue sample by a pathologist. There 
are more than 100 types of cancer, which are named from the organs or tissues where 
the cancers form. 
The general guidance for cancer contained in the NICE guidelines is NG12 for 
suspected cancer: recognition and referral [44]. This guideline outlines appropriate 
investigations in primary care on children, young people, and adults with symptoms 
that could be caused by cancer. The recommendations are organised by the site of the 
suspected cancer, the symptom, and the findings of primary care investigations. The 
guideline is provided for healthcare professionals, people involved in clinical 
governance in both primary and secondary care, and also for people with suspected 
cancer and their families and/or carers. 
2.1.6 Cancer types 
The following sections discuss the three types of cancer analysed in this study, which 
are colorectal, breast, and endometrial cancers. The selection was based on 
discussions with clinical experts to get representative cohorts of cancer patients in 
those three datasets. 
2.1.6.1 Colorectal cancer 
Colorectal cancer is cancer that develops from the colon or rectum (part of the large 
intestine). It is also known as bowel cancer, colon cancer, or rectal cancer. The risk of 
getting colorectal cancers is increased by old age and lifestyle factors. Less than 5% 
of cases are due to genetic disorders. The five year survival rate in the United States 
is around 65%. Globally, colorectal cancer is the third most common type of cancer, 
making up about 10% of all cases [45]. 
Diagnoses may be obtained through a physical exam and history, faecal occult blood 
test (FOBT), x-rays, sigmoidoscopy or colonoscopy, followed by medical imaging 
[46, 47]. Surgery is the most common treatment for all stages, especially for cancers 
that are confined within the wall of the colon.  The other types of treatment such as 
chemotherapy and immunotherapy are undertaken in specific conditions. In people 
with incurable colorectal cancer, palliative care is recommended. Palliative care can 
consist of procedures to relieve symptoms or complications from the cancer but do 
not attempt to cure the underlying cancer. 
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2.1.6.2 Breast cancer 
Breast cancer is the development of cancer from breast tissue. Globally, breast cancer 
affects about 12% of women and is the most common cancer in women. The risk of 
breast cancer is increased by many factors, including a family history of breast cancer. 
It is sometimes caused by BReast CAncer (BRCA) gene mutations [48]. 
There are 34 guidance points, 4 pathways, 2 quality standards, and 8 advice points 
contained in the NICE guideline for breast cancer. Most of them are related to specific 
treatment or diagnostics guidance. The general guidance topics are: Advanced breast 
cancer diagnosis and treatment (CG81) [49]; Familial breast cancer (CG164) [50]; 
and Suspected cancer recognition and referral (NG12) [44]. The LTHT guidelines for 
the treatment pathway of breast cancer is started with a referral from a GP or other 
source [51]. Breast cancer is diagnosed by physical exam, mammogram, ultrasound, 
MRI, blood chemistry studies, and biopsy of the affected area of the breast. Surgery 
is the main treatment for breast cancer, which may be followed by chemotherapy or 
radiation therapy, or both. There might also be adjuvant therapy and neoadjuvant 
therapy applied. Adjuvant therapy is drug used after and in addition to surgery, while 
neoadjuvant therapy is chemotherapy or other types of therapy before surgery. 
2.1.6.3 Endometrial cancer 
Endometrial cancer is a uterine cancer that begins in the inner uterine lining 
(endometrium) because of an abnormal growth of cells that then can spread to other 
parts of the body. This is the third most common cause of death in cancers (newly 
occurred in 320,000 women in 2012) which only affect women, after ovarian and 
cervical cancer. This mostly occurs in women between the ages of 60 and 70. The 
most frequent type of endometrial cancer (80%) is endometrioid carcinoma [52]. 
There is only one NICE guidance point specific for endometrial cancer, that is the 
laparoscopic hysterectomy for endometrial cancer, published in September 2010 [53]. 
This is a surgical procedure to remove the uterus. The more general guideline related 
to endometrial cancer is the NICE guideline NG12 for suspected cancer: recognition 
and referral [44]. The LTHT guidelines for the treatment pathway of endometrial 
cancer is started with a referral from a GP to post-menopausal bleed clinic [54]. It is 
triaged by the benign Gynaecology team. Some tests are done including ultrasound 
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and hysteroscopy. If cancer is confirmed, the most common treatment is surgery, with 
consideration for radiotherapy or chemotherapy for special cases. 
2.1.7 Cancer waiting times 
One important performance indicator for cancer treatment in the UK is the cancer 
waiting time. The NHS has set maximum waiting time standards for cancer treatment. 
The achievement of the national cancer waiting times is considered to be an indicator 
of the quality of cancer diagnosis, treatment, and care. There are some standards for 
waiting times for cancer [12], including: 
1. 14-day (two weeks) wait. This requires patients who had an urgent GP referral for 
suspected cancer to be first seen by a specialist within two weeks. This is targeted 
to support early diagnosis in order to spot cancer early and improve survival.  
2. 31-day wait. This requires patients to receive their first cancer treatment within 
31 days of a decision to treat. It is also required for a maximum 31-day wait for 
subsequent treatment where the treatment is surgery, or is a course of 
radiotherapy, or is an anti-cancer drug regimen. 
3. 62-day wait. This requires patients to wait for no more than two months (62 days) 
between the date of an urgent GP referral for suspected cancer or an NHS cancer 
screening service and the first definitive treatment for cancer. There are also 
requirements for a maximum 62-day wait for the first definitive treatment 
following a priority upgrade of the patient for all cancers. 
In the UK, cancer waiting times data are collected from NHS providers in monthly 
and quarterly reports. These reports are used to monitor cancer waiting times targets 
and plan service improvements. Summary of overall performance against all cancer 
waiting time standards in 2018-2019 ranged from 79.1% to 99.3%. The lowest 
performance (79.1%) was for the 62-day wait for first treatment following an urgent 
GP referral for all cancers. The highest performance (99.3%) was for the 31-day wait 
for second or subsequent treatment on anti-cancer drug treatments [55]. 
Understanding cancer waiting times standards is important in this study as a starting 
point to understand the important quality indicator of cancer treatment. Pathway 
analysis with a process mining approach is useful to examine factors contributing to 
the achievement of these standards. 
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2.2 Technical background 
The literature reviewed in this technical background section starts with an overview 
of workflow technology and process modelling. Workflow technology is the root of 
process mining, both aim to analyse the sequence of activities in a process and create 
a process model based on the sequence. It is then followed with a focus on process 
mining, process mining in healthcare, and process mining to analyse process change 
analysis. This section is closed with a presentation of the statistical approaches used 
in this study. 
2.2.1 Workflow technology and process modelling 
Workflow technology was formalised by the Workflow Management Coalition 
(WfMC) through the Workflow Reference Model [56]. The WfMC was founded in 
1993 and is a global organisation of adopters, developers, consultants, analysts, as 
well as university and research groups working in workflow and BPM. The 
formalisation of the Workflow Reference Model was followed by the Workflow 
Patterns initiative, started in 1999 [57], as a conceptual basis for workflow technology 
and process modelling.  
A workflow management system is a system that defines and manages processes 
through the software whose order of execution is driven by a computer representation 
of the workflow process logic [60, 62]. Historically, models of the workflow have 
spanned from the very informal to the very formal. Other pieces of literature use the 
term “business process” or “process” to refer to “workflow”. 
There are many approaches for representing processes, such as state transition 
diagrams [59], Unified Modelling Language (UML) [69, 70], Business Process 
Modelling Notations (BPMN) [62] and Petri nets [63]. All of these process model 
types are useful for different purposes, for example, to view the process from various 
angles, to structure discussions among stakeholders, to analyse performance, or to 
“play out” different scenarios and provide feedback. Each of these four process 
modelling notations (state transition diagram, UML, BPMN, and Petri nets) are 
described in more detail in Section 2.2.2. 
  
- 26 - 
2.2.2 Process modelling notations 
In process modelling, many notations can be used, including transition systems, UML 
activity diagrams, BPMNs, and Petri nets. Each of these notations is described in this 
section along with an example for a typical pathway to illustrate the similarity and 
differences. 
1) Transition system diagram 
The most basic process modelling notation used is a transition system or state 
transition diagram. It consists of states and transitions, which may be marked with 
labels chosen from a set [64]. The formal definition of a transition system is a set of 
states, activities, and transitions (S, A, T) [4]. A state is an identifier with a unique 
label. A transition connects two states and is labelled with the name of an activity. A 
transition from state p to state q is written as p à q. The states are represented by 
black circles, the actions by directed arcs, and the transitions connected two nodes by 
an arc. Multiple arcs can have the same label. 
Figure 2.1 shows an example of a transition system modelling six defined activities 
in a hospital administration process of a cohort of patients. The formal definition is as 
follows: S = {S1, S2, S3, S4, S5, S6, S7, S8}, Sstart = {S1}, Send = {S8}, A = {ED reg, 
admission, ED out, discharge, death, death|discharge} and T = {(S1, ED reg, S2), 
(S2, ED out, S3), (S2, ED out, S4), …, (S7, discharge, S8)}. 
 
Figure 2.1 A transition system example. Transitions represent activities in the process 
flowing from one state to the other. The modelled process flows from START to END. 
 
Any process model with executable semantics can be mapped into a transition system. 
Transition systems are simple but have limitations to express concurrency [65]. Given 
the concurrent nature of business processes, there are a variety of options for more 
expressive models. 
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2) Unified Modelling Language Activity Diagrams (UML ADs) 
UML AD is one of the UML diagram types, which consist of structural diagrams and 
behaviour diagrams. The UML structural diagrams represent the static view of a 
system model, which include a class diagram, component diagram, and deployment 
diagram. The UML behaviour diagrams represent the dynamic view of a system 
model, which include a sequence diagram, activity diagram, and state machine 
diagram [61]. All of these diagrams were created to standardise the design of a system. 
A UML AD is constructed from a number of shapes connected with arrows. The 
actions are represented by rounded rectangles, decisions represented by diamonds, the 
start (split) or end (join) of concurrent activities represented by bars, the start (initial 
state) of the workflow represented by a black circle, and the end represented by an 
encircled black circle. In process modelling, actions are also known as activities. 
There is also a possibility to represent multiple actors involved in a process through 
the swim lanes. A swim lane is a visual representation of a route through the activity 
diagram which represents the activities performed by a particular set of actor(s). 
Figure 2.2 shows a UML activity diagram of the same hospital administration process. 
This diagram consists of six actions (admission, ED reg, ED out, death | discharge, 
death, discharge) with one pair of concurrent activities, and three decisions.  
 
Figure 2.2 A UML activity diagram. Rounded rectangles represent the activities, diamonds 
represent the decisions. The modelled process flows from a black circle as the START to a 
encircled black circle as the END. 
 
One advantage is that this diagram follows the UML modelling language that is 
intended to provide a standard way to visualise the design of a system. It can be seen 
as a combination of a structured flowchart with a traditional data flow diagram. If a 
typical flowchart cannot express concurrency, the join and split symbols in the UML 
activity diagrams can resolve this. Therefore, it is easily understood by both analysts 
and stakeholders. This diagram can also be mapped into a state transition diagram or 
a flowchart [66]. 
- 28 - 
3) Business Process Modelling Notation (BPMN) 
BPMN was developed by the Business Process Management Initiative (BPMI) and is 
maintained by the Object Management Group (OMG). BPMI was established in 2020 
and is a non-profit organisation that promote the standardisation of common business 
processes. OMG was founded in 1989 and is a consortium that develops a 
heterogeneous distributed object standard. BPMI and UML were merged in 2005. 
BPMN was adopted as a standard by OMG in 2006. BPMN is a standard for capturing 
business processes in system development. [62]. 
An example of a process model in the BPMN notation is shown in Figure 2.3. This 
process model represents a hospital administration process of a cohort of patients. The 
obvious differences compared to the UML AD are in the notations that represent the 
start and end actions, decisions, split and join (and/ or). The use of gateways in BPMN 
makes it simpler than the use of diamonds and bars in the UML AD. 
 
Figure 2.3 A BPMN process model. Rounded rectangles represent the activities, gateways 
represent the decisions. 
 
Both BPMN and UML are managed by OMG, which make both diagrams very similar 
to each other. Both BPMN and UML AD were developed to be equally easy to 
understand by the analysts and the stakeholders [67]. BPMN emphasises the 
possibility to model different events and exceptions for routing a process. This makes 
BPMN is suitable to model clinical pathways in healthcare domain [68, 69].  
4) Petri Nets 
A Petri Net is a process modelling technique invented by Carl Adam Petri [63]. Since 
then, Petri Nets have been used to model and analyse many kinds of processes. Petri 
Nets are widely used for workflow modelling [75, 76] because of the clear and precise 
formal semantics, intuitive graphical nature, basic properties, and the availability of 
many analysis techniques.  
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An example of a Petri Net showing the hospital administration process of a cohort of 
patients is presented in Figure 2.4. It consists of places and transitions, connected by 
arcs from a place to a transition or vice versa. 
 
Figure 2.4 A Petri Net. Empty nodes are places and rounded rectangles are transitions that 
represent the transitions of activities in the event log. 
As described above, a large number of process modelling notations can be used as 
care pathway modelling techniques in healthcare research. Process models can be 
used for many purposes, such as: to structure discussions with stakeholders from 
several backgrounds; to support documentation; to verify and find errors in a process; 
to analyse performance; or to configure a system [4]. In this study, process models 
are used in the process discovery task of process mining based on the data recorded 
in the event log. 
2.2.3 Process mining 
The development of workflow technology was continued by the establishment of the 
Institute of Electrical and Electronics Engineers (IEEE) Task Force on Process 
Mining in 2009 [3]. This task force promotes the research, development, education 
and understanding of process mining. The term “process mining” was coined by van 
der Aalst to describe a specific type of workflow analysis and has been used widely 
since 2003. Process mining joins the ideas of process modelling and analysis on one 
side and data mining and machine learning on the other side.  
The idea of process mining is to discover, monitor, and improve real processes by 
extracting knowledge from event logs readily available in the information systems 
[72]. The processes being analysed are the real processes as they were recorded in the 
information systems, not the assumed processes. The goals of process mining are to 
detect previously unknown process structures, to analyse the occurrence of process 
pathways in the system, or to quantify the conformance of the process to guidelines 
[73]. Three general steps of process mining are process discovery, conformance 
checking, and enhancement. Each of those will be explored in this section. 
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Process mining can be done from several perspectives [74]: 
• The control-flow perspective focuses on the ordering of activities. 
• The organisational perspective focuses on how resources (e.g. people, systems, 
roles, and departments) are involved and related. 
• The case perspective focuses on the properties of cases. A case can be 
characterised by its path in the process, by the actors working on it, or by the 
values of the corresponding data elements. 
• The time perspective is concerned with the timing and frequency of events. 
The main focus of this research is the control-flow perspective to understand the 
patterns of activity sequences. However, an additional perspective is needed in this 
research, which is the time perspective, to analyse the process change over time. 
2.2.3.1 Process discovery 
Process discovery is the most common and challenging task in process mining 
projects to create a process model based on traces captured in the event log. Some 
algorithms have been proposed for this process discovery task. The models can be 
presented following notations mentioned in Section 2.2.1 such as transition systems, 
UML activity diagrams, BPMN, or Petri Nets. These models could then be used for 
conformance checking, enhancement, and further analysis. The main algorithms for 
process discovery are: 
1) Alpha (α) miner  
The α algorithm [75] is one of the first process discovery algorithms that can handle 
concurrency. This algorithm receives an input of an event log and returns an output 
of a Place/Transition net (P/T-net). The α algorithm checks the relationships of two 
activities, e.g. if a task is always followed by another task, it is likely that there is a 
causal relation between them. The algorithm marks the relationships as: follows (>), 
causality (à), parallel (||), or choice (#). Those relationships are formalised as follow. 
Let W be an event log over T, i.e., 𝑊	 ⊆ 𝑇∗. Let 𝑎, 𝑏	 ∈ 𝑇: 
1. Follows relation: 𝑎 >" 𝑏 iff there is a trace 𝜎 = 𝑡#	𝑡%𝑡&	…	𝑡'	and 𝑖	 ∈
{1, … , 𝑛 − 1} such that 𝜎 ∈ 𝑊 and 𝑡#	 = 𝑎 and 𝑡()#	 = 𝑏, 
2. Causality relation: 𝑎 →" 𝑏 iff 𝑎 >" 𝑏 and 𝑏 ≯" 𝑎, 
3. Parallel relation: 𝑎 ∥" 𝑏 iff 𝑎 >" 𝑏 and 𝑏 >" 𝑎, and 
4. Choice relation: 𝑎#"𝑏 iff 𝑎 ≯" 𝑏 and 𝑏 ≯".  
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These marked relationships are then used to create a process model. The resulting 
process model contains activities with ingoing arcs and outgoing arcs. 
The advantage of the alpha miner is its ability to work on a structured process. The 
limitation is that it is really depends on the relationship between two tasks. It means 
that this algorithm cannot correctly mine incomplete and/or noisy event logs and 
cannot detect the occurrence of duplicated tasks in a process. The alpha algorithm 
infers wrong relationships in incomplete and/or noisy event logs. Duplicate tasks will 
never be captured by the alpha algorithm because they will have the same label [76].   
2) Fuzzy miner 
A fuzzy miner [77] was proposed to overcome problems with unstructured processes. 
This algorithm uses the concept of significance and correlation metrics to simplify 
views of a process at a suitable level of abstraction. Significance measures the relative 
importance of activities (nodes) and/or their relations (edges). It can be defined based 
on the level of interest. Correlation measures how two events following one another 
are closely related. In the simplified model, the algorithm preserves highly significant 
activities and activity relations (behaviours), aggregates less significant but highly 
correlated behaviours, and abstracts other behaviours.  
The fuzzy miner works based on an approach to measure long-term relationships. For 
example, when the sequence A,B,C is found in an event log, the relations are not only 
Aà B and Bà C, but also the length-2-relationship Aà C. Subsequently, this 
algorithm applies three transformation methods to the process model, which are 
conflict resolution, edge filtering, and aggregation and abstraction. The conflict 
resolution solves the problem of conflicting nodes, which include length-2-loops (e.g. 
Aà Bà Aà B), exception (e.g. most of the time AàB but there are also insignificant 
Bà A), and concurrency (i.e. if A and B can be in any order). The edge filtering 
approach evaluates each edge Aà B by its utility, which is a weighted sum of its 
significance and correlation. This is formulated as 𝑢𝑡𝑖𝑙(𝐴, 𝐵) = 𝑢𝑟. 𝑠𝑖𝑔(𝐴, 𝐵) +
(1 − 𝑢𝑟). 𝑐𝑜𝑟(𝐴, 𝐵), where 𝑢𝑟 ∈ [0,1] is a configurable utility ratio. A larger value 
for ur will preserve more significant edges, while a smaller value will only include 
highly correlated edges. The aggregation and abstraction step preserves highly 
correlated groups of less-significant nodes as aggregated clusters and removing 
individual less-significant nodes, based on the node cut-off parameter. This approach 
results in an adjustable level of abstraction of process models. 
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3) Inductive miner 
An inductive miner (IM) [78] is a process discovery framework based on process trees 
as hierarchical representations of process models. A process tree is an abstract 
representation of a block-structure network. The IM works by recursively selecting 
the root operator that best fits the event log, dividing the activities in the log into 
disjoint sets, and splitting the log using those sets into sub-logs. IM can handle 
infrequent behaviour and deal with huge models and numbers of event logs. The 
limitation is that an IM often produces models with high fitness but low precision due 
to over-generalised behaviours within the log. 
There are some variants of Inductive Miner, including the Inductive Miner – 
infrequent (IMf), Inductive Miner - incompleteness (IMc), and Inductive Miner – life 
cycle (IMlc). The IMf proposed to add infrequent behaviour filter based on the Pareto 
principle (80-20 rule) to create an 80% model by filtering out the infrequent activities. 
Compared to IM, models discovered by IMf have a lower fitness, higher precision, 
equal generalisation and comparable simplicity [79]. The IMc proposed probabilistic 
behavioural relations to make IM less sensitive to incompleteness [80]. The IMlc 
handles life cyle data and distinguishes concurrency and interleaving.  
Inductive miner and its variants have also been implemented as a plugin in ProM (see 
Section 2.2.3.5). The output of the ‘Mine Petri net with inductive miner’ is a Petri net, 
while the output of the ‘Mine process tree with inductive miner’ is a process tree. A 
process tree is a hierarchical representation of a process model. The root is ‘seq’ 
represents sequence/ order of all of its children, with the leaves represent the activities 
connected by some operators. Those operators are xor (one of its children need to be 
executed), or (at least one of its children needs to be executed), and (all of its children 
need to be executed in any order), concurrent (all of its children need to be executed 
and may overlap in time), and loop (the first child must be executed and followed by 
a choice to terminate or execute the second child and the first child, and make the 
same choice again). 
For example, the event log from experiment 1 in case study 1 as discussed in Section 
4.3, can be processed using IM and resulted in a process tree or in a statechart as 
presented in Figure 2.5. 
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Figure 2.5 An example of a process tree. The root ‘seq’, with the leaves represent the 
activities connected by operator xor, or, and, or concurrent.  
The process tree can later be visualised as a process tree itself, as a BPMN, as a state 
chart, or as a Petri net, using the ‘Convert process tree to Petri net’ plugin. Inductive 
miner provides an expressive sematics to create process a model as a process tree, 
which is convertible into other notations. 
4) Heuristics miner 
A heuristics miner algorithm [81] focuses on calculating dependency and trace 
frequencies of events in building a process model. This algorithm consists of three 
steps: (1) Constructing a dependency graph based on the event log, (2) Establishing 
the input-output expressions based on the type of dependencies between activities, 
and (3) Discovering the long-distance dependency relations.  
In step 1, a dependency graph is created by analysing causal dependencies. The causal 
dependencies in a heuristics miner can be seen as an extension of the alpha algorithm. 
Let W be an event log over T, i.e., 𝑊	 ⊆ 𝑇∗. Let 𝑎, 𝑏	 ∈ 𝑇: 
1. Directly follows relation: 𝑎 >" 𝑏 iff there is a trace 𝜎 = 𝑡#	𝑡%𝑡&	…	𝑡'	and 𝑖	 ∈
{1, … , 𝑛 − 1} such that 𝜎 ∈ 𝑊 and 𝑡#	 = 𝑎 and 𝑡()#	 = 𝑏, 
2. Dependency relation: 𝑎 →" 𝑏 iff 𝑎 >" 𝑏 and 𝑏 ≯" 𝑎, 
3. Never follow relation: 𝑎#"𝑏 iff 𝑎 ≯" 𝑏 and 𝑏 ≯" 𝑎, and 
4. Concurrent relation: 𝑎 ∥" 𝑏 iff 𝑎 >" 𝑏 and 𝑏 >" 𝑎, 
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5. Short loop: 𝑎 ≫" 𝑏 iff there is a trace 𝜎 = 𝑡#	𝑡%𝑡&	…	𝑡'	and 𝑖	 ∈ {1, … , 𝑛 − 2} 
such that 𝜎 ∈ 𝑊 and 𝑡#	 = 𝑎 and 𝑡()#	 = and 𝑡()%	 = 𝑎, 
6. Long distance dependencies: 𝑎 >>>" 𝑏 iff there is a trace 𝜎 =
𝑡#	𝑡%𝑡&	…	𝑡'	and 𝑖 < 𝑗 and 𝑖, 𝑗	 ∈ {1, … , 𝑛} such that 𝜎 ∈ 𝑊 and 𝑡#	 = 𝑎 and 
𝑡*	 = 𝑏. 
The additional feature proposed in heuristics miner compared to alpha miner is the 
frequency-based metrics, to indicate the certainty of dependency relation between two 
activities A and B. In step 2, a causal matrix is then built to map the input-output 
expressions based on the type of dependencies between activities. In step 3, long 
distance relationships are considered to be included in the final process model. 
The heuristics miner is one of the algorithms with a good performance in process 
mining [82]. It can be used to discover the main behaviour recorded in an event log. 
This algorithm can handle noise and incomplete event logs. Heuristics miner has also 
been implemented as a plugin in ProM as described in Section 2.2.3.5.  
Heuristics miner is also the basic algorithm of the interactive Data-aware Heuristics 
Miner (iDHM) [83], which improved this algorithm with an interactive parameter 
setting and a built-in conformance checking. This plugin accepts an event log as the 
input and can produce many results in an interactive manner. Process models can be 
presented as a directly-follows graph, a dependency graph, a causal net, a data causal 
net, a data Petri net, and a Petri net. This plugin can export the resulting model for 
further analysis. 
2.2.3.2 Conformance checking 
Conformance checking is the second common task in process mining that focuses on 
checking if the event log conforms to the model and vice versa [4]. The model can be 
discovered through process mining or created based on the standard expected from 
the process. This checking can be used to detect, locate, and explain deviations, to 
quantify trace variants, and to measure performance of the model. When a case in the 
log does not conform to the model (or the other way around), it can be analysed 
whether the model does not reflect reality or if the case deviates from the model. 
There are four main criteria to evaluate the quality of the discovered model in process 
mining, which are fitness, precision, generalisation, and simplicity [79, 87]. These 
four metrics are computed on a scale from 0 to 1, where 1 is optimal. A good model 
has high values on all four criteria. Each of those will be described as follows. 
- 35 - 
1) Replay fitness 
A model with a good replay fitness allows the behaviour seen in the event log. This 
means that all traces in the log can be replayed by the model from beginning to end. 
In other words, a fitness of 1 means that the model can reproduce every trace in the 
log. There are various ways of defining fitness at the case level or at the event level. 
The alignment-based fitness metric [85] is the most commonly used in process mining 
that compares the sequences of activities in the event log aligned to the process model 




𝑚𝑖𝑛𝑖𝑚𝑎𝑙	𝑐𝑜𝑠𝑡	𝑡𝑜	𝑎𝑙𝑖𝑔𝑛	𝑒𝑣𝑒𝑛𝑡 log 𝑜𝑛	𝑚𝑜𝑑𝑒𝑙	𝑎𝑛𝑑	𝑣𝑖𝑐𝑒	𝑣𝑒𝑟𝑠𝑎 
where the denominator is the minimal costs when there is no match between the event 
log and process model. Conformance checking to check on trace fitness has also been 
implemented as a plugin in ProM in Section 2.2.3.5. 
2) Precision 
A model is precise if it does not allow for too much behaviour and it is not 
underfitting. An underfitting model allows for behaviours very different from what 
was seen in the log. A precision of 1 indicates that any trace produced by the model 
is contained in the log. 
The alignment-based precision metric [85] calculates based on an aligned event log 
and compares the number of different activities that occurred to the total number of 




where the context is related to the level of precision being measured, i.e. in the log 
level or the case level. Conformance checking to check on precision and 
generalisation has also been implemented as a plugin in ProM as described in Section 
2.2.3.5. 
3) Generalisation 
A model should generalise and not restrict behaviour to the traces seen in the event 
log [86]. A model that does not generalise is “overfitting”, which means that it 
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specifically fits only the examples in the event log. In a tree representation, consider 
the frequency of each node to be visited to produce the given log. The formula is as 
follows: 
𝑄. = 1 −
Σ'/012(√#𝑒𝑥𝑒𝑐𝑢𝑡𝑖𝑜𝑛𝑠)3#
#𝑛𝑜𝑑𝑒𝑠	𝑖𝑛	𝑡𝑟𝑒𝑒  
The alignment-based generalisation is related to alignment-based fitness and 
alignment-based precision.  
4) Simplicity 
This metric is based on the fact that the best model is the simplest model that can 
explain the behaviour seen in the event log [86]. Simplicity can be measured through 
complexity, with the lower complexity representing the more simple model. The 
complexity of a model can be measured by the number of nodes and arcs in the graph. 
In a tree representation, this can be measured by comparing the size of the tree with 
the number of activities in the log. If each activity is represented exactly once in the 
tree, the simplicity is high. This is represented by the following formula. 
𝑄2 = 1 −
#𝑑𝑢𝑝𝑙𝑖𝑐𝑎𝑡𝑒	𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑖𝑒𝑠 + #𝑚𝑖𝑠𝑠𝑖𝑛𝑔	𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑖𝑒𝑠
#𝑛𝑜𝑑𝑒𝑠	𝑖𝑛	𝑝𝑟𝑜𝑐𝑒𝑠𝑠	𝑡𝑟𝑒𝑒 + #𝑒𝑣𝑒𝑛𝑡	𝑐𝑙𝑎𝑠𝑠𝑒𝑠	𝑖𝑛	𝑒𝑣𝑒𝑛𝑡	𝑙𝑜𝑔 
The effort to make the model simpler is mostly related to pre-processing the steps, for 
example, by filtering the activities included in the process discovery. 
2.2.3.3 Enhancement 
The third task in process mining is enhancement. The idea of enhancement is to adapt 
the target process model to better reflect the reality based on process dicovery and 
conformance checking tasks. This task repairs or extends the discovered process 
model using additional information from different perspectives of the process 
recorded in the event log.  
The first type is process model repair. A model might need to be repaired to comply 
with the real execution of the process. For example, if the model shows two sequential 
activities that in reality can happen in any order, the model may be corrected to reflect 
the reality. The second type is the extension, where additional perspectives are 
considered to improve the discovered process model, such as the data perspective, the 
resource perspective, and the performance perspective. 
- 37 - 
2.2.3.4 Process mining methodology 
This section presents several process mining methodologies from the literature. The 
first formal process mining methodology is the L* life-cycle model, published by the 
process mining community in the process mining manifesto in 2011 [3]. This model 
has been further improved as a Process Mining Project Methodology (PM2) [15], to 
support iterative analysis. Other methodologies are the Process Diagnostics Method 
(PDM) [87] to discover several perspectives of a business process and Business 
Process Analysis in Healthcare environments (BPA-H) [88] for the healthcare 
domain. Another methodology proposed in healthcare process mining is the Question-
Driven Methodology [89] that focuses on the importance of defining questions to be 
answered with process mining. Related work by Zhou et al. [90] proposed a 
framework where a business process is continuously optimised using process mining. 
The ClearPath method [91] extended the PM2 with a process simulation approach, 
which is beneficial in engaging with domain experts. 
All those methodologies can be related to the general data mining method, such as the 
Cross-Industry Standard Process for Data Mining (CRISP-DM) [92]. CRISP-DM is 
the most widely-used analytics model in data mining projects. This model breaks the 
process of data mining into six major phases: business understanding; data 
understanding; data preparation; modelling; evaluation; and deployment. An 
overview of the main process mining methodologies is as follow. 
1) L* Life-cycle model 
The L* life-cycle model [3] is the first model proposed for process mining projects. 
This model covers the five stages of a process mining project. The Planning and 
justification (Stage 0) is to understand the data and the domain. The process mining 
team needs to extract the event data, models and other inputs (Stage 1). Those inputs 
are needed to create a control-flow model and connect the event log (Stage 2). When 
the process is structured, the next step is to create integrated process model (Stage 3). 
The insights can be used for operational support (Stage 4).  
The L* life-cycle model is useful as a basic sequential methodology. This model 
provides a general description of each of its stages, making it more flexible in 
covering different techniques and methods, but the description is not technical enough 
to be implemented directly. Another limitation is that the L* life-cycle model does 
not explicitly encourage iterative analysis. 
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2) Process Mining Project Methodology 
The Process Mining Project Methodology (PM2) [15] consists of six stages. The 
Planning (Stage 1) aims to set up the project by identifying research questions, 
selecting business processes, and composing the project team. The Extraction (Stage 
2) contains three activities, which are: determining the scope, extracting event data, 
and transferring process knowledge. The Data Processing (Stage 3) is then done by 
creating views, aggregating events, enriching event logs, and filtering logs. The 
Mining and Analysis (Stage 4) includes process discovery, conformance checking, 
enhancement, and process analytics. The Evaluation (Stage 5) is to diagnose, verify 
and validate the analysis findings to improvement ideas based on the project goals. 
The results would be used in Process Improvement and Support stage (Stage 6) to 
modify the actual process execution. The main stages in PM2 are shown in Figure 2.6. 
 
Figure 2.6 The overview of PM2 methodology.  Reproduced from [15]. The key components 
are listed under them main diagram and the key stakeholders on the top right. 
 
This methodology was designed to support process mining projects aiming to improve 
process performance or compliance with rules and regulations. This methodology is 
suitable for both structured and unstructured processes. The PM2 methodology is 
highly iterative and emphasises the need for collaboration between process analysts 
and business experts. It also provides detailed guidance in every stage, which makes 
it more actionable in real projects. Both L* life-cycle model and the PM2 methodology 
are adopted in this study, with more specific approaches needed to adjust to the 
specific purpose of the experiments. 
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3) Question-driven methodology 
This methodology was proposed by Rojas et al. [89] as an approach for healthcare 
process mining. Healthcare process mining needs to provide answers to frequently-
posed questions about processes in the healthcare system. This methodology contains 
six stages and each one of those is described in the following paragraph. 
The data extraction (Stage 1) contains an identification of available data in the 
Hospital Information System (HIS), ensuring the availability, and verifying the data 
quality. This includes the identification of frequently-posed questions from the 
domain experts. The questions drive the steps in the next stages. The event log 
creation (Stage 2) identifies specific data needs, creates the event log, and includes 
characteristics of each activities. The filtering (Stage 3) covers basic, clinical, and 
question-driven filtering. The data analysis (Stage 4) includes the selection of data, 
statistical, and data mining analyses. The process mining (Stage 5) includes 
identifying the tool, data analysis and process mining cycle. The results evaluation 
(Stage 6) identifies domain experts, defines feedback instruments, and obtains 
feedback. 
4) ClearPath method 
This method was proposed by Johnson et al. [91] by extending the PM2 method with 
a process simulation approach to address issues of poor quality and missing data. This 
approach is also useful to support stakeholder engagement. The main stages follow 
those in PM2. The main difference is that clinical experts were engaged as 
interviewees within an iteration and/or in the Clinical Review Board at the end of each 
iteration. It is suggested that this be done through the use of simulations. In this study, 
the idea of engaging clinical experts within an iteration is done through discussions 
providing the visualisations resulted from process mining approaches. 
In this research, the L* life-cycle model and the PM2 method are referred to 
as two well-known base methodologies. The basic stages are following those of the 
L* life-cycle model. The iteration approach and detailed steps of the data processing 
were derived from the PM2. Other methods including the question-driven method and 
ClearPath method were used in the detailed steps within the stages. More details about 
the general methodology followed in this study are described in chapter 3. Some 
additional methods applied and described in specific experiments. 
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2.2.3.5 Process mining tools 
Process mining tools range from the commercial software to open-source, from 
implementation of one algorithm to a framework for many algorithms. Some 
important tools are presented in this section. 
1) DISCO 
DISCO is a commercial software for process mining produced by Fluxicon [93]. It is 
a visualisation tool with process models and metrics compatible with ProM. DISCO 
is focused on being a tool to create visual maps from process data, optimise the 
performance, control deviations, or explore variations. DISCO is based on the fuzzy 
miner [77] with several improvements in scalability and robustness. The fuzzy miner 
allows for simplification and abstraction based on the activities and paths. Further 
discussion on the fuzzy miner is presented in Section 2.2.3.1. 
2) ProM framework 
ProM is an open-source process mining framework used for academic purposes that 
combines different tools and algorithms on the same dataset and compares the mining 
results [94]. This framework accepts event log input in an XES, MXML, CSV, and a 
generic eXtensible Markup Language (XML) format, typically contained in an audit 
trail or transaction log of some complex information systems. Process discovery and 
conformance checking can be done using several plugins in ProM. The ProM 
framework allows for interaction between a large number of plugins. A plugin is a 
module that implements an algorithm, where the implementation agrees with the 
framework. Some plugins are provided for import, export, mining, analysis, and 
conversion purposes. Some process discovery plugins used in this study are described 
in more detail in Section 2.2.3.1. 
3) The bupaR packages in R  
bupaR is an open-source suite to handle and analyse business process data in R. It was 
developed by the Business Informatics research group at Hasselt University, Belgium. 
The bupaR packages provide R libraries to explore and visualise event data and 
monitoring processes [95]. The main package is bupaR, which provides the basic 
functionality for handling event data. The other supporting packages are included for 
exploratory and descriptive analysis, reading and writing eXtensible Event Stream 
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(XES) files, creating process visualisations, and creating process dashboards. More 
details about bupaR are given in Appendix F.2. 
This study uses ProM as the main tool for process mining because its plugins 
support many types of analysis in this study. DISCO and bupaR packages are used as 
supplemental tools. DISCO was used because of the simplicity of use, while bupaR 
is used because of the availability in R supports a huge range of functionalities. 
2.2.4 Process mining in healthcare 
Process mining has been useful to analyse healthcare processes for process discovery 
from event logs [101, 102], for conformance checking [98], and for mapping 
resources to processes [78, 104]. Previous studies found that process mining 
algorithms are not sufficiently efficient for unstructured processes [100]. Most mining 
algorithms have problems in analysing event data from clinical workflows, either due 
to difficulties in constructing a valid process model or in reflecting reality in the 
models [73]. Despite the flaws, the concept of process mining carries great potential 
in helping to analyse clinical workflows and their variations. This sets a strong 
background to improve currently available process mining techniques for clinical 
pathway analysis. 
A previous review was done by Eric Rojas et al. [101] on process mining in healthcare. 
They found that most process mining case studies in healthcare were in oncology. 
However, there were only four different oncology datasets at the time of the review, 
including the dataset in the Business Process Intelligence Challenge (BPIC) 2011. 
This finding suggests that there is a great opportunity to find other oncology datasets 
to be analysed using process mining with a wider range of clinical questions. This 
review suggested three main algorithms, in process mining for healthcare, which are 
fuzzy miner [77], heuristics miner [81], and trace clustering [102]. 
2.2.4.1 Process mining in oncology 
As part of this study, a systematic review of previous studies using process mining in 
oncology has been published [25]. This section summarised that paper.  
This systematic review was done in July 2016 to analyse the current literature based 
on the following query: 
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(“process mining” OR “data mining” OR “machine learning” OR 
“pathway analysis”) AND (“event log” OR “patient flow”) AND 
(“oncology” OR “cancer”) 
There were 758 papers retrieved in Pubmed, BMJ Open, Journal of Clinical 
Oncology, ACM DL, and Google Scholar. Three steps were undertaken to find the 
most related papers: title-based, abstract-based, and full-text filtering. In each step, 
the article was included if it was: (i) no duplication, (ii) a peer-review conference 
paper or journal article, and (iii) relevant to process mining in oncology. At the end 
of the filtering steps, in-depth ancestor search was performed  to include articles in 
the references of the selected papers. As a result of this, 37 papers were selected. Five 
themes emerged in the study: (1) process and data types; (2) research questions; (3) 
process mining perspectives, types and tools; (4) methodologies; (5) limitations and 
future work. A summary of the results is presented in the following paragraphs.  
(1) The most commonly used dataset was from the BPIC 2011 [103], which was used 
by 24 of the 37 papers. It is an anonymous dataset from the Netherlands which was 
made available for the challenge. The most common cancer type analysed was 
gynaecological cancer (24 papers), all using the BPIC dataset.  
(2) The most common research question was the applicability of process mining in 
the healthcare domain, specifically in oncology. This research question was broken 
down into several questions that included what happened, why did it happen, what 
will happen, and what is the best that can happen. 
(3) All 37 papers applied at least one of three perspectives (control-flow, performance, 
and organisational) and one of three types (discovery, conformance, and 
enhancement) of process mining [3]. All papers, except one [104], discussed the 
control-flow perspective by analysing the pattern of the activity sequences. Most of 
the papers (27 of the 37) discussed the performance perspective, but only 5 discussed 
the organisational perspective. All papers, except two [109, 110], studied discovery 
from a control-flow perspective. In terms of tools, 24 papers used the ProM toolkit 
(www.promtools.org) [94]. ProM toolkit is the de facto standard in the process mining 
research community and can be combined with other tools, such as R Studio and Java 
[106], Alchemy and BUSL [107]. Other papers proposed their own tool [113–120]. 
In case studies other than oncology, process mining was implemented using the 
DISCO commercial tool (www.fluxicon.com/disco), such as in [121–123].  
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(4) Only one paper [119] clearly mentioned the L* life-cycle model as the 
methodology used in the study. Eleven papers [84, 110, 112, 114, 125–132] proposed 
new algorithms and/or techniques. The methodology followed by the other ten papers 
was using available plugins and/or functionalities in existing tools to solve the 
problem in their case study.  
(5) The paper identified data, techniques, and team limitations. Data limitations were 
related to limited access to the data, data quality problems, attributes not available 
from the data being extracted, or the dataset was available in inappropriate levels of 
detail [108, 114, 115, 125–127, 134–136]. Technique limitations were related to the 
chosen functionalities. Team limitations were identified in two papers [136, 137]. 
This systematic review gave insight that process mining is applicable in oncology, 
and there is a great opportunity for this to be improved,especially with regard to the 
technical aspect. This research works on the control-flow and performance 
perspectives. In terms of process mining types, this research will explore discovery, 
conformance checking, and enhancement. The literature review suggested that the 
most widely-used package is the ProM toolkit, which will also be used in this research. 
2.2.4.2 Challenges for process mining in healthcare 
An obvious challenge for process mining in healthcare is the data quality. Process 
mining projects work with event logs, which are automatically generated by the 
information system within a hospital. Data quality issues in process mining as 
discussed in a book by van der Aalst [4] can be related to the quality of the event logs.  
In this study, the quality of data being used in process mining was assessed using 
Weiskopf and Weng framework [133] as a generic data quality assessment approach. 
This framework structures data quality assessment in five dimensions and seven 
methods. The five dimensions are completeness, correctness, concordance, 
plausibility, and currency. The seven methods are comparison with gold standards, 
data element agreement, data source agreement, distribution comparison, validity 
checks, log review, and element presence. 
A previous study by Homayounfar [134] found that the challenging characteristics of 
healthcare processes are that they are complex, multidisciplinary, ad hoc, and 
dynamic. The complexity is mainly caused by the heterogeneity of the diseases, the 
treatments of patients, and the clinical expert judgements. This is also related to the 
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multidisciplinary characteristic of healthcare processes. Treatment of a patient would 
involve hospital departments consisting of many different roles (doctors, nurses, etc.) 
which are highly specialised in their areas.  
The main challenge addressed in this study is related to the ad-hoc and dynamic nature 
of the healthcare processes. Ad hoc changes in healthcare processes are an inevitable 
result of the dynamic nature of the healthcare provision. Those changes can happen 
within different levels of the healthcare system, for example, a new clinical target 
from the government, an introduction of new procedures, or technological 
developments.  
This is related to Leavitt’s diamond [135], where the healthcare data can be seen as 
an output of a complex relation of four forces (structure, process, technology, people). 
The idea is that in any organisation, everything is connected and changing one thing 
can impact another. Those four forces are always changing and affecting each other. 
For example, a change in the technology used in the healthcare information system 
will change the way a task is done by the people in the hospital organisational 
structure. It is therefore not suitable to treat the healthcare process as a static process 
and analysing the changes over time becomes crucial. The four interconnected forces 
of Leavitt’s diamond are illustrated in Figure 2.7. 
 
Figure 2.7 Leavitt’s diamond [135]. It illustrates the four interconnected forces (structure, 
process, technology, people) in healthcare data.  
 
A common analysis of healthcare processes by treating dataset across a long duration 
of time as one static dataset would result in a high number of variants, which is 
difficult to interpret. The dynamic characteristic is especially interesting in this study, 
which further analyses the healthcare process changes over time. Those four forces 
are being analysed through discussions with both clinical- and technical experts. 
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2.2.5 Process mining to analyse process changes 
2.2.5.1 Concept drift 
In process analytics, the process might be changing while being analysed, due to 
periodic/seasonal changes, or due to changing conditions. This condition is known as 
concept drift [136]. Two types of concept drift detection approaches have been used, 
i.e. stream evolution monitoring [142, 143] and data distribution comparison in two 
time windows [144, 145]. 
Three challenges exist when dealing with concept drift. These are:  
1) Change point detection (Did the process change? If so, when?) 
2) Change localisation and characterisation (What has changed?) 
3) Change process discovery (How to unravel the process change?) 
There are four perspectives in business process analysis: control flow, data, resource, 
and time perspectives. One or more of these perspectives may change over time. The 
control flow perspective deals with the behavioural and structural changes in a process 
model. The data perspective refers to the changes in the requirement, usage, and 
generation of data in a process. The resource perspective deals with the changes in 
resources, their roles, and organisational structure, in relation to the process. The time 
perspective concerns the timing and frequency of events [141]. 
Four classes of drift are: sudden drift, gradual drift, recurring drift, and incremental 
drift. Sudden drift refers to a substitution of an existing process P1 with a new process 
P2 where P1 ceases to exist from the moment of substitution. Gradual drift refers to a 
scenario where a current process P1 is replaced with a new process P2 where both 
processes coexist for some time with P1 discontinued gradually. Recurring drift 
corresponds to a scenario where a set of processes P1 and PN  reappear after some time 
(substituted back and forth) that commonly caused by a seasonal influence. 
Incremental drift refers to a scenario where a substitution of process P1 with PN  is 
effected via smaller incremental changes [16]. 
Most approaches use a sliding window approach [146–148], where events in different 
windows are compared using statistical methods to detect significant changes. The 
data of process features are split into groups based on time windows. The options are 
to split it with overlapping or non-overlapping windows, with same-size or same-
duration windows, or with a more advanced technique of adaptive windowing. For 
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each iteration, two subsequent windows are compared statistically to investigate if 
there is a significant difference between the two windows. More details about the 
statistical approach are presented in Section 2.2.6. 
A new approach is proposed in this study to use process mining techniques to detect, 
localise and characterise process change over time. The main input of this approach 
is an event log. An event log L can be split into sub-logs of s traces each. An additional 
challenge is that an event log consists of traces that span in a time duration rather than 
data points. More details about the statistical approach are presented in Section 2.2.6.  
2.2.5.2 Change point detection 
In process change analysis, the first challenge is to detect concept drift in the processes 
and to identify the periods at which these changes have taken place. Change point 
detection involves two primary steps, which are capturing the characteristics of the 
traces, and identifying when the characteristics change. Some approaches to detect a 
change point include statistical testing [141], trace clustering [144], or abstract 
representation [145].  
A change point can be detected by statistical testing over feature vectors. Potential 
control-flow changes in the processes over time are detected through analysing the 
event log. Statistical hypothesis testing is used to evaluate and compare groups of 
data. Because there is no known a priori distribution of the feature values in an event 
log, non-parametric tests are suitable methods for change point detection. For each 
iteration, two subsequent sub-logs are compared, which means that two-sample tests 
are needed. Both univariate and multivariate hypothesis tests are considered, because 
the comparison can be made to one activity or a set of activities. The limitation is that 
it requires identification of the features and window sizes for change point detection 
[141].  
Another approach for change point detection is trace clustering. The idea of change 
point detection using trace clustering is to cluster the traces inside a time window 
based on the average distance between each pair of activities in the traces. A similarity 
matrix is used to record the similarity between cases. To detect potentially interesting 
change points, compute the change in the values of the similarity matrix over time. 
This method requires that window size be defined; it also cannot deal with loops 
[144].  
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Another approach is based on an abstract representation of a polyhedron. This 
approach sets prefixes in a random sample of traces in the event log and computes the 
fitness of subsequent prefixes of traces against the constructed polyhedron. A 
polyhedron can be described as the sets of solutions of a set of linear inequality 
constraints with rational (Q) coefficients. Let P be a polyhedron over Qn, then it can 
be represented as the solution to some system of m inequalities 𝑃 = {𝑋|𝐴𝑋 ≤ 𝐵} 
where 𝐴 ∈ 𝑄4×' and 𝐵 ∈ 𝑄4. The domain of polyhedra provides the operations 
required in abstract interpretation, including intersection and join. The limitation of 
this approach is that the entire detection process has to be executed from the start, 
which decreases the scalability of the approach [145]. 
2.2.5.3 Change localisation and characterisation 
When a process change has been detected, the next step is to localise the regions of 
change and to characterise the nature of the change. This is related to both the nature 
of the change (sudden, seasonal, gradual, or incremental) and the perspective of the 
change (control-flow, data, resource, or performance). The general approach [16] is 
to analyse each activity pair individually or as a subset. One important task in the 
analysis of process change is process comparison. Four papers proposed several 
aspects related to process comparison are presented in the following paragraphs. 
Delta analysis [146] provides a basis for process comparison by generating a 
similarity measure between the model and event logs. This method maps sequences 
of the traces, compares them to the reference model, and evolves the reference model 
based on the deviations in the log. This method is suitable for business process 
improvement in general, but allows free modelling of activity flow that result in an 
exponential space and time to check whether a log fits a process model.  
Another approach has been to explore three similarity metrics [147], including (i) 
node matching similarity that compares the labels and attributes of the process model 
elements, (ii) structural similarity that compares element labels as well as the topology 
of process models, and (iii) behavioural similarity that compares element labels as 
well as causal relations captured in the process model. The node matching similarity 
was based on pairwise comparisons of nodes or attributes, the structural similarity 
was based on the graph-edit distance between two graphs, and the behavioural 
similarity was based on the indirect relations between nodes or attributes. This 
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approach is simple as it is based on the well-known causality graph, but the 
experimental results showed that the time performance is not optimal.  
A cross-organisational comparison [118] using comparison points with process 
mining techniques has also been proposed. Using this approach, the models of a 
similar process in many different organisations can be compared based on pre-defined 
comparison points. This approach is limited as it relies on the domain experts to 
provide a set of pre-defined comparison points. 
In general, there are four categories of process comparison, which are: model-based 
comparison, conformance-based comparison, log-based comparison, and 
performance-based comparison. Model-based comparison is based on the control-
flow comparison, where the structural properties of the models are compared [148]. 
A limitation of this approach is that the differences in terms of frequency or any other 
process metrics are not detectable. Conformance-based comparison is based on the 
conformance perspective of process mining. Two event logs can be compared based 
on their conformance to one reference model. A limitation of this approach is that it 
relies on the validity of the reference model. Log-based comparison [149] detects 
relevant differences between processes based on the event logs, as implemented in the 
‘Process Comparator’ plugin in ProM [150]. This approach takes two event logs and 
visualises the differences using annotated transition systems. A limitation of this 
approach is that the event logs need to be completely representative of the process. 
Performance-based comparison compares process performance based on pre-defined 
comparison points such as waiting times, throughput, and Length of Stay (LoS) [118]. 
A limitation of this approach is that it relies on the availability and capability of 
domain experts to define the comparison points.  
2.2.5.4 Change process discovery 
The next step is to discover process change or to unravel the nature of the change. 
One important approach for change process discovery is through focus group 
discussions with domain experts [151] to discuss the findings and reveal the nature of 
change. This method involves a group of people participating in an interactive 
discussion focussing on specific issues. The nature of change can be related to one or 
more forces in the Leavitt’s diamond, i.e. the technology, people, structure, or task/ 
process. Process mining approaches can be used to support the discovery of process 
change based on the recorded data of the process in the event log. 
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In terms of process change analysis, this study focuses on an offline setting for process 
change analysis in healthcare. The change point detection is done using a windowing 
approach to find significant changes in the execution of the process over time. The 
statistical approach is used to test the hypothesis of this study. Process comparison is 
done based on all four categories, which are model-based, log-based, conformance-
based, and performance-based comparisons. The purpose of using all of those 
comparison categories is to get a thorough understanding of the process change. 
2.2.5.5 Process mining and user interface (UI) design 
In this research, process mining is used to test the effects of UI design on care 
processes within an EHR system. The goal of UI design is to create systems that are 
modelled based on the characteristics and tasks of the users. The systems are built to 
increase user productivity, satisfaction, and acceptance as well as decrease user errors, 
and user training time [152]. 
An EHR system is an information system processing and managing the patient records 
in a hospital. It covers organisational processes such as medical order entry and the 
medical treatment processes such as diagnostic procedures for a particular patient 
[153]. While organisational processes help to coordinate healthcare professionals and 
organisational units, treatment processes are linked to the patient. Those two types of 
processes should be covered within a hospital, either separately or in a centralised 
system, to support better care delivery to the patients. 
Healthcare providers are challenged by the increasing amount of information 
collected routinely in clinical settings. There is a greater need to utilise technologies 
to manage such information efficiently. Information technology is changing the way 
patient information is obtained and gathered and can impact the decision-making 
processes of clinicians. For example, if poor information is displayed, the delivery of 
care might be inefficient, which may include redundant ordering of tests or missing 
important information in the diagnosis of the patient. The key is to have the right 
information at the right time in the right place for the right clinicians. 
The previous literature summarised in this section builds an understanding of the 
challenges of this study. There are some techniques implemented in the literature, 
including process change analysis and concept drift, but they haven’t been 
implemented in the healthcare domain. As presented in Section 2.2.4.2, process 
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mining in healthcare is challenging, with one particular challenge on the change over 
time. In this research, process change analysis will focus on how EHR system change 
affects the actual process represented in the event logs of the EHR system. 
2.2.6 Statistical approach 
Statistical approaches have been used in process mining projects. Different statistical 
approaches can be used in descriptive and inferential ways to describe the event log 
[86, 106], to check conformance of the model to the log [153], or to compare between 
two logs [16]. These references show that the statistical approach can be applied in 
different stages of process mining projects to improve the confidence of the findings. 
In this study, descriptive statistics are used to describe the sample data being collected, 
while the inferential statistics of the sample data are used in the process comparison.  
The main statistical tests are required in the process comparison step of this study. 
Hypothesis testing was needed to evaluate and compare groups of data. The choice of 
a particular test is dependent on the nature of the data and the objectives of the 
experiment. The parametric test can be used when the data have a particular 
distribution, e.g., normal distribution, and non-parametric test if no particular 
distribution is known. There are two groups of data to be compared, so that the suitable 
test is a two-sample test. Tests dealing with scalar data elements are called univariate 
tests, while those dealing with vector data elements are multivariate tests. For 
example, the independent univariate two-sample t-tests are suitable where data are 
collected from two separate groups of parametric scalar data [154].  
There are some plugins in ProM that implement statistical tests, including Process 
Comparator and Concept Drift plugins. These two plugins were explored in the early 
stage of the study. Both of them are not sufficient to be used as the only technique in 
this study and need to be combined with other techniques. These two plugins are 
described in the following subsections. 
2.2.6.1 Process comparator: compare variants of a process 
The Process Comparator plugin [150] compares variants of a process, which can be 
derived from the same process in different locations, in different groups of people, or 
in different timeframes. This plugin requires two event logs or more to be compared. 
The differences visualised using transition systems annotated with measurements. 
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The statistical test used in this plugin is the two-tailed “Welch’s t-test”, also known 
as the “two-tailed t-test with different variances”. This test is suitable when the two 
sets of measurements come from independent populations, such as from two event 
logs from two groups of patients. The results are visualised in an annotated transition 
system, using visual properties (e.g. thickness and colour) of nodes and arcs. The 
graphic visualisation can be adjusted to represent trace frequency, elapsed time, 
sojourn time, remaining time, or duration. This plugin also allows us to filter out rare 
behaviour with the frequency filtering capability. The default alpha significance level 
(α) in this test is 5%. 
The differences will be presented in a range of colours based on the effect size oracle 
which, given two multisets of measurements, returns the size of the effect (i.e. how 
small or large is the difference) and the sign of the difference (+/-) within a certain 
scale. Cohen’s d is used to measure effect size, which measures the difference of 
sample means in terms of pooled standard deviation units. The ranges of d values can 
be categorised: d = ± 0.2 is considered as a small effect, d = ± 0.5 is considered as a 
medium effect and d = ± 0.8 is considered as a large effect. 
2.2.6.2 Concept drift: hypothesis test to analyse process changes 
The Concept Drift plugin [16] is available in ProM for hypothesis testing and is useful 
in analysing process changes. The analysis of the process change was done by splitting 
the event log into two sub-logs (before-log and after-log) with non-overlapping 
windows. The change point can be set to a specific date where there may be a specific 
change that has happened on a known date. In order to make this test more general, 
the date of the change point will be incrementally changed with a moving window 
approach. The test would then compare those two logs based on several comparison 
methods. Statistical hypothesis testing can then be used to evaluate the differences 
between the before- and after-logs. 
Based on general statistical approaches, two-sample univariate and multivariate tests 
are used. The two hypothesis tests for univariate two-sample are Kolmogorov-
Smirnov test (KS test) and the Mann-Whitney U test (MW test), and the test for 
multivariate data is the two-sample Hotelling T2 test. The hypothesis tested by the KS 
test is “Do the two independent samples (populations P1 and P2) represent two 
different cumulative frequency distributions?”, while the hypothesis tested by the 
MW test is “Do the two independent samples have different distributions with respect 
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to the rank-ordering of the values?”. The multivariate Hotelling T2 test is a 
generalisation of the t-test and evaluates the hypothesis “Do the two samples have the 
same mean pattern?”. All of these tests yield a significance probability assessing the 
validity of the hypothesis on the samples [141]. 
The suggested framework for analysing concept drifts in process mining consists of 
five steps: (1) feature extraction and selection, (2) generate populations, (3) compare 
populations, (4) interactive visualisation, and (5) analyse changes. The main input is 
an event log, and the main output is the detected change. 
2.3 Summary 
This chapter has reviewed the related literature that builds the background of this 
study, including the published systematic literature review [25] in 2016 that has been 
cited in 28 articles. The complexity of the healthcare domain makes it important to 
build an understanding of healthcare background. Cancer as a specific disease 
analysed in this study to understand the definition, characteristics, and the target of 
cancer treatment. The technical background in this study is in process mining and how 
this approach has been applied in healthcare and process change analysis.  
Based on the literature review on the healthcare background, it is evidenced that there 
are limited numbers of process mining projects in healthcare. Most process mining 
studies in healthcare have used artificial data provided in process mining challenges. 
On the other side, with the high complexity nature of healthcare data, process mining 
is a potential approach to analyse the processes in healthcare settings. One of the 
important challenges is that many aspects of healthcare practices might change over 
time. Based on the literature of the technical background, it is shown that many 
articles have been published to propose different techniques for process mining and 
detecting change from the data, but none of them have been specifically proposed to 
tackle the complexity of healthcare data. Based on this understanding of the current 
literature, the general methodology and data sources to be used in this study are 
presented and described in Chapter 3. 
  
 
Chapter 3  
Methodology 
Chapter 2 presented the healthcare and technical background that helped build an 
understanding of the literature for this study. Chapter 3 presents the general 
methodology, the details of each stage and the three datasets that have been used in 
this study. The general methodology has been built based on the background 
knowledge of the complex nature of healthcare data and the suitability of the available 
techniques in process mining and process change analysis in the literature. The 
general methodology has been adjusted to the specific characteristics of each case 
study. One additional methodology related to this chapter has been presented and 
published as a jointly-authored publication in the 2018 Process-Oriented Data Science 
for Healthcare entitled “The ClearPath method for care pathway process mining and 
simulation” [91].  
3.1 Main stages of the general methodology 
The main methodology used in this research is the Process Mining Project 
Methodology (PM2) [15] as an improvement of the original L* life-cycle model [3]. 
Table 3.1 shows the main stages in those two methods, along with the main stages of 
the general methodology in this study. 
Table 3.1 Main stage development 
Process mining method 
L* life-cycle (2011) PM2 (2015) This study 
0. Plan and justify 1. Planning 1. Planning and 
justification 
1. Extract 2. Extraction 2. Extraction, 
Transformation, and 
Loading (ETL) 
3. Data processing 
2. Create control-flow model 
and connect event log 
4. Mining and analysis 3. Mining and analysis 
3. Create integrated process 
model 
<< side stage during Stages 2 to 
4: interpret, redesign, adjust, 
intervene, support >> 
5. Evaluation 4. Evaluation 
4. Operational support 6. Process improvement 
and support 
<< not applicable >> 
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As presented in Table 3.1, the methodology in this study commenced with Stage 1 
(Planning and justification). Both the L* life-cycle model and the PM2 method started 
with the planning stage, to set the scene and justify the importance of the process 
mining project. In the L* life-cycle model, Stage 1 consists of understanding the 
available data and understanding of the domain, while the PM2 method suggested that 
Stage 1 consists of selecting the business process, identifying research questions, and 
composing the project team. In this study, Stage 1 followed the same stage as in the 
PM2 method but extended it with the question-driven method for identifying research 
questions [89]. It is also important to note that very little is mentioned about 
justification in the PM2 methodology. In this study, justification is important as this 
is necessary for academic research to justify the planning scientifically. The suitability 
of the data to be used in this study has also been extensively explored through a data 
quality assessment following the Weiskopf & Weng framework [133]. 
Stage 2 (ETL) is the next stage of this study. It combines the extraction and data 
processing stages in the PM2 method. It is renamed to make it consistent with the 
general data analysis approach, i.e. ETL. This was also done to reflect the specific 
conditions in the three datasets in this study. The full datasets were accessible for this 
study, and each analysis required an iteration of ETL as a subset of the datasets based 
on a specific cohort of patients. The L* life-cycle model did not explain the extraction 
steps in detail but suggested that the output of this stage are historical data, handmade 
models, objectives, and questions. The PM2 method specified three steps in the 
extraction steps: determining scope, extracting event data, and transferring process 
knowledge. The PM2 method explicitly added a data processing stage that consisted 
of creating views, aggregating events, enriching logs, and filtering logs. In this study, 
both extraction and data processing were combined and renamed as Stage 2 (ETL). 
The name was chosen to improve clarity and was based on the basic approach for 
general data analysis. The steps in Stage 2 follow the steps suggested in the extraction 
and data processing stages in the PM2 method. 
Stage 3 (Mining and analysis) was named after the same stage in the PM2 method and 
is the main part of this study. In the L* life-cycle model, process discovery and 
conformance checking are done in the ‘create control-flow model and connect event 
log’, while the enhancement is done in the ‘create integrated process model’. This 
study followed the PM2 method, where process mining and process analytics are 
combined into one stage. Process mining includes process discovery, conformance 
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checking, and enhancement. Process analytics were focused on process change 
analysis based on a concept drift analysis [16]. Process analytics in the Patient 
Pathway Manager (PPM) Cancer case study was done with and without a known 
change. When a change is known, the event log is split into before and after the 
change. It is followed by process comparison of those two sub-logs. When there is no 
prior information on a change, other methods adopted in the process analytics are the 
signal decomposition method [155] and the Statistical Process Control (SPC) method 
[156]. 
Stage 4 (Evaluation) was the final stage of this study. In the L* life-cycle model, the 
evaluation was included as additional steps to interpret, redesign, adjust, intervene, 
and support the analysis of the process of interest. In the PM2 method, the evaluation 
was done to diagnose, verify, and validate the results of the previous stages. In this 
study, Stage 4 was done to evaluate the findings in the statistical and clinical 
perspectives. The statistical evaluation done in this study was focused on the 
hypothesis testing to find statistically significant differences between the sub-logs 
over time. The clinical evaluation was done to ensure that the results are meaningful 
from a clinical perspective. 
The methods were followed by the Operational support in the L* life-cycle model 
and by the Process improvement and support in the PM2 method. Both stages 
suggested the implementation of the findings into the real-life process. This is not 
applicable in this study and is not included in the method. 
 
3.2 General methodology 
The general research methodology was developed as described in the previous 
section. It is based on the PM2 method and is extended for process change analysis. 
There are four main stages as mentioned in Section 3.1: (1) Planning and justification, 
(2) ETL, (3) Mining and analysis, and (4) Evaluation. The overview of the general 
methodology is presented in Figure 3.1. 
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Figure 3.1 Research methodology. The dashed blocks represent main stages, the boxes 
represent steps within a stage, connected by straight arrows. The blue texts explain the details 
of each step specific in this study. 
 
Each stage presented in Figure 3.1 is discussed in more detail in Sections 3.2.1–3.2.4. 
Process change analysis is an important part of this study and is described separately 
in Section 3.3. 
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3.2.1 Planning and justification 
This stage focused on identifying the business process, research questions, and project 
team as starting points for the project. This stage followed PM2 except on: (i) 
additional data quality assessment which followed the Weiskopf & Weng framework, 
(ii) research questions were identified which followed the question-based 
methodology, and (iii) project team involvement followed the ClearPath method. 
In this study, the business process was defined based on a cohort of cancer patients, 
which included colorectal cancer, breast cancer, and endometrial cancer patients. 
Those cohorts were chosen through careful discussion with clinical experts. A careful 
data quality assessment was also done to check if the dataset was suitable for process 
mining. The assessment was done following the Weiskopf & Weng framework. 
Datasets were assessed to check their completeness, correctness, concordance, 
plausibility, and currency to be analysed with process mining. 
Research questions were identified based on previous related studies and general 
research questions for process mining projects. The additional methodology referred 
to in this stage was question-driven methodology, which suggests that frequently 
posed questions are identified from the very beginning of the data analysis. Some 
frequently posed questions were adapted as the initial questions: 
1) What are the most followed paths and the exceptional paths? 
2) Are there differences in care paths followed by different patient groups? 
3) Do we comply with internal and external guidelines? 
4) How was the process changed over time? 
5) Can process mining be used to analyse the effect of User Interface (UI) 
changes to the care process?  
Project team identification was defined in the early stage of this study, which included 
computer scientists and clinical experts. The two clinical experts are: (1) Professor 
Geoff Hall, a senior oncologist and senior lecturer in Medical Oncology and Cancer 
Informatics, and (2) Dr Kieran Zucker, an honorary clinical oncology registrar and 
clinical research fellow at the University of Leeds. Based on the ClearPath method, 
an important focus on composing the project team was to engage clinical experts 
through a clinical review meeting at the end of every stage of the study.  
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3.2.2 Extraction, transformation, and loading 
This stage follows the PM2 method except that the full datasets were accessible so 
that a sequence of ETL was done for each experiment. The additional step is to 
initially re-build the database in a database management system or to access the 
database directly. 
The Extraction stage was done to extract event data and (whenever possible) 
reference models from the system, based on the initial planning and justification made 
in the previous stage. The extraction scope can be defined for each cohort of patients, 
based on the focus on the analysis in that cohort. This stage requires an understanding 
of the available data to determine the level of granularity, time period, and attributes 
needed for the analysis. 
For formalisation purpose in this study, the following definitions were used: 
Definition 1 (Event logs). An event log E is a set of events (c, a, t). An 
event happening in a timestamp t is described by a case identifier c and an 
activity label a. A trace T is a sequence of a subset of events happening to 
a case c ordered by a timestamp t, where TÎ E. 
Definition 2 (Process models). A process model M is a directed graph 
modelling the traces T in the event log E. The process model M draws 
activities a as nodes and the possible paths p between nodes as arcs from 
one node to another. Standard process mining algorithms can be used to 
discover process models with additional components identified, such as 
the frequency of nodes and arcs as the occurrence of a and p in E, 
respectively.   
The Transformation stage was based on the data processing stage in PM2, as follows:  
1) Creating views 
The views created in this study are based on the understanding of the data structure 
and the research questions. Generally, the view would be to analyse the patient 
journey during a cancer treatment pathway, where patient ID is the case ID, a 
particular action during the treatment is the activity, the clinician who did the activity 
is the resource, and the time when that activity was done by the resource is the 
timestamp. The event log is then a collection of events recorded in {case ID, activity, 
resources, timestamp} format. 
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2) Aggregating events 
The events might need to be aggregated to reduce complexity and improve the 
readability of the process model being discovered. This can be done to get process 
models with different levels of details, based on the details required in the research 
question. 
An example in this study is in the analysis of a chemotherapy pathway. In the analysis 
of chemotherapy cycles, fine-grained event names were used, which are Cycle 1, 
Cycle 2, Cycle 3, etc. When it was required to get a general pathway of patient 
journeys, the event name is Chemotherapy, which was then being analysed with other 
events such as Referral, Outpatient, and Surgery.  
3) Enriching logs 
Log enrichment was done by adding information to the event log. This can be done 
by computing additional data or by adding external data. An example in this study 
was by adding duration and year of diagnosis. The process duration for each patient 
was calculated as the number of days between the first activity and the last activity. 
The year of diagnosis was used to group the patients based on the year of diagnosis 
date for each patient.  
4) Filtering logs 
The last type of transformation is the filtering, which can be done based on the 
attribute, the variance, and/or the compliance. Attribute-based filtering was done by 
removing events or traces based on the values of a specific attribute, such as the event 
names, or the duration. For example, in one experiment of the PPM Cancer case 
study, to focus on the pathways from referral to diagnosis, all events that happened 
before referral and after diagnosis would be filtered out. Variance-based filtering was 
done to group similar traces to split the event log to discover simpler process models. 
For example, in this study, the log was partitioned based on the year of the diagnosis. 
Compliance-based filtering was done to remove traces or events that do not comply 
with a given rule or process model. For example, in this study, patients were not 
included if there was no referral recorded in the 120 days before a cancer diagnosis. 
The Loading stage was done by loading the extracted and transformed event data to 
the process mining tools, including DISCO [93], ProM [94], and bupaR [95]. In 
DISCO and ProM, extraction and transformation are straight forward and are easily 
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performed  through the UI. A form is provided in both tools to upload an event log in 
.csv or .xes file, then specify the case-id, event-id, resource, start- and end- time. In 
bupaR, an event log can be recorded as a data frame, for example, to create an event 
log from a table {PID, act, time}, as follow: 
event_log %>%  
  eventlog(case_id = “PID”, activity_id = “act”, timestamp = “time”) 
DISCO was used to gain a quick insight from an event log along with the statistical 
details of the event log for further analysis. The limitation is that DISCO only 
provided a process discovery using a fuzzy miner. ProM was used to explore other 
algorithms for process discovery, such as a heuristics miner [83] and an inductive 
miner [157]. The bupaR was used for better support in statistical analysis and 
discussion with clinical experts. 
3.2.3 Mining and analysis 
This stage includes the main tasks of process mining, which are: process discovery, 
conformance checking, and enhancement. Those were done as a process analytics 
approach to gain insights about the process from the data. Each of those main tasks is 
described in the following sections. 
3.2.3.1 Process discovery  
In this study, process discovery was performed using several available algorithms 
DISCO, ProM, or R language. The main algorithms used for process discovery are 
the fuzzy miner in DISCO, the interactive Data-aware Heuristics Miner (iDHM) 
plugin in ProM 6.8, and bupaR in the R language. The fuzzy miner in DISCO was 
mainly used in the MIMIC-III case study, because it was straight forward and reliable 
to use in common situations. The iDHM plugin in ProM was used as a comparable 
tool that provided better connectivity with other tasks in ProM through data filtering 
and conformance checking plugins. Especially in the PPM Cancer case study, bupaR 
was used because the R language was originally supported in the hospital-networked 
PC, while DISCO and ProM had limited support due to regular updates that needed 
to be done by IT support in the hospital. More details about fuzzy miner, heuristics 
miner, and bupaR have been presented in Section 2.2.3.1. The decision to use an 
algorithm and a tool was based on the data characteristics, the capability of the 
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algorithm to handle that type of data, and the suitability of the output of the algorithm 
for the next analysis in the study.  
In this study, the results of process discovery task were presented through process 
models, trace variants, dotted charts, and other visualisations from the event log. The 
main visualisation is a process model, which usually followed by other visualisations 
to support the specific analysis. Unless otherwise stated, the properties of each 
visualisation are described as follows. 
1) Process model 
A process model presents a sequence of events as defined in Definition 2 in Section 
3.2.2. In this study, a process model can be visualised as a directly-follows graph, a 
heuristics net, a state transition diagram or a Petri Net.  
Figure 3.2 shows an example of a process model from an experiment in Chapter 6. It 
begins with a START node and finishes with an END node. These properties of the 
process model resulted from three tools DISCO, bupaR, and ProM.  
 
Figure 3.2 An example of a process model (bupaR). A node represents an activity and an 
arc represents a path from one activity to another. Nodes and arcs are labelled with the number 
of patients having those activities and paths. Nodes and arcs are colour-coded with a darker 
colour representing a more frequent activity or path.  
 
The input is event log in .csv or .xes format. In ProM, an event log in .csv format can 
be transformed into .xes format using a plugin “Convert CSV to XES”. The event log 
can go through some transformation steps as described in Section 3.2.2. The tools 
would then create a process model. In DISCO, the process model can be seen in the 
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“Map” tab and is adjustable to filter based on the percentage of the most frequent 
activities and/or paths. In bupaR, the syntax to create a process model from an event 
log is as follow: 
event_log %>% process_map() 
There are also some other syntaxes to adjust the frequency value shown in the process 
model. For example, to show relative frequency and median (day), as follow: 
event_log %>% process_map(type=frequency(“relative”)) 
event_log %>% process_map(performance(median,“day”)) 
In ProM, an additional step is needed to select a process discovery plugin, for example 
by choosing a plugin “interactive Data-aware Heuristics Miner (iDHM)”. The 
resulting process model could then be adjusted to show some features needed for the 
next analysis. 
2) Trace variant diagram 
A trace variant diagram represents trace variants as the sequence of events. A trace 
variant diagram can be created in ProM, DISCO, or bupaR. Figure 3.3 shows an 
example of a trace variant diagram from an experiment in Chapter 6, showing the 
most frequent trace variants (top five variants showing >85%).  
 
Figure 3.3 An example of a trace variant (ProM). A colour-coded and named shape 
represents an event. Each line represents one trace variant. Additional information on the left 
show the number of traces of each trace variant and the percentage from the complete log. 
 
In ProM 6.8, an event log can be visualised in a dotted chart by Select visualisation 
>Explore Event Log (Trace Variants/ Searchable/ Sortable) (LogEnhancement). In 
DISCO, trace variants can be found in the Cases tab and are shown as a table or a 
flowchart-like graph. In bupaR, trace variants can be shown using following syntaxes: 
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  event_log %>% trace_explorer() 
  event_log %>% trace_explorer(coverage=0.8) 
The two syntaxes show all trace variants and the top 80% variants, respectively. 
 
3) Dotted chart 
A dotted chart shows traces over time. In this research, a dotted chart shows patient 
pathways over the treatment duration. Figure 3.4 shows an example of a dotted chart 
from an experiment in Chapter 5.  
 
Figure 3.4 An example of a dotted chart (ProM). An activity is presented as a colour-coded 
dot, including the START and END activities. The x-axis shows the time relative to the start 
of the trace and the y-axis shows patient, ordered from the shortest to the longest duration. 
    
A dotted chart can be created in ProM or bupaR. In both tools, an event log is needed 
as an input. In ProM 6.8, an event log can be visualised in a dotted chart by Select 
visualisation > Dotted Chart (LogProjection). The resulted dotted chart can be 
adjusted by setting the x-axis attribute, y-axis attribute, trace sorting, color attribute, 
shape attribute, attribute statistics, and connect/ disconnect events. In bupaR, a dotted 
chart can be created using the following syntax: 
  event_log %>% dotted_chart(x=”absolute”, y=”start”) 
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4) Process comparison diagram 
A process comparison diagram shows an annotated transition system resulting from 
the Process Comparator plugin in ProM, as presented in Section 2.2.6.1. Figure 3.5 
shows a process comparison diagram from an experiment in Chapter 6. 
 
Figure 3.5 An example of a process comparison diagram. A node represents an activity 
and an arc represents path between activities. Node and arc thickness represent trace 
frequency. Colours represent the percentage differences in activities and paths in the two 
event logs. Blue means the percentage of trace frequency in the first group is higher than in 
the second group and red means the reverse. 
 
Figure 3.5 shows a process comparison diagram. In this study, the trace frequency is 
chosen. The alpha significance level was set as the default 5%. In ProM 6.8, this 
diagram can be built from at least two event logs using the Process Comparator 
plugin. The plugin asks to set Group A and Group B, then shows the graph. There are 
two settings that can be adjusted, which are transition system settings (graph 
properties and filter) and comparison settings (process metrics and alpha significance 
level). 
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3.2.3.2 Conformance checking  
Conformance checking was done to check if the resulting model could represent the 
reality captured in the event log. Conformance checking can also be seen as an attempt 
to measure the quality of the process model resulted from the process discovery. The 
conformance checking was performed using some plugins in ProM, including: 
1) Replay Log on Petri Net for Conformance Analysis 
This plugin accepts a Petri net and an event log. It provides conformance values based 
on cost-based fitness analysis [158, 159]. This plugin measures fitness that represents 
to what extent the process model captures the observed behaviour. This is achieved  
by identifying skipped and inserted activities. Skipped activities are activities that 
should be performed based on the model, but do not happen in the log. On the other 
hand, inserted activities are activities that occur in the log, but should not happen 
based on the model. Both skipped and inserted activities affect fitness value. The 
output is a Petri net annotated with replay results. For example, in Figure 3.6, Petri 
net can be presented with a legend and its global statistics. 
 
Figure 3.6 An example of a Petri net with a legend and its global statistics. The Petri net 
is annotated with replay results. The left window shows the log-model alignments, while the 
right window shows the list of deviations.  
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In Figure 3.7, the log-model alignment maps each case with the process model to 
show deviations. Some statistics are also presented, which include the statistics from 
reliable alignments and statistics including unreliable alignments. Other options of the 
visualising the results are ‘time between transition analysis’, ‘trace alignment of 
alignments’, ‘visualise p-alignments as graphs, and ‘visualise p-traces as graphs’. 
 
Figure 3.7 An example of a replay result presented as the alignment to the log. The left 
window presents the log-model alignments. The list of deviations is in the legend in the right 
window. 
   
The ‘Replay a log on Petri Net for Conformance Analysis’ plugin can be used for 
checking conformance of a log to a process model in Petri net notation. The results 
can be presented in many ways, including the annotations in the Petri net along with 
detail information for each activity, each transition, and for the complete model. The 
information include calculation time, trace fitness, move-model and move-log fitness. 
2) Measure Precision/Generalisation 
This plugin provides precision and generalisation values as mentioned in [85]. This 
plugin measures the precision of a process model given an event log by first aligning 
the traces in the log to the model. In this study, the “Replay a log on Petri Net for 
Conformance Analysis” plugin was used by providing a Petri net, the Petri net replay 
result from point (1), and the event log. The results are presented simply as the 
precision and generalisation values. 
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For example, the event log from experiment 1 in case study 1 as discussed in Section 
4.2 can be used as an input along with the Petri net resulted from the iDHM plugin as 
shown in Figure 3.6 and the Petri net replay results as presented in Figure 3.7. The 
results are a precision value of 0.86345 and a generalisation value of 0.99586. 
The enhancement involved additional data, time, and performance 
perspectives to analyse the process model. An example of additional data perspective 
involved adding details from other tables in the database. Another example in the 
additional time perspective was the calculated time duration. In the performance 
perspective, the additional data was gathered from discussions with clinical experts to 
define several ways to describe performance of patient treatment. 
The process analytics focused on process change analysis, following the approaches 
in concept drift analysis. More details about the process change analysis done in this 
research are presented in Section 3.3. 
3.2.4 Evaluation 
The objective of the evaluation stage was to ensure that the findings could answer all 
the original research questions and were meaningful for the domain experts. 
Evaluation of this study includes both statistical evaluation and clinical evaluation. 
The evaluation was effected  through a series of focus group discussions in formal 
meetings. The statistical and clinical experts were invited to a discussion at the end of 
an iteration to verify and validate the results. Group discussions were also conducted 
during all the stages of the study to evaluate the approaches taken in each step and to 
gather inputs from the experts to enrich the next steps. 
The statistical evaluation was performed to evaluate the results of the mining and 
analysis stage. Process models discovered in the process mining stage were evaluated 
using the conformance values of trace fitness, precision, and generalisation metrics 
using the plugins in ProM 6.8.  Process change analysis was evaluated using t-test and 
hypothesis testing approaches. When a change point was detected, statistical 
evaluation was performed to test if the detected change was statistically significant. 
A complete statistical evaluation was done in the PPM Cancer experiments. It was 
performed based on the insights from the MIMIC-III and the PPM Chemotherapy 
experiments. Ciaran McInerney, Ph.D., a statistical analyst helped in the statistical 
evaluation in the PPM Cancer experiments. 
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The clinical evaluation was conducted through discussions with clinical experts. This 
was done in the PPM Chemotherapy and PPM Cancer analyses. Whenever required, 
other experts were also consulted. In the PPM Chemotherapy case study, there were 
also discussions with the previous research team, including Karl Baker and Elaine 
Dunwoodie. In the PPM Cancer case study, there were also discussions with the PPM 
training team, the PPM development team, and the Leeds Care Record (LCR) research 
team. The PPM development team members with whom discussions were held in this 
study included Colin Johnston, Nigel Stanworth (PPM Release Manager), and Jonny 
Smith. Discussions with the LCR research team was effected through Julia Millman, 
the program manager of LCR. The final evaluation was done by Professor Geoff Hall, 
a senior lecturer in Medical Oncology and Chief Clinical Information Officer at the 
LTHT. 
3.3 Process change analysis 
Process change analysis followed the approaches in concept drift analysis [16]. This 
step analysed the treatment processes and how they had changed over time. There are 
three main challenges in dealing with concept drift analysis. These are: change point 
detection, change localisation and characterisation, and change process discovery. 
The approaches taken in this study to address those challenges are as follows: 
3.3.1 Change point detection 
The first challenge was to detect a point in time where the process had been changed. 
A straightforward method to do this was to split the data based on a specific event as 
a reference. This was done in the analysis of the PPM Cancer data by partitioning the 
event log based on a pre-defined duration/ window size. In this study, the partitioning 
was done based on the diagnosis year, as illustrated in Figure 3.8. 
  
Figure 3.8 Illustration of log partitioning approach. Each year partition consists of traces 
of patients diagnosed in that particular year. For each iteration, two subsequent year partitions 
are being compared. 
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In addition to Definition 1 and 2 in Section 3.2.2, the following definition is applied: 
Definition 3 (Log partitions). A partition P is a subset of an event log E 
based on partitioning criteria. The partitioning is done such that a trace is 
grouped into a partition with no duplication in other partitions. For this 
study, the partitioning was done based on the year of the timestamp t of 
the diagnosis. The event log was therefore split into partitions based on 
the year of diagnosis of each patient. There are clearly many partitioning 
options that could be adopted. 
As presented in Section 2.2.5.2, some approaches have been proposed to detect 
change points. This study used a statistical testing approach to find significant 
differences between the processes. This approach is flexible enough to test differences 
based on various features describing processes. 
In this study, change detection was performed in the PPM Chemotherapy and PPM 
Cancer analyses. Change detection was not possible in the MIMIC-III dataset due to 
the date shifting approach during the data creation by the MIMIC-III team. The 
documentation of the MIMIC-III data mentioned that the hospital information system 
from which the MIMIC-III data were collected had been changed and this was used 
as a starting point to analyse changes in the MIMIC-III database.  
In the PPM Chemotherapy and PPM Cancer analyses, the PPM Electronic Health 
Record (EHR) from which the data was collected is continually growing. The 
development team works to make many changes in many aspects of the PPM EHR 
based on the changing needs of the clinical teams. In the PPM Chemotherapy analysis, 
change detection was done by comparing traces in different years. In the PPM Cancer 
analysis, change detection was done to a GP Tab change as a known change and by 
analysing monthly records to detect the unknown changes. Two different approaches 
in the PPM Cancer case study were the multi-level approach and a combination 
approach of signal decomposition and Statistical Process Change (SPC) chart. Each 
of them will be described in the following sections. 
3.3.1.1 A multi-level approach for identifying process change 
In this approach, the process comparison was done using several metrics at three 
different levels: process model level, trace level, and activity level. For the model-
level comparison, a general process model was built using interactive Data-Aware 
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Heuristics Miner (iDHM) in ProM from the complete event log. iDHM was chosen 
because this plugin supported interactive adjustment to the level of details needed in 
the analysis. The model-level behaviour was described by the conformance values in 
the replay fitness, precision, and generalisation of each sub-log to the general model. 
The trace-level behaviour was described by durations and the proportion of trace 
variants in the sub-logs. The activity-level behaviour was described by activity 
frequency and its percentage in the sub-logs.  
The metrics for those three levels of process comparison are presented in Table 3.2. 
This approach was used in a case study of endometrial cancer pathways from GP 
referral to the diagnosis of cancer, as presented in experiment 6 of the PPM Cancer 
case study in Section 6.3. 
Table 3.2 Metrics for multi-level process comparison 
Level Metrics Description 
Model Replay fitness The ability of the model to accurately reproduce the traces 
recorded in the log. 
Precision The proportion of the behaviour allowed by the model 
which is not seen in the event log. 
Generalisation The ability of the model to reproduce the future behaviour 
of the process. 




The proportion of variants in the sub-log that were one of 
the most frequent variants in the complete log. 
Activity Frequency The number of patients having a specific event within one 
year. 
Percentage The percentage of patients having a specific event out of all 
patients within a year. 
3.3.1.2 Signal decomposition and Statistical Process Control (SPC) chart for 
identifying process change 
This approach identifies process change based on the pattern of monthly records in 
the EHR system. The hypothesis is that it is possible to detect change points based on 
the monthly records over time. A plot was created based on the observed number of 
monthly records per activity. The observed plots were decomposed using a signal 
decomposition technique [160]. The underlying assumption of this approach is that 
the observed plot can be decomposed to find the trend, seasonal, and remainder 
patterns over time, such that: 𝑦! = 𝑇! +	𝑆! + 𝑅! ,	where 𝑦6 is the observed data, 𝑇6	is 
the trend component,	𝑆6 is the seasonal component, and 𝑅6 is the remainder/ random 
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component, all at period t. The remainder plot was then being analysed using the 
Statistical Process Control (SPC) chart [161] to get the change points with statistically 
significant different values from the previous period. 
Two main functions in R were used in this approach: (1) the decompose() function in 
the fpp2 package for signal decomposition, and (2) the qic() function in the qicharts2 
package for SPC chart. The decompose() function accepted a time series object of the 
observed data. For example, the monthly frequency of an activity can be defined and 
plotted as follow. 
# define and plot time series data 
ts_data = ts(data$monthly, start=c(year_start,month_start), 
end=c(year_end,month_end), frequency=12) 
The signal decomposition processed the monthly records of an activity to separate the 
trend, seasonal, and remainder patterns in the observed data. This study uses the 
classical additive decomposition to separate trend and seasonal patterns from the 
remaining/random data. 
The trend pattern was based on the moving average smoothing, i.e. m-MA, meaning 
a moving average of order m. An m-MA can be written as  𝑇)! =
"
#
∑ 𝑦!$%&%'(& , where 
m = 2k+1. The estimate of the trend-cycle at time t is based on the average values of 
the time series within k period of t. The idea is that the observations during the nearby 
periods are likely to be close in value. The average is therefore eliminating some of 
the randomness in the data. A trend can be a long-term increase or decrease in the 
data, or a ‘changing direction’ when it goes from an increasing trend to a decreasing 
trend or vice versa. In this study, the trend pattern was based on the 12-MA smoothing, 
meaning that an average was counted from 6 months before and 6 months after a 
specific month. The consequence of this was that no value was calculated in the first 
6 months and the last 6 months of the duration of the study. Other options to use 3-
MA, 4-MA, and 6-MA were also tested but did  not improve the results. This is why 
the 12-MA was chosen, which also implies the yearly average of  monthly frequency. 
The seasonal pattern is a fixed and known frequency. In this study, seasonal pattern 
is the monthly frequency. It was chosen to make sure that enough data are available 
in each season (month) while the individual data is not de-identified. Other options to 
analyse seasonal pattern in the daily, weekly, or quarterly frequency are also possible. 
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The observed data were de-trended by subtracting the trend component from the 
observed data. The average was then calculated from the same period over the years, 
such that  𝑆+! = 	𝑦! −	𝑇)!. For example, the seasonal component for January is the 
average of all de-trended January values over the years.  
The random/ remainder component was calculated by subtracting the estimated 
seasonal and trend-cycle components: 𝑅)! = 	𝑦! −	𝑇)! −	𝑆+! .	It represents the observed 
signal after subtracted by the trend and seasonal patterns. For example, signal 
decomposition of a monthly frequency of an activity is as follows: 
#signal decomposition 
decompose_data = decompose(ts_data, "additive") 
plot(decompose_data) 
An example result is shown in Figure 3.9. 
 
Figure 3.9 An example of a signal decomposition result. It shows the observed pattern, the 
trend pattern, the seasonal pattern, and the random/ remainder pattern. The x-axis is time and 
the y-axis is variance over the means. 
 
The random/ remainder component was further analysed using the Statistical Process 
Control (SPC) chart. SPC is commonly used for understanding process variation over 
time [156]. The remainder pattern was plotted to see the variability of the monthly 
records. The signals were compared to the upper and lower control lines. Change 
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points were detected where the signal varied outside the control lines. This approach 
was used in an experiment on cancer pathways, as presented in experiment 8 of the 
PPM Cancer case study in Section 6.5. 
In this study, the SPC chart was built using qicharts2 library in R. The main function 
used in this study is qic() function, which creates run charts from time series data. A 
run chart is a point-and-line graph showing measures or count over time. Three 
horizontal lines are presented as the control lines. A centre line (CL) expressing the 
median, while upper control limit (UCL) and lower control limit (LCL) represent the 
upper and lower boundaries of variations in the data. The control limits are placed at 
± 3 standard deviations from the centre line. Variation of values between LCL and 
UCL is considered as common cause variation that is present in any process, which is 
also called random variation or noise. Values outside the the control lines are 
considered as non-random variation or signal, which is caused by phenomena that are 
not normally present in the system. For example, the SPC chart of the remainder 
pattern of a monthly frequency of an activity can be resulted from a code as follow: 
#input:  
data_df <- ts_reshape(dec_data$random, type=”long”) 
qic(value, data=data_df, chart="i", ylab='Count', xlab='Month') 
This syntax resulted in an SPC chart as presented in Figure 3.10. 
 
Figure 3.10 An example of the SPC chart. It shows the variability over the means of the 
random/ remainder pattern. The x-axis shows month and the y-axis is count. Red dots 
represents the points where there were significant changes in the variability over means. 
3.3.2 Change localisation and characterisation 
After a change point was detected, the next task was to localise and characterise the 
change. This task involved both the identification of change perspective (for example: 
control-flow, data, resource, sudden, gradual, recurrent, incremental) and the exact 
change itself. Different types of data and process change require different techniques 
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in change localisation and characterisation. In this study, the method for change 
localisation and characterisation was built and improved in the three datasets. 
Change localisation and characterisation stage in the MIMIC-III data consisted of 
model-based and log-based comparisons. The model-based comparison was done 
using the DifferenceGraph plugin in ProM. This plugin compares two process models 
and visualises the differences between those two models. The log-based comparison 
was done using the Process Comparator plugin in ProM. This plugin compares trace 
frequencies in two event logs and visualises the significant differences. This stage in 
the PPM Chemotherapy data was done following the conformance-based change 
detection. Sub-logs created based on the diagnosis years were then being compared 
to each other on their trace fitness, precision, and generalisation. This stage in the 
PPM Cancer data was done based on the metrics for multi-level process comparison, 
as presented in Table 3.2. For change point detection using the multi-level approach, 
this stage was required to be done for each metric in the three different levels. A 
specific challenge in this task was to identify a significant change in the process based 
on those metrics in the three different levels of process comparison. 
3.3.3 Change process discovery 
Having now identified, localised, and characterised the changes, the next step is to 
relate the findings with the discovery of the change process to unravel the evolution 
of the process. This step can be done by analysing different perspectives of the 
changing process, such as using the performance metrics. The most important method 
in this step is the frequent focus group discussions with the domain experts. 
The detected change points were discussed with the clinical experts. The discussions 
focused on the possible nature of the changes. The changes can be caused by several 
reasons, such as a change in the organisational structure in the hospital, a change in 
the guideline for cancer treatment, a change in the technology used within the hospital 
information system, or a change in the people who did the treatment process. 
In this study, the change process discovery was done in the PPM Chemotherapy and 
PPM Cancer case studies. The change process discovery was conducted through 
discussions with clinical experts and the development team. Change process 
discovery was not possible in the MIMIC-III analysis because there is no direct access 
to clinical experts and because of the date shifting approach for anonymisation.  
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3.4 Case studies 
Three case studies were built from the three datasets in this study: the MIMIC-III, the 
PPM Chemotherapy, and the PPM Cancer datasets. Each one of these is introduced 
in this section and explored in more detail in Chapters 4 to 6. 
3.4.1 Case study 1: Experiments using the MIMIC-III dataset 
The MIMIC-III dataset is a large, single-centred database comprising information 
relating to patients admitted to the Intensive Care Units (ICUs) in the Beth Israel 
Deaconess Medical Center (BIDMC) [25, 26, 168]. The MIMIC-III database was 
developed and has been maintained by the Laboratory of Computational Physiology 
at Massachusetts Institute of Technology (MIT) since 2003 [25, 26]. This database 
has been de-identified by removal of all protected health information. Public access 
to this data was made available through the National Institutes of Health (NIH).  
The data covers 53,423 distinct hospital admissions for 38,597 adult patients (aged 16 
years or above) admitted to the ICUs between 2001 and 2012. It contains data such as 
medication, laboratory measurements, charted observations during a patient’s stay in 
the intensive care unit, and de-identified notes of the patient’s stay. One important 
challenge was to select suitable tables for process mining. This challenge and how it 
was addressed in this study are described in Chapter 4. There are 16 out of 26 tables 
in the MIMIC-III database containing timestamped events. Those tables were used to 
discover process models based on the specific cohort of interest. The other 10 tables 
were used as reference tables during the analysis, such as PATIENT table to support 
analysis of the selected patients in a cohort. 
Two different systems were in place over the data collection period. The Philips 
CareVue Clinical Information System (CV) was used between 2001–2008 and the 
iMDsoft MetaVision ICU (MV) was used between 2008–2012. This condition leads 
to the opportunity to compare the process models of those two systems. The MIMIC-
III team provided the database combining data from both systems. In this study, 
clinical data from two systems were separated to be compared one another and 
analysed further with process mining approach. One limitation of using this dataset is 
that the deidentification process obscured the real dates. Another limitation is that 
there was no direct access to the clinical experts of this hospital, so that it was not 
possible to discuss the findings with the clinical experts. Despite the limitations, the 
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MIMIC-III dataset was useful to build initial method for process change analysis 
using process mining in this study, because (1) the MIMIC-III dataset is publicly 
accessible, therefore supports reproducibility of related research using the same 
dataset, and (2) there was a known system change to replace the CV system with the 
MV system, so that change characterisation and localisation can be done. 
3.4.2 Case study 2: Experiment using the PPM Chemotherapy dataset 
The Patient Pathway Manager (PPM) Chemotherapy dataset is the clinical data of 
cancer patients receiving chemotherapy treatment in the Leeds Cancer Centre during 
the period 1996–2015. This dataset was used in two previous studies in the research 
group entitled (1) “Using Routine Clinical Dataset to Develop Risk Algorithms in 
Oncology” (Ref: 13/NS/0128) [34] and (2) “Profiling Neutrophil Counts in Patients 
with Cancer During Cycle One of Chemotherapy” (IRAS ID 207804). The PPM 
Chemotherapy dataset consists of the clinical data of 31,511 patients in 13 tables. It 
was de-identified for the purpose of the previous study. There is no timestamp 
identified, but there is the possibility to obtain the sequence based on Age (in the 
number of days) and Years, which enable a historical pathway to be extracted for 
every patient. Those tables are related with a Patient ID (PID) which identify patient 
IDs. Later during this study, the dataset was backed up in a secured external driver for 
easier and safer access by restricted researchers. 
The data came through automated extraction processes from patient hospital records 
and financial data held at the Leeds Teaching Hospitals NHS Trust (LTHT) to support 
patient care. Data analysts within LTHT provided non-identifiable data from records 
of all cancer patients in the PPM EHR system used by the hospital. The non-
identifiable data had been encrypted and transferred to a secure environment – the 
University of Leeds Integrated Research Campus (UoL IRC). There was no known 
change identified at the beginning of the experiment of this case study.  
In this study, the PPM Chemotherapy data was used to analyse six cycles of adjuvant 
chemotherapy in patients diagnosed with breast cancer between 2004 and 2013. 
Process mining was used to highlight variations from standard pathways of 
chemotherapy including the evidence of incomplete treatment and adverse events. 
This has also shown changes in the pathway over time.  
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The limitation of using these data in this study is related to the anonymisation 
undertaken during data collection, where all dates were replaced with the patient age 
as a number of days. This anonymisation approach makes it impossible to include the 
fine-grained level of dates. For example, it was not possible to analyse busy days in 
the hospital, because there was no real date included in the anonymised dataset. 
Despite this limitation, the number of days recorded for each event can be used to 
infer sequence of events in patient treatments. 
3.4.3 Case study 3: Experiments using the PPM Cancer datasets 
The Patient Pathway Manager (PPM) is the EHR system developed and used in the 
LTHT. It holds the records of more than 3 million patients. Initially developed in 2003 
[165] to support the collection of key information for the National Cancer Dataset and 
reporting of Cancer Outcomes Services Dataset [166]. The PPM system was built 
around a standard SQL Server 2005 infrastructure and is viewed and administered via 
a User Interface (UI) application constructed and developed using Visual Basic. It 
was then extended by LTHT in 2010 as a web-based Electronic Patient Record (EPR) 
and known as PPM+. The web-based PPM Portal went live in March 2012. This 
system integrates electronic data held within the Trust into a single EHR database. 
PPM+ is the current development of the PPM system which delivers the EPR for 
LTHT staff and the Leeds Care Records (LCR). LCR integrates patient records across 
health and social care organisations in Leeds citywide. The PPM system was 
developed into PPM+ and used within Trust since 2013. The PPM+ accesses the same 
database of the PPM with additional connections to other IT systems, including 
primary care data. Following common terms used in the LTHT, the web-based PPM+ 
is now referred to as PPM and the older version of PPM is referred to as PPM1. 
In this study, the data is extracted from the PPM Query database, a copy of a real-life 
PPM database. The ethics approval of the PPM Cancer dataset was through an NHS 
honorary contract and an Integrated Research Application System (IRAS) to gain the 
Health Research Authority (HRA) Approval (REC Reference 18/HRA/0410). LTHT 
provided non-identifiable data from records of a group of cancer patients. An 
automated process was used to produce the non-identifiable row-level data in line 
with the Information Commissioner’s Office (ICO) and NHS standards. 
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Along with the data from the PPM Query database, this study used data from the PPM 
Splunk and PPM JIRA. The PPM Splunk records all user access to the PPM system, 
which is useful in analysing system usage for specific functionalities being examined. 
The PPM JIRA contains details of changes that had happened to the system, including 
the type of changes, contents of the release when the change(s) were applied, when 
they were applied, and any supporting training notes.  
In this study, the PPM Cancer dataset was used to analyse process change over time. 
One experiment explored a process before and after a known change happened, while 
two experiments were done to explore process change without a known change at the 
beginning of the experiment. The limitation of using this dataset is that the growing 
nature of the database makes it difficult to analyse the data alone without analysing 
documentations of the PPM system and discussing with clinical experts and the 
development team. The documentation and discussions were needed to reveal the 
changes that happened to the system during the long period of data collection. 
 
3.5 Summary 
This chapter has explained the general methodology and datasets used in this study. 
The main stages in the general methodology were built based on the L* life-cycle 
model and the PM2 method. The four main stages were: (1) planning and justification, 
(2) ETL, (3) mining and analysis, and (4) evaluation. Additional methods were 
followed to complete some other steps within the stages, which are the question-based 
methodology, the ClearPath method, the concept drift analysis, and signal 
decomposition and SPC methods. The ClearPath method has been published [91] and 
cited in 11 articles. Some of the steps in the general methodology were not applicable 
in the case studies because of the specific limitations of each case study. 
The next three chapters present the three case studies based on the three datasets used 
in this research. All three case studies apply the methodologies that has been presented 
in this chapter. Chapter 4 describes the MIMIC-III data as the first case study. Chapter 
5 describes the PPM Chemotherapy data as the second case study. Chapter 6 describes 
the PPM Cancer data as the third case study.  
 
Chapter 4  
Case study 1: Experiments using the MIMIC-III dataset 
The MIMIC-III is the first case study and is presented in this chapter. The data quality 
assessment part in Section 4.1.3 has been presented in a poster at the Informatics for 
Health 2017 conference in Manchester, UK. The abstract was published in the Journal 
of Innovation in Health Informatics [167]. The work was extended and published in a 
full journal paper entitled “The assessment of data quality issues for process mining 
in healthcare using MIMIC-III, a freely available e-health record database” in the 
Health Informatics Journal [168]. Section 4.2 has also been presented in an IEE 
conference in Indonesia and published in a conference paper entitled “Process mining 
in oncology using the MIMIC-III dataset” in the Journal of Physics: Conference Series 
[169]. Part of the work in this chapter was also presented in a joint presentation in the 
workshop of the Worldwide Universities Network (WUN) 2017 in New York, USA. 
4.1 Data description 
Overview of the MIMIC-III dataset has been presented in Section 1.4.2 and has been 
described in Section 3.4.1. More details of this dataset are presented in this section. 
4.1.1 Data characterisation 
The data source of the MIMIC-III dataset has been described in Section 1.4.1, and the 
overview of the dataset has been described in Section 3.4.1. The concept-level Entity-
Relationship (E-R) diagram of the MIMIC-III database is displayed in Figure 4.1. 
 
*event-related entities are in bold 
Figure 4.1 The concept-level E-R diagram of the MIMIC-III database. Five reference 
tables are: drgcodes, d_icd_diagnosis, d_icd_procedures, diagnosis_icd, procedure_icd. 
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Figure 4.1 shows the concept-level E-R diagram of the MIMIC-III database. Time in 
the MIMIC-III database is stored with one of two suffixes: TIME (down to the minute) 
and DATE (down to the day). There is also charttime indicating when the observation 
was made and storetime indicating when it was validated. In this study, the event logs 
were created using charttime attributes, as this is closest to the time of actual 
measurement. All patient data in the MIMIC-III database were de-identified and all 
dates randomly shifted to the future so that dates are internally consistent for the same 
patient but inconsistent across patients. 
4.1.2 Scope 
In this study, the MIMIC-III v1.3 was used. This version was released on 10 
December, 2015 [162]. It contains a wide range of data such as the admissions and 
discharges, ICU stays, laboratory measurements, outpatients, and charted 
observations during patient stays in the ICU. Data were curated by the MIMIC-III 
team from archives of critical care information systems, hospital Electronic Health 
Record (EHR) databases, and the Social Security Administration Death Master File. 
The rich nature of the MIMIC-III dataset provides the timestamped data of clinical 
events in the 16 event tables, which is suitable for process mining. 
In this study, the MIMIC-III database was used to provide a test case and to build a 
methodology for healthcare process mining. The patients from the MIMIC-III 
database were included if they were diagnosed with colorectal cancer, at least once. 
Colorectal cancer was chosen as a case study because this is one of the most common 
types of cancer. Colorectal cancer has already been discussed in Section 2.1.6.1 by 
providing related pieces of literature. 
4.1.3 Data quality 
The data quality assessment of the MIMIC-III dataset was done following the 
Weiskopf & Weng framework [133]. The data quality was assessed with a specific 
focus for process mining projects. The data quality assessment, as presented in the 
journal paper, was conducted following the L* life-cycle model [3] with an adaptation 
before the extraction stage. This was done by reconstructing the database in a local 
database management system (PostgreSQL). The idea was to get the fullest possible 
dataset from the MIMIC-III database that can be iteratively extracted later to create 
smaller subsets, mined, and assessed for the quality. 
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Five out of the seven methods suggested in the Weiskopf & Weng framework have 
been used to assess the data quality of the MIMIC-III database for process mining. 
Those methods resulted in some findings in four out of five dimensions of data 
quality. Two methods (gold standard and log review) were not applicable due to the 
anonymisation process done by the MIMIC-III database provider. A summary of the 
data quality assessment is presented in Table 4.1.  
Table 4.1 Data quality assessment of the MIMIC-III database 
dimension 
method 
completeness correctness concordance plausibility currency 
Element presence Y Y Y Y N 
Data element agreement Y N N N N 
Data source agreement Y Y Y N N 
Distribution comparison Y N Y Y N 
Validity check Y Y N N N 
Gold standard <<not applicable>> 
Log review <<not applicable>> 
*Y = yes (applied) *N = no (the method cannot be used to assess the dimension) 
4.1.3.1 Element presence 
Element presence was done by checking the presence of the three minimum attributes 
for process mining: case_id, activity and timestamp. The case_ids are available in the 
16 event tables are the subject_id and hadm_id. Another possible case id is icustay_id, 
but it is not available in seven tables (admissions, callout, cptevents, labevents, 
microbiologyevents, noteevents, and services). One patient (subject_id) might have 
more than one hospital admission (hadm_id) and one admission might have more than 
one ICU stay (icustay_id). The icustay_id is only available for events recorded during 
ICU stays. Those ids represent the event granularity options for process mining that 
process miners should be aware of in the analysis. 
The activities are available in all 16 event tables. Activity names are recorded directly 
in nine tables (admissions, callout, cptevents, icustays, noteevents, prescriptions, 
microbiologyevents, services, and transfers). The activity names were referred from 
the d_items table in the other six tables (chartevents, datetimeevents, inputevents_cv, 
inputevents_mv, outputevents, and procedureevents_mv). There are two levels of 
granularity in the d_items table: label (fine-grained level) and category (coarse-
grained level). Another table (labevents) has to refer to the d_labitems table. 
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The timestamps are available in all 16 event tables. The date versus time and charttime 
versus storetime issues, as presented in Section 4.1.1, are important in process mining 
projects. The different granularities of the timestamps (date – down to the day, and 
time – down to the minute) presents some issues in process mining. When tables 
having different granularity of timestamps are combined, the sequence of the events 
and the process duration might be incorrect. Four tables can be used to analyse activity 
duration because they recorded the start and end times. Those tables are the icustays, 
inputevents_mv, procedureevents_mv, and transfers tables. 
4.1.3.2 Data element agreement 
Data element agreement was done to compare two or more elements in the database 
to see if they report the same or have compatible information. In this study, the data 
element agreement was done by tracing back to the MIMIC-III website and the data 
descriptor. The preliminary assumption was that the data descriptor described the 
MIMIC-III database accurately, but this was not always the case. 
There are three findings related to completeness of the case_ids, level of detail of the 
timestamps, and plausibility of the data. Completeness of the case ids was found to be 
dependent on the case_id chosen for the analysis. When the case_id is subject_id or 
hadm_id, the admissions and transfers tables are complete. But when the case id is 
icustay_id, the icustays and transfers tables are complete. Depending on the case_id 
used in the analysis, completeness of all other tables can be checked by reference to 
those tables. The plausibility issues have been found by comparing the data duration 
with the MIMIC-III data descriptor. The MIMIC-III data descriptor specified that the 
dates had been shifted into the future to the years 2100 to 2200. It was found that some 
events were dated before 2100 and after 2200. This might be caused by historical data 
such as test results and scheduled events, such as scheduled treatments. In this study, 
there are no immediate data quality issues, but this could cause an error if the events 
were selected by a date range. 
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4.1.3.3 Distribution comparison 
Distribution comparison was done to compare the records in the MIMIC-III database 
to the data descriptor [162]. This was done to check completeness, concordance, and 
plausibility of the event tables in the MIMIC-III database. 
The subject_id is complete in all event tables, but the hadm_id and icustay_id are not. 
There are 70 missing spec_itemid in the microbiologyevents table, but those can be 
replaced entirely by spec_type_desc. In the admissions table, there are missing 
timestamps (37%) that represent patients who are not dead or not admitted in the 
Emergency Department (ED). Without access to the data source, there is no way to 
decide if the missing values are because the events did not happen or because they 
were not recorded correctly. 
Some tables have missing timestamps: callout (26%), cptevents (82%), 
microbiologyevents (7.5%), noteevents (15%), and transfers (11%). The MIMIC-III 
documentation mentions that the collection of callout data only began part way 
through the MIMIC-III database and with date shifting this missing data has been 
spread at random. Incomplete timestamps in the charttime of microbiologyevents and 
noteevents tables can be derived by linking to chartdate but consider that the 
granularity level would be different. This incompleteness also happened in cptevents, 
prescriptions, and transfers tables so process mining would be unreliable. 
4.1.3.4 Validity checking 
Validity checking was done by querying data from each table and between related 
tables, to determine if the values ‘make sense’ in the problem domain. The findings 
were related to the ICD-9 codes and duplicate records between different tables. 
The MIMIC-III database provides reference tables, which are d_icd_diagnosis 
describing the diagnosis codes and d_icd_procedures describing the procedure codes. 
The analysis of those two tables found that 144 out of 14,711 (0.98%) diagnosis codes 
are missing and 16 out of 258,082 (0.01%) procedure codes are missing. The 
percentages of the missing codes are small, but they can be significantly affected the 
analysis of a specific cohort containing those missing codes. 
There was also a duplication problem between different tables, for example, 
datetimeevents and admissions tables. In the datetimeevents table, there is a ‘hospital 
admit date’ that is duplicated with admittime in the admissions table. For those 
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duplicates, 1,696 out of 24,549 (7%) admissions are matched, while 22,658 out of 
24,549 (92%) have earlier admission dates in the admissions table compared to those 
in the datetimeevents table. In this case, the admission dates in the admissions table 
was selected, and the duplicated records in the datetimeevents table were ignored. 
4.1.3.5 Data source agreement 
Data source agreement was checked to compare data from two sources of the 
MIMIC-III database, which are CV and MV. The CV system was used during 2001–
2008 and the MV system was used during 2008–2012. The CV system was provided 
by Philips and was used to archive clinical data at the bedside of the ICU patients 
admitted to the BIDMC during 2001–2008. The MV system was used to archive the 
clinical data of patients admitted during 2008–2012. It is important to note that the 
duration of the records in the CV system (8 years) was longer than the duration of the 
records in the MV system (4 years). Patients in those two systems have data archived 
in different formats. Another consequence is that the patients recorded in the CV 
system have records from a longer duration than those in the MV system. 
In this study, it is important to know that the data source of the MIMIC-III database 
had been changed. A backward approach has been used to create separate event logs 
from the two EHRs. Those event logs were then used to discover two process models 
that could then be compared. This is described in more detail in Section 4.3 
(Comparing CV and MV systems). 
4.1.4 Representativeness 
Patients were included in the MIMIC-III database if they had at least one ICU stay. 
All clinical data for those patients were also included. This database is therefore a 
comprehensive example of EHR data from a large hospital. Representativeness of this 
database has been explored based on age group at first admission. 
A description of the MIMIC-III dataset was presented in Section 3.4.1. Figure 4.2 
shows the age groups at first admission. There were 1,991 patients (4.28%) excluded 
because their age was calculated to be over 300 at their first admission. This limitation 
is due to the time-shifting done by the MIMIC-III team to protect patient 
confidentiality. The MIMIC-III data description also mentioned that patients who 
were older than 89 years at any time in the database have had their date of birth shifted 
to obscure their age. 
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Figure 4.2 Distribution of age groups at the first admission. The x-axis shows the number 
of patients (in thousand/ K) and the y-axis shows the age groups at first admission. Gender 
are colour-coded with Male on the left and Female on the right. 
 
Figure 4.2 shows the distribution of age groups at first admission. Of a total of 46,520 
patients in the MIMIC-III dataset, there were 7,872 neonates (18%) and 36,674 adult 
patients (82%) aged 16–89. There were 25,424 male (57%) and 19,150 female (43%) 
patients. Those numbers have been checked to be in agreement with the MIMIC-III 
data descriptor. The patients in the 0–9 years group are from the CV system, which 
included newborns. 
Representativeness of the MIMIC-III dataset is high. Figure 4.2 shows that all patient 
groups and both genders are represented in the data. There was a small number of 
patients in the young age group (10–19), which corresponds to the real-life situation.  
However, a result of this small number of young patients means that the analysis of 
this cohort may not be robust. 
4.1.5 Data variety 
The data variety of the MIMIC-III dataset can be explored by describing the variety 
of diagnosis and procedure codes of the patients. The distribution of patients in 18 
diagnosis groups is presented in Table 4.2. It shows that all groups of diagnoses are 
represented in the MIMIC-III patients, allowing a range of analysis from ICD code 
001 to 999, and E&V. Each patient had 0 to 144 different diagnosis codes. The most 
common diagnosis group is the External causes of injury and supplemental 
classification (n = 34,457/ 74.1%), followed by the Diseases of the circulatory system 
(n = 32,503/ 69.8%) and the Endocrine, nutritional and metabolic disease, and 
immunity disorders (n = 27,440/ 58.9%). There are 47 patients had a null (0.10%). 
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Table 4.2 Distribution of diagnosis groups. A patient might have more than one diagnosis 
and included in more than one group. Percentage (%) is calculated over the total patients. 
ICD code Diagnosis Label n % 
001-139 Infectious and parasitic diseases 11,577 24.89 
140-239 Neoplasms 7,361 15.82 
240-279 Endocrine, nutritional and metabolic diseases, and immunity 
disorders 
27,440 58.99 
280-289 Diseases of the blood and blood-forming organs 15,661 33.64 
290-319 Mental disorders 13,400 28.80 
320-389 Diseases of the nervous system and sense organs 12,744 27.39 
390-459 Diseases of the circulatory system 32,503 69.87 
460-519 Diseases of the respiratory system 19,973 42.93 
520-579 Diseases of the digestive system 16,730 35.96 
580-629 Diseases of the genitourinary system 16,765 36.04 
630-679 Complications of pregnancy, childbirth, and the puerperium 161 0.35 
680-709 Diseases of the skin and subcutaneous tissue 5,097 10.96 
710-739 Diseases of the musculoskeletal system, connective tissue 8,391 17.97 
740-759 Congenital anomalies 2,990 6.43 
760-779 Certain conditions originating in the perinatal period 5,321 11.44 
780-799 Symptoms, signs, and ill-defined conditions 16,910 36.35 
800-999 Injury and poisoning 19,318 41.53 
E&V External causes of injury and supplemental classification 34,457 74.07 
Null  47 0.10 
 
The distribution of patients within the 18 procedure groups is presented in Table 4.3. 
It shows that all groups of procedures are represented in MIMIC-III, allowing the 
analysis of many types of procedures, from procedure 01 to procedure 99. Each 
patient had 1 to 98 different procedure codes. The most common procedure group is 
the Miscellaneous diagnostic and therapeutic procedures (n = 32,939/ 78.03%), 
followed by the Operations on the cardiovascular system (n = 24,623/ 58.33%) and 
the Operations on the digestive system (n = 9,885/ 23.42%). There are also 4,079 
patients (9.66%) having Procedures and interventions, not elsewhere classified.  
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Table 4.3 Distribution of procedure groups. Note thata patient might receive more than one 
procedure and thus be included in more than one group. Percentage (%) is calculated over the 
total patients. 
ICD code Procedure label n % 
00 Procedures and interventions, not elsewhere classified 4,079 9.66 
01-05 Operations on the nervous system 5,105 12.09 
06-07 Operations on the endocrine system 189 0.45 
08-16 Operations on the eye 194 0.46 
17 Other miscellaneous diagnostic and therapeutic procedures 37 0.09 
18-20 Operations on the ear 56 0.13 
21-29 Operations on the nose, mouth, and pharynx 700 1.66 
30-34 Operations on the respiratory system 7,208 17.07 
35-39 Operations on the cardiovascular system 24,623 58.33 
40-41 Operations on the hemic and lymphatic system 1,239 2.94 
42-54 Operations on the digestive system 9,885 23.42 
55-59 Operations on the urinary system 1,066 2.53 
60-64 Operations on the male genital organs 2,234 5.29 
65-71 Operations on the female genital organs 286 0.68 
72-75 Obstetrical procedures 52 0.12 
76-84 Operations on the musculoskeletal system 3,465 8.21 
85-86 Operations on the integumentary system 2,595 6.15 
87-99 Miscellaneous diagnostic and therapeutic procedures 32,939 78.03 
The distribution of diagnosis and procedure groups in Table 4.2 and Table 4.3 show 
that the variety of the data in the MIMIC-III database is wide. This means that this 
database, despite the limitation due to the anonymisation, is suitable for a range of 
healthcare studies.  
4.1.6 Limitations of using MIMIC-III for process mining 
The MIMIC-III database represents real healthcare data, with some limitations that it 
contains only the data of Critical Care patients and there is no direct access to the 
clinicians in the hospital. This leads to the limitation that the full analysis can only be 
done based on the available data. Despite this limitation, there are also some 
publications and websites describing this data that can be used to support analysis in 
this study. 
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Some identified limitations specific for process mining were omissions, incorrectness, 
incompleteness, and inaccuracy. Those can happen in different levels i.e. the events, 
case attributes, activity names or codes, timestamps, and attributes. This means that 
quality checking should be done thoroughly. This is because, for example, 
incorrectness could happen to an event, an activity name, a timestamp, or any other 
attribute. Another significant limitation is that all the dates have been shifted to future 
years (between 2100 and 2200) consistently for each patient to randomly distributed 
future dates. This means that analysis related to time between different patients, such 
as workflow analysis looking at busy days and the impact of bottlenecks e.g. of 
patients waiting for care on a busy day, cannot be deduced. 
Despite these issues, the overall data quality of the MIMIC-III dataset was found to 
be good; there is a rich set of detailed event data covering a 10-year period and it 
comes from a representative of a real-life hospital. The MIMIC-III dataset still 
contains detailed information of real healthcare processes for individual patients 
during their time in the hospital including comprehensive details on administrative 
activities (admission, discharge, transfer to a ward, etc.) and clinical activities (triage, 
test and scans, diagnosis, etc.). Another reason why this dataset was suitable for this 
study was that there were a system change in the MIMIC-III dataset with a possibility 
to work out on separating patient admissions from those two different systems. It was 
a great opportunity for this study to compare processes in those two systems. 
Section 4.1 has described the data characteristics, scope, data quality, 
representativeness, data variety, and the limitations of using MIMIC-III dataset in this 
study. Sections 4.2 and 4.3 go on to present two experiments using the MIMIC-III 
dataset. Section 4.2 presents the first experiment to apply process mining on the 
MIMIC-III dataset. The challenge of this experiment was on selecting the suitable 
tables to represent the patient pathways. Section 4.3 presents the second experiment 
to compare process in CV and MV as two subsequent systems. The challenge was to 
find a way to separate records in CV and MV and then compare the processes. Section 
4.4 summarises this chapter. 
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4.2 Experiment 1: Process mining on the MIMIC-III dataset 
This section presents the first experiment aimed to assess the suitability of the 
MIMIC-III dataset to be analysed using process mining approaches. A cohort of 
patients diagnosed with cancer was selected based on an initial discussion with UK-
based clinical experts. Implementation of the main stages of the general methodology 
in this case study is presented in this section. 
4.2.1 Stage 1: Planning and justification 
Stage 1 was done by understanding the available data from the data descriptions on 
the official website and in papers related to MIMIC-III [162]. Historical data were 
generated from 16 event tables in MIMIC-III. There were no handmade models used 
in this study. The general research question was “Can the MIMIC-III database be 
used for process mining in healthcare?”. This detailed research question was based 
on generic types of questions that are frequently posed by medical professionals in 
process mining projects, which are: 
1) What are the most followed paths and what exceptional paths are followed? 
2) Are there differences in care paths followed by different patient groups? 
3) Where are the long waiting time activities in the process? 
4.2.2 New stage: Database reconstruction 
An additional stage in this study was database reconstruction. It was necessary to 
reconstruct the MIMIC-III dataset from the csv files to create a relational database in 
a local database management system (PostgreSQL). This stage included downloading 
the 26 csv files (6.2 GB in total) along with scripts to import the data into the 
PostgreSQL database. 
Figure 4.3 presents the concept-level E-R diagram of the 26 tables in the MIMIC-III 
database. The approach of this study was to reconstruct the database to get the fullest 
possible dataset. The reconstructed database was then used for iterative extractions 
based on several criteria.  
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Figure 4.3 Entity-Relationship (E-R) diagram of the MIMIC-III database. The entities 
in red contain timestamped information which can be used to construct event log data for 
process mining. 
4.2.3 Stage 2: Extraction, transformation, and loading 
This stage started with selecting records of patients diagnosed with cancer. This 
selection was based on the ICD codes in the diagnoses_icd table for cancer diagnosis 
(140x-239x) [170]. Those patients were later grouped based on the cancer types, as 
presented in Table 4.2 in Section 4.1.5. 
In total, 7,361 patients had at least one cancer diagnosis and were selected in this 
study. Those patients were then grouped based on the 13 types of cancer (see Table 
4.4). The three largest groups are group 7, group 2, and group 8.  The median age of 
patients in each cancer types ranges from 46 years (group 5) to 74 years (group 9). 
Median hospital length of stays (LOS) is 8 to 15 days, while the median ICU length 
of stay ranges from 2 to 3 days.  
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Table 4.4 Summary of cancer type in the MIMIC-III data 
Type Description  (ICD9 codes in brackets) a b c d e f 
1 Malignant neoplasm of lip, oral cavity, and pharynx (140-149) 87 135 135 65 8 3 
2 Malignant neoplasm of digestive organs and peritoneum (150-159) 1,400 2,012 2,148 68 10 2 
3 Malignant neoplasm of respiratory and intrathoracic organs (160-165) 1,056 1,540 1,561 69 8 2 
4 Malignant neoplasm of bone, connective tissue, skin, and breast (170-175) 238 337 336 61 8 2 
5 Kaposi's sarcoma (176) 14 19 20 46 8 2 
6 Malignant neoplasm of genitourinary organs (179-189) 724 1,025 1,076 73 9 2 
7 Malignant neoplasm of other and unspecified sites (190-199) 2,846 3,950 4,003 64 8 2 
8 Malignant neoplasm of lymphatic and hematopoietic tissue (200-209) 1,110 1,692 1,876 62 14 3 
9 Neuroendocrine tumours (209-209) 26 38 42 74 15 3 
10 Benign neoplasm (210-229) 1,215 2,036 2,127 59 8 2 
11 Carcinoma in situ (230-234) 45 65 66 70 13 2 
12 Neoplasms of uncertain behaviour (235-238) 588 1,065 1,145 65 10 2 
13 Neoplasms of uncertain nature (239) 60 105 108 67 9 2 
Note: a = distinct patients, b = distinct admissions, c= distinct ICU stay id, d = median age (years), 
 e = median hospital LOS (days), f = median ICU LOS (days) 
Extraction of all cancer patient records was done by selecting records of cancer 
patients from each event table in MIMIC-III. For example, the query to extract cancer 
patient records in chartevents table is as follow. 
SELECT  
  c.subject_id, c.hadm_id, d.label, d.category, c.charttime 
FROM  
  Chartevents c, d_items d, diagnoses_icd di 
WHERE  
  c.itemid = d.itemid AND c.subject_id IN 
  (SELECT DISTINCT subject_id FROM mimiciii.diagnoses_icd  
 WHERE icd9_code BETWEEN '14%’ AND ‘24%'); 
All 16 event tables in the MIMIC-III database had been extracted using this method. 
They were then combined to create an allevents table. The three largest tables are 
chartevents, labevents, and inputevents_cv. A summary of the extracted records is 
presented in Table 4.5. 
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Table 4.5 Summary of table extracted 
# Table Name Patients Activities Rows Percentage 
1 admissions 7,361 5 35,843 0.07 
2 callout 4,771 6 27402 0.05 
3 chartevents 7,359 2,580 38,766,594 76.07 
4 cptevents 6,707 4 19,310 0.04 
5 datetimeevents 5,648 148 925,542 1.82 
6 icustays 7,345 2 22,976 0.05 
7 inputevents_cv 3,924 756 1,833,886 3.60 
8 inputevents_mv 3,850 251 664,209 1.30 
9 labevents 7,351 556 6,912,233 13.56 
10 microbiologyevents 3,553 47 11,670 0.02 
11 noteevents 5,351 584 129,712 0.25 
12 outputevents 7,278 415 824,665 1.62 
13 procedureevents_mv 3,853 114 53,440 0.10 
14 prescriptions 6,900 2,697 685,648 1.35 
15 services 7,357 18 15,657 0.03 
16 transfers 7,361 8 29,708 0.06 
allevents table 51,649,231  
The allevents table was created by combining all tables contained 51,649,231 rows, 
which would result in a ‘spaghetti’ model if directly used for process discovery. It is 
also important to mention that the original allevents table is dominated by chartevents 
(76.07%). Straightforward use of process mining will contain only chartevents and 
exclude other events. Further transformation of the dataset was then essential. 
Transformation was performed in several steps, as shown in Figure 4.4. A 
transactional table was created consisting of subject_id, activity, category, tname, 
charttime and records were inserted from all tables extracted before.  
Data processing was followed the steps in PM2 methodology: (1) Filtering log – by 
excluding tables with a high percentage of missing data (callout, cptevents, and 
prescription) and handling duplicate records by keeping only one of them, (2) 
Enriching log –by creating three levels of details (table name, category, and activity 
label), (3) Creating views – this was done based on the level of detail needed in the 
next stage based on two general types of events recorded in the tables, administrative 
and clinical events, and (4) Aggregating events – this was done by applying “Merge 
subsequent events >> Merge taking first event” plugin in the ProM software. 
A summary of those data transformation steps is shown in Figure 4.4. 
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Figure 4.4 Data transformation. It includes log filtering, log enrichment, views creation, 
and event aggregation. 
 
Loading, the final step in this stage was done by importing the file to ProM and 
processing it to discover process models using the specified algorithm/plugin. Unless 
otherwise stated, all plugins in ProM were applied with default parameter settings. 
4.2.4 Stage 3: Mining and analysis 
The next stage of this study was process mining and analytics. Process mining was 
done through process discovery, conformance checking, and enhancement. Process 
analytics was done to compare pathways of patient groups and analyse waiting times. 
The general research question for this step was “Can the MIMIC-III database be used 
for process mining in healthcare?”. The initial algorithm was the heuristics miner. 
Analysis and conformance checking were done to ensure that the discovered models 
represent realities in clinical settings. This was done by balancing the fitness, 
precision, and generalisation measures of the process model quality dimensions. 
Figure 4.5 shows the trace variant diagram as one result. It shows the five most 
common variants out of 104 variants from 8,912 traces. The pathways represented the 
reality where patients could be admitted to standard hospital admission or registered 
through the ED, and could later be discharged from the hospital. The interesting 
pattern was that there were some patients discharged fully before actually being 
discharged from the ICU (ICU out) (see the fourth and fifth traces). This finding 
reflected the administrative process within the hospital. 
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Figure 4.5 The five most common variants (from ProM). It shows the top five variants 
covering for >70% traces in the event log. 
 
Figure 4.6 shows the discovered process model in the Business Process Modelling 
Notation (BPMN). This process model has a fitness score of 0.971, a precision score 
of 0.881 and a generalisation score of 0.989. All three conformance values were high, 
showing that the discovered model is indeed a good representation of the event log. 
A UK-based oncologist then reviewed the discovered models for sense-checking. One 
possible data quality issue was that discharge took place after death and ICU out took 
place after discharge. Those were found to reflect the hospital’s standard 
administrative processes. There are also variations in the administrative steps as 
presented in Figure 4.6. 
 
Figure 4.6 The BPMN process model of admissions and ICU stays  (from ProM). This 
model shows variations in the administrative steps. 
 
Following the same method, process models were created from each group to answer 
the research question “Are there differences in care paths followed by different patient 
groups?”. The pathways of the three most common groups are shown in Figure 4.7.  
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Figure 4.7 Process models of three most frequent cancer types  (from ProM). The 
process models show visual differences between patient groups. 
 
The models of cancer type 2, type 7, and type 10 were reviewed by a UK clinical 
expert based on their visual utility. Some important findings are: (1) ICU in, ICU out, 
admission and discharge always happened in all three cancer types regardless of the 
sequence; (2) ED registration, ED out and death are possible events in all three types; 
(3) admission happened as the first event or after ED registration in all five types; and 
(4) death in type 10 is possibly happened only after ICU out, while it can happened 
before ICU out in the other four types. 
Analysing differences of the pathways of different types of cancer can also be done 
by comparing conformance values, i.e. trace fitness, precision, and generalisation. 
The result is summarised in Table 4.6. Summary of the results shows that process 
models of all cancer types are representative of the traces, with average fitness of 
0.843, average precision of 0.798, and average generalisation of 0.966. The minimum 
value is on the precision of cancer type 13 (0.692) and the maximum value is on the 
precision of cancer type 5 (1.000). 
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Table 4.6 Conformance values of each type of cancer 
* F = fitness, P = precision, G = generalisation, MN = malignant neoplasm 
Type Description F P G 
1 MN of lip, oral cavity, and pharynx (140-149) 0.813 0.767 0.961 
2 MN of digestive organs and peritoneum (150-159) 0.813 0.816 0.977 
3 MN of respiratory and intrathoracic organs (160-165) 0.830 0.826 0.981 
4 MN of bone, connective tissue, skin, and breast (170-175) 0.819 0.822 0.952 
5 Kaposi’s sarcoma (176) 0.800 1.000 0.978 
6 MN of genitourinary organs (179-189) 0.825 0.809 0.982 
7 MN of other and unspecified sites (190-199) 0.835 0.822 0.991 
8 MN of lymphatic and hematopoietic tissue (200-209) 0.894 0.716 0.995 
9 Neuroendocrine tumours (209-209) 0.898 0.619 0.855 
10 Benign neoplasm (210-229) 0.830 0.808 0.982 
11 Carcinoma in situ (230-234) 0.882 0.859 0.975 
12 Neoplasms of uncertain behavior (235-238) 0.849 0.813 0.978 
13 Neoplasms of uncertain nature (239) 0.872 0.692 0.950 
average 0.843 0.798 0.966 
Further analysis in this stage has been done to explore the waiting times for the 
admission pathways of all cancer patients, in order to answer research question 
“Where are the long waiting time activities in the process?”. In this stage, the models 
have been extended by adding a time perspective.  
The BPMN model was analysed with the “Replay a Log on Petri net for Performance/ 
Conformance Analysis” in ProM. The result was added on the original BPMN, as 
shown in Figure 4.8.  
 
Figure 4.8 Waiting time analysis. This is a combined output from the BPMN Analysis, 
Convert BPMN diagram to Petri Net, and Replay a Log on Petri net plugins. 
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The analysis revealed that the longest waiting time is in ICU out (4.07 days on 
average), while the second longest waiting time is ICU in (2.70 days on average). The 
long waiting times in ICU in and ICU out give the insight to dig deeper into the lower 
level of activities between ICU in and ICU out to understand which activities 
contribute to the long waiting time in the ICU. 
4.2.5 Stage 4: Evaluation 
Evaluation of this experiment was done by analysing the suitability of the MIMIC-III 
dataset for process mining. The MIMIC-III database does not contain an event log, 
but it is possible to analyse the clinical processes in the MIMIC-III database with 
process mining approaches through the extraction of event data in 16 out of 26 tables 
within the MIMIC-III database. A new stage is needed to reconstruct the database in 
a database management system, such as MS SQL Server or PostgreSQL. The database 
reconstruction stage has been presented in Section 4.2.2. Evaluation of the findings 
was achieved by discussions with a UK-based oncologist. This approach has a quality 
concern that the UK-based oncologist might not have enough knowledge about the 
USA healthcare system. The task of the oncologist was only to do sense-checking and 
raise concerns on any possible issues related to the USA healthcare system. 
An additional evaluation was done using 5-fold cross-validation. The event log was 
randomly partitioned into five equal-sized partitions (also called as folds). One fold 
was used as the validation data to test the model while the remaining four  folds were 
used as the training data to build the process model. The cross-validation was done 
five times so that each of the five folds used exactly once as the validation data. The 
final results were estimated from the average of the five values of fitness, precision, 
and generalisation. The results of this evaluation are presented in Table 4.7. It shows 
that the process model represents the traces in the event log (high fitness) with 
relatively high precision and high generalisation. 
Table 4.7 The results of five-fold cross-validation 
# Training folds Validation fold Fitness Precision Generalisation 
1 2, 3, 4, 5 1 0.97024 0.6984 0.9873 
2 1, 3, 4, 5 2 0.96156 0.8254 0.9794 
3 1, 2, 4, 5 3 0.96961 0.9029 0.9838 
4 1, 2, 3, 5 4 0.97389 0.6803 0.9873 
5 1, 2, 3, 4 5 0.96792 0.8793 0.9784 
average 0.968644 0.79726 0.9832 
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4.3 Experiment 2: Comparing CV and MV systems 
This experiment aimed to identify the effects of the change in the EHR system from 
CareVue (CV) to MetaVision (MV). In this experiment, all patients in the MIMIC-III 
dataset were included. The first challenge in this experiment was to separate 
admissions from the CV and MV systems.  
4.3.1 Stage 1: Planning and justification 
Stage 1 (planning and justification) was done by understanding the dataset and 
identifying research questions. The research questions are: 
1) Is it possible to create separated logs from CV and MV systems? 
2) Can process mining be used to analyse differences in care paths in two systems? 
Because all dates in the MIMIC-III have been shifted, a simple comparison of dates 
was not possible. However, there is a db_source column in the d_items table to 
identify the data source of each admission in the tables linked to the d_items table. 
This column will be used to create separated logs for CV and MV systems. In this 
experiment, process mining approach will be used in the model-based and log-based 
comparisons to analyse differences in care paths in the two systems.  
4.3.2 Stage 2: Extraction, transformation, and loading 
The checking on itemid column in d_items table is presented in Table 4.8. The 
differences between the two EHR systems can be identified through four tables: 
chartevents, datetimeevents, inputevents, and outputevents. The dbsource hospital 
would be ignored because our focus was on the CV and MV systems used. 
Table 4.8 Details of itemid in d_item table 
dbsource linksto occur 














hospital microbiologyevents 436 
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This logic was used to insert a field in the admissions table that indicated which of 
the two systems had been used to record the admission. These new fields were used 
to extract the records in those tables and transform them into event logs of the CV 
and MV systems. The proportion of patients in the CV, MV, and both systems, is 
shown in Figure 4.9. 
 
Figure 4.9 Proportion of CV, MV and both systems' patients.  The ‘both’ group refers 
the number of patients who had records in both CV and MV systems. 
As presented in Figure 4.9, the number of patients in the CV and MV only groups are 
not balanced. It is also important to note that within the data collection, the durations 
of the system usage were indeed imbalanced. The CV system was used for eight years 
(2001–2008) while the MV system was used for four years (2008–2012). A patient 
might have admissions in both the CV and MV systems. Only patients in the CV and 
MV groups were used. 
The two separated event logs were then loaded to the process mining tools. Both logs 
compared to each other within the model-based and log-based comparison. The 
model-based comparison was done to compare process models discovered in those 
two systems. The log-based comparison was done to compare event logs in those two 
systems. Both model-based and log-based comparisons were done in the mining and 
analysis (stage 3) of this experiment. 
4.3.3 Stage 3a: Model-based comparison 
The model-based comparison started with discovering the process models of the 
separated event logs and followed by comparing those two process models. The 
process discovery step was done by loading the allevents table into the process mining 
tools to create a process map using several algorithms. Some tools used in this study 
were DISCO, ProM, and bupaR. The process model of all 16 events is not presented 
here because it is too complex.  
As an illustration, Figure 4.10 shows the process model of five admission events of 
26,762 patients in the CV system. There are 74,779 events in total for all patients, 
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consisting of 30 variants. The most frequent variant is: Admission à Discharge (n= 
9,273 / 40.2%). The median case duration is 7.4 days and the mean is 11 days. The 
second most frequent variant is ED registration à Admission à ED out à Discharge 
(n= 9,263 / 40.16%). The median case duration is 7.4 days and the mean is 10.6 days. 
These two variants are the two most frequent ones with and without the ED episode. 
 
Figure 4.10 Process model of admissions in the CV system showing 70% of the most 
common paths (from DISCO) 
The process models discovered from the CV and MV event logs were then compared 
using the DifferenceGraph plugin in ProM 5.2. This plugin identifies differences and 
commonalities between two process models. The result is presented in Figure 4.11. 
 
Figure 4.11 DifferenceGraph of admissions in CV and MV resulted from ProM. The red 
arcs represent the differences in the two event logs. 
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Figure 4.11 shows the differences between admissions in the CV and MV systems, 
which found changes in the last activities that happened within those two systems. 
The admissions in CV ended with either discharge (35,788 or 99.874%), death (26 or 
0.073%), or ED out (19 or 0.053%). But all admissions in MV ended with discharge 
(19,623 or 100%), suggesting that MV has better consistency on the administrative 
records than CV.  
The CV process model gave a fitness score of 0.9996, a precision score of 0.8784, 
and a generalisation score of 0.9006; while the MV process model gave a fitness score 
of 0.9990, a precision score of 0.9382, and a generalisation score of 0.8916. This 
suggested that both models can replay the observed behaviour (high fitness), describe 
the system generally (high generalisation), and not allow for too much divergent 
behaviour (high precision). The combination of interpreting event frequencies, the 
DifferenceGraph, and the conformance measures leads to the conclusion that the EHR 
system change did affect the process model and quality and required further 
investigation. More results of model-based comparison is presented in Appendix C.3. 
The limitation of this approach is that it is depended on the visual difference of the 
models. Future improvements are needed to improve this approach. 
4.3.4 Stage 3b: Log-based comparison 
Log-based comparison of patient data in CV and MV systems was done using log 
profiling and process comparator approaches. The grouping into CV and MV 
admissions were done based on the method described in Section 4.3.1. Log profiling 
was done for each table in the MIMIC-III database. 
For example, from the admissions table, some important information is: 
- NEWBORN admissions only happened in CV, and are excluded in the 
experiment. The proportion is presented in Table 4.9. 
Table 4.9 Proportion comparison of CV and MV 
Database Admission type Patients Admissions % Admissions 
CareVue EMERGENCY 15,499 18,508 80.24 
ELECTIVE 3,433 3,594 15.58 
URGENT 941 964 4.18 
MetaVision EMERGENCY 13,492 16,112 83.53 
ELECTIVE 2,831 2,955 15.32 
URGENT 223 223 1.16 
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- The average admission duration in MV (8.97 days) is shorter than CV (10.67 
days). 
- There were data quality issues detected in CV where ED duration < 0. After non-
valid data were excluded, the average ED duration in MV (0.23 days) was shorter 
than CV (0.28 days), as presented in Figure 4.12. 
    
Figure 4.12 Comparison of hospital admission of CV and MV patients on admission 
durations (left) and ED durations (right). 
 
Figure 4.12 shows that both the average of admission durations and the average of ED 
durations in MV are shorter than in CV. The results of log profiling from the other 
tables are documented in detail in Appendix C.2. 
Log-based comparison [149] aims to detect relevant differences between processes 
based on what was recorded in event logs. In this study, the log-based comparison 
was done using the Process Comparator plugin in ProM [150]. This plugin compares 
two event logs: CV as the first log and MV as the second log. The traces in those two 
event logs are merged to create the reference log. Process metrics in this experiment 
is trace frequency, with an alpha significant level of 5%. The significant difference 
between the two logs is presented as a state transition diagram annotated with colours 
based on the oracle of the effect size. The colour legend is shown in Figure 4.13. 
- 103 - 
 
Figure 4.13 Colour legend in the Process Comparator plugin (from ProM). Darker 
colours represent higher significance differences. Red represents lower average in group 1 
than in group 2; blue represents higher average in group 1 than in group 2. 
 
The log-based comparison was done per table to compare processes in the CV and 
MV systems. For example, the log-based comparison was done to the admissions in 
the CV and MV systems. Characteristics of the admissions in the two systems are 
presented in Table 4.10. 
Table 4.10 Characteristics of the admissions in CV and MV systems 
Characteristics CV MV 
Cases [hadm_id] 23,066 19,290 
Events 74,779 65,213 
Event classes 5 5 
Events per case * 3 [2-5] 3 [2-5] 
Event classes per case * 3 [2-5] 3 [2-5] 
Variants 30 20 
Pair-wise difference 71.43% 
* average [min – max] 
Table 4.10 shows that admissions in the CV system are larger than the MV system. 
The number of event classes (5), events per case (3 [2-5]) and event classes per case 
(3 [2-5]) are the same in both systems. The number of variants in CV (30) is larger 
than in MV (20), suggesting that the variability in the older system is higher than in 
the new system. The Process Comparator plugin shows that the pairwise difference is 
71.43%.  
The detailed differences are shown in Figure 4.14. The comparison diagram in Figure 
4.14(a) shows that the frequency of patients having ED registration and ED out in MV 
are larger than CV, while the frequency of patients with death records in CV is larger 
than MV. Figure 4.14(b) shows that the trace durations are similar in both systems, 
with slightly longer duration in CV than MV. 
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(a) metric: trace frequency (b) metric: duration 
Figure 4.14 Comparison diagrams of hospital admission of CV and MV patients. The 
trace frequency metric shows more significant differences than the duration metric. 
 
A technical challenge in doing this comparison is that the processing time of the 
Process Comparator plugin in ProM 6.8 is high. Some tables could not be compared 
using this plugin because of the processing time. There are only six tables that can be 
compared using the process comparator plugin. Those are: admissions, callout, 
labevents, noteevents, outputevents, and services. Of those six tables, the noteevents 
table has the highest difference (92.31%) between the CV and MV systems. This was 
followed by outputevents (87.50%) and services (78.75%). The highest difference in 
the noteevents is apparently due to the highly different number of event classes in CV 
(21) and MV (1165). The number of events per case and variants is consequently high. 
The outputevents both in CV and MV have 12 event classes, but the number of events 
per case and variants in those two systems are highly different. The services have 19 
event classes in CV and 17 event classes in MV. The high difference is apparently 
because the average number of events per case in both systems is one, meaning that 
most patients only have one event in services. The results are summarised in Table 
4.11. 
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Table 4.11 Log-based comparison summary 
Tablename DB Cases Events Event classes Events per case* Var Diff.(%) 
admissions 
CV 23,066 74,779 5 3 [2-5] 30 
71.43 
MV 19,290 65,213 5 3 [2-5] 20 
callout 
CV 7,037 32,635 4 5 [3-23] 85 
50 
MV 15,698 89,245 6 6 [3-35] 366 
labevents 
CV 22,763 1,744,263 6 77 [1-300,203] 21,108 
72,73 
MV 19,176 878,686 6 46 [1-76,333] 16,774 
noteevents 
CV 22,081 347,882 21 16 [1-931] 244 
92.31 
MV 7,331 175,715 1165 24 [1-701] 6,724 
outputevents 
CV 21,915 1,781,202 12 81 [1-5208] 943 
87.50 
MV 18,697 1,228,067 12 66 [1-2104] 3,352 
services 
CV 23,045 29,530 19 1 [1-7] 484 
78.75 
MV 19,278 24,810 17 1 [1-9] 505 
* average [min – max] 
4.3.5 Stage 4: Evaluation 
Evaluation of this experiment has been done by analysing the suitability of the 
methods used to compare processes in two different systems. The source of the data 
collected in the MIMIC-III was changed in 2008. A backward approach was done to 
mark hospital admissions with the data source from which they had been recorded, 
which are the CV and MV systems.  
Comparison of the processes in those two data sources (CV in 2001–2008 and MV in 
2008–2012) was conducted to explore the effects of a system change to the treatment 
process. The comparison was done based on the process model and log conformance. 
The model-based comparison on the administrative events in CV and MV found some 
interesting results, such as that discharge is recorded in all patients in MV, but not in 
CV. This suggested that the system change has improved the consistency of the data 
recording. The log-based comparison with the Process Comparator plugin in ProM 
resulted in the percentage of difference between two logs at a time. This method is 
robust and based on a statistical test that can be adjusted as required.  The examples 
of the resulted comparison diagrams in Figure 4.14 are easy to understand and 
showing the differences of two logs based on trace frequency and duration of the 
process. The limitation of using the process comparator plugin was that this method 
was technically limited and only applicable to five out of 11 tables in this experiment. 
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This suggested a potential research experiment to create a new method for log-based 
comparison. This is explored further with the PPM Cancer data in Chapter 6. 
4.4 Summary 
This chapter has described the analysis of the MIMIC-III dataset. The assessment of 
the data quality has been published in a journal paper in 2018 [168] and cited in 7 
articles. Some parts of experiment 1 have been published in a conference paper in 
2018 [169] and cited in 7 articles. 
This case study can be analysed based on different perspectives, as described in 
Section 1.2. From the health service perspective, process mining has been able to 
answer frequency posed questions, such as those in the first experiment in Section 
4.2. Health service professionals can get some insights into the most followed paths 
and the exceptional paths, the differences in care paths followed by different patient 
groups, and the long waiting time activities in the process. From the process mining 
perspective, this case study has been shown how MIMIC-III can be used for process 
mining in healthcare. Some limitations have been discussed, but the experiments have 
shown that process discovery and conformance checking can be applied to analyse 
MIMIC-III dataset. From the information system perspective, experiment 2 in Section 
4.3 concluded an important lesson learned that a system change affected the data 
recorded in the system. Limited discussion of the clinical perspective in this case study 
is due to the limited access to the data source of the MIMIC-III database.  
 
Chapter 5  
Case study 2: Experiments using the PPM Chemotherapy Data 
Analysis of the MIMIC-III dataset as the first case study was presented in Chapter 4. 
This chapter presents the experiments using the Patient Pathway Manager (PPM) 
Chemotherapy dataset as the second case study. Section 5.1 presents the data 
description of the PPM Chemotherapy dataset. Section 5.2 and Section 5.3 present the 
two experiments in this case study. Section 5.2 has already been presented in a poster 
in the NCRI Cancer Conference 2018 in Glasgow, UK, entitled “Process mining to 
explore variation in chemotherapy pathways for breast cancer patients”. The abstract 
of the poster has been published in the British Journal of Cancer supplement [171]. 
5.1 Data description 
The PPM Chemotherapy dataset was introduced in Section 1.4.2 and described in 
Section 3.4.2. This section explores this dataset in more detail. 
5.1.1 Data characterisation 
The PPM Chemotherapy dataset is a pseudonymised dataset transferred from the 
LTHT to a secure SQL database on a virtual machine at the University of Leeds 
(UoL). The data has been checked, cleaned, and aggregated before approval for 
transfer to the research team. The previous study used the PPM Chemotherapy data 
to define a predictive model identifying patients receiving cancer treatment who were 
at the highest risk of developing life-threatening complications, such as neutropenia. 
There are 13 event tables in the PPM Chemotherapy dataset, as presented in Figure 
5.1. All tables are related based on the Patient Identification (PID), except the 
TestResultsBlood and the TestResultsMicrobiology tables that are linked based on the 
Knowledge Transfer Partnership ID (KTPId) and were extracted from the Result 
database. The KTPId was the identifier used in the previous study using this dataset. 
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Figure 5.1 The database structure of the PPM Chemotherapy data.  Blue dot marks the 
Age attribute that later be used to create a generated timestamp. 
 
5.1.2 Scope 
The scope of the dataset for this study can be described as follows. This dataset 
contains the routinely collected data of cancer patients (ICD-10 codes C00–C97, 
D00–D48) who were first diagnosed between 2004 and 2012, and treated with 
chemotherapy, in the Leeds Cancer Centre. As of 13 August 2013 (PPM 
Chemotherapy data collection), there were 1.76M patients in the PPM EHR system 
with 92,044 of them having received chemotherapy or radiotherapy. The PPM EHR 
system has been used since 2003 to hold the clinical records of all cancer patients 
including their diagnosis, treatment and outcome treated at the LTHT. 
The data included patient demographics (age, gender, ethnicity, distance from LTHT), 
details of chemotherapy drugs and doses, details of the cancer diagnosis and related 
co-morbidity, results of blood tests, results of microbiological investigations, details 
of acute admissions and outpatient reviews. Further discussions with clinical experts 
- 109 - 
suggested that the selection of events included in the PPM Chemotherapy dataset are 
suitable in analysing the chemotherapy pathways in cancer patients. Specific scope 
was suggested to focus on breast cancer patients receiving EC-90 as an adjuvant 
chemotherapy. 
5.1.3 Data quality 
Data quality of the PPM Chemotherapy dataset was assessed based on the Weiskopf 
& Weng framework [133]. The completeness was checked through element presence 
checking, the correctness and plausibility were checked through validity checking, 
and the concordance through element agreement. Each of the data quality dimensions 
is presented in the following paragraphs. 
The completeness of the data was checked based on the element presence checking 
of the three minimum required attributes for process mining, which are case_id, 
activity, and timestamp. There were no timestamps available in the dataset, but Age 
(in the number of days) was recorded for each activity. Those Age columns were then 
used to generate dates by assigning ’01-01-2020’ as the date of birth for all patients. 
A summary of the element presence checking is presented in Table 5.1. 
Table 5.1 Element presence checking of PPM Chemotherapy dataset 
Table source Element presence 
case_id [%] Activity [%] Time (AgeAt-) [%] 
Admissions PID [91] AdmissionMethod [91] Admission, Discharge [91] 
AdmissionWard_ 
StayLocation 




ChemoCycles PID [92] Cycle Number [92] CycleStarted [92] 
ChemoDrugs PID [99] Drug Label [99] DrugGiven [99] 
ChemoRegimens PID [99] RegimenLabel [99] RegimenStartDate [99] 
Death PID [56] ‘Death’ [56]  Death [56] 
Diagnosis PID [98] dx_ICD10Label [98] Diagnosis [64] 
Outpatients PID [92] AppointmentTypeDesc [91] TimeOfOPClinic [92] 
Patients PID [100] **‘Death’ [36] Death [36] 
Radiotherapy PID [53] IntentLabel+ SiteCode [53] Radiotherapy [53] 
Surgery PID [68] ProcedureLabel Surgery [68] 
TestResultsBlood PID [93] Term [93] OrderDate [93] 
TestResultsMicrobiology PID [50] Source [50%] OrderDate [50] 
* Activity names are created based on available recorded Age (in number of days) 
** ‘Patients’ table contains only Death events, duplicated but Death’ table is complete 
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The correctness of the PPM Chemotherapy dataset was examined through a validity 
check. Some doubts had been discussed with the domain experts and those have been 
validated, such as: (1) Chemotherapy cycle numbers were recorded with a range of 1 
to 93; (2) Cycle max days were recorded with a range of -7 to 547; and (3) Year of 
diagnosis ranged from 1921 to 2015. The recorded year of diagnosis 1921 suggested 
a data quality problem and required a filtering step to include only a reasonable range 
of diagnosis year. Some others were excluded from the data, such as: (1) Age at 
discharge = NULL; (2) Four cases ended with Admissions; (3) Age at Radiotherapy 
= -13959; and (4) Six missing values in ProcedureLabel. All those findings represent 
incorrect records in the data. This condition happened because, when the PPM 
database had begun to be used to record data, older records were manually typed in 
from the paper-based records. 
The concordance of the PPM Chemotherapy dataset was checked through element 
agreement. Some important findings are: (1) the ChemoCycles, ChemoDrugs, and 
ChemoRegimens tables contain different numbers of patients, as should be the case. 
A discussion with clinical experts revealed that the ChemoCycles table is the most 
reliable among those three tables. (2) ‘Death’ events were recorded in two tables: the 
Death table and the Patients table. The records in the Death table are more than those 
in the Patients table. 
The plausibility was checked through validity checking. The PPM Chemotherapy 
dataset contains the records of 31,511 patients diagnosed with cancer between 1921 
and 2012, of whom 29,009 had received chemotherapy, 21,395 surgery and 16,792 
radiotherapy in Leeds. From a discussion with a domain expert in the early stages of 
this study, we had confirmed that these numbers did not represent the whole number 
of cancer patients. This is because the data collection was focused on the patients 
receiving chemotherapy only and was not meant to reflect the reality where there 
should be more patients receiving radiotherapy than those receiving chemotherapy. 
5.1.4 Representativeness 
The representativeness of the PPM Chemotherapy dataset is related to the PPM 
Cancer data, the database where the PPM Chemotherapy dataset was extracted from. 
The PPM Cancer data was extracted from the PPM EHR system in the LTHT. The 
Leeds Cancer Centre in the LTHT is one of the largest specialist cancer centres in the 
UK [21]. Based on this fact, the data of cancer patient treatment in the PPM Cancer 
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dataset can be argued to be representative of the data of cancer patient treatment in 
the UK. Additional analysis of the representativeness was done by checking if the 
most common cancers in the UK can also be found as the common cancers in the PPM 
Cancer dataset. 
In the UK, there were 303,135 new cancer diagnoses registered in 2016. Over half 
(52.7%) of all registrations were either one of four cancer types (ICD-10 codes): 
breast cancer (C50), prostate cancer (C61), lung cancer (C34), and colorectal cancer 
(C18–C20) [172]. The PPM Chemotherapy dataset consists of the data of patients 
who had at least one diagnosis of cancer between 1921 and 2015. Table 5.2 shows the 
occurrence of those four most common cancer types in the PPM Chemotherapy 
dataset. 
Table 5.2 Representativeness of PPM Chemotherapy dataset 
Cancer diagnosis Occurrence Patients (%) Rank 
Breast cancer (C50) 5,616 3,952 (32.6%) 2 
Prostate cancer (C61) 1,116 901 (7.4%) 10 
Lung cancer (C34) 4,286 3,205 (26.4%) 3 
Colorectal cancer (C18-C20) 6,151 4,418 (36.4%) 1 
All four cancers 17,169 12,131  
Table 5.2 summarises number of patients in the PPM Chemotherapy dataset for the 
four most common types of cancer. The differences in the rank of the most common 
types of cancer is possibly because the PPM Chemotherapy dataset contains the data 
of patients treated with chemotherapy only. It is also possible that the patients are 
different, especially due to the referral hospital aspect. Based on an article on the 
Cancer Research UK website [173], the treatments for patients diagnosed with 
prostate cancer are radiotherapy (30%), surgery (15%), and chemotherapy (3%). 
Based on this analysis, the PPM Chemotherapy dataset is representative of colorectal 
cancer, breast cancer and lung cancer, but not for prostate cancer patients. 
5.1.5 Data variety 
The data variety of the PPM Chemotherapy dataset can be explained by exploring the 
diagnosis groups. The diagnosis in the PPM Chemotherapy dataset was recorded 
based on the ICD-10 diagnosis codes. The distribution of the diagnosis groups is 
presented in Table 5.3. 
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Table 5.3  Diagnosis group distribution in PPM Chemotherapy data 
# Description Patients 
1 (C00–C14) Malignant neoplasms, lip, oral cavity and pharynx 1,418 
2 (C15–C26) Malignant neoplasms, digestive organs 8,914 
3 (C30–C39) Malignant neoplasms, respiratory system and intrathoracic 
organs 
3,563 
4 (C40–C41) Malignant neoplasms, bone and articular cartilage 268 
5 (C43–C44) Malignant neoplasms, skin 1,326 
6 (C45–C49) Malignant neoplasms, connective and soft tissue 966 
7 (C50–C58) Malignant neoplasms, breast and female genital organs 6,318 
8 (C60–C63) Malignant neoplasms of male genital organs 1,745 
9 (C64–C68) Malignant neoplasms, urinary organs 1,832 
10 (C69–C72) Malignant neoplasms, eye, brain and central nervous system 835 
11 (C73–C75) Malignant neoplasms, endocrine glands and related structures 153 
12 (C76–C80) Malignant neoplasms, secondary and ill-defined 749 
13 (C81–C96) Malignant neoplasms, stated or presumed to be primary, of 
lymphoid, haematopoietic and related tissue 
4,248 
14 (C97) Malignant neoplasms of independent (primary) multiple sites 0 
15 (D00–D09) In situ neoplasms 803 
16 (D10–D36) Benign neoplasms 1,778 
17 (D37–D48) Neoplasms of uncertain or unknown behaviour 370 
 
The PPM Chemotherapy dataset contains all cancer diagnosis groups, except on 
Malignant neoplasms of independent (primary) multiple sites (C97). Of all 31,511 
patients recorded in the PPM Chemotherapy dataset, the three most common 
diagnoses are the cancer of digestive organs (8,914 patients/ 28%), breast and female 
genital organs (6,318 patients/ 20%), and lymphoid, haematopoietic and related tissue 
(4,248 patients/ 13%). 
5.1.6 Limitations of using the PPM Chemotherapy dataset 
The PPM Chemotherapy dataset was used for analysing cancer treatment pathways in 
the Leeds Cancer Centre. Some limitations identified in this study are in its 
representativeness, anonymisation on dates, and data granularity. 
The representativeness limitation was due to the specific focus on data extraction. 
The PPM Chemotherapy dataset consists only of the clinical data of cancer patients 
receiving chemotherapy. Chemotherapy is one of three common treatments for cancer 
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patients (other than surgery and radiotherapy). This means that the dataset consists 
only a part of the total number of cancer patients and is not representative of the whole 
population of cancer patients in the LTHT.  
The anonymisation limitation was due to the approach taken to de-identified dates in 
the database. The dates were replaced with a calculated age of the patients (in the 
number of days since date of birth) when they experienced the events. In this study, 
this is a limitation because one of the required attributes needed in process mining is 
the timestamp. This limitation has been approached by creating generated dates. This 
makes it possible to analyse activity sequences for each patient, but not for cross-
patient analysis, such as workload and bottleneck analysis.  
The granularity limitation was that all the generated dates provide only analysis 
measured down to the day and there was no way the order of activities that happened 
on the same day could be further defined. This was not an issue in analysing 
chemotherapy cycles because it is not possible for a patient to get two cycles within 
the same day. This issue became a problem when analysing chemotherapy combined 
with other events, such as pathology and investigation. 
 
5.2 Experiment 3: Process mining the PPM Chemotherapy dataset 
The PPM Chemotherapy dataset was used previously to develop risk algorithms in 
oncology. This dataset contains non-identifiable data of chemotherapy patients treated 
in the LTHT. This experiment aims to apply process mining approach to analyse the 
variability of the treatment process in the PPM Chemotherapy dataset. The analysis 
was focused on chemotherapy treatment. The initial challenge was that the dataset has 
been de-identified, where all dates were transformed into the patient age in the number 
of days. The sequence of activities is reliable, but analysis across patients such as 
examining busy time was not possible.  
5.2.1 Stage 1: Planning and justification 
This experiment aimed to reproduce the previous research [34] using the same data. 
The contribution of this experiment was to improve the previous study by providing 
a structured method for pathways analysis using process mining approaches. The 
primary research question was “Can process mining be used to analyse the variability 
of treatment in the PPM Chemotherapy dataset?”. 
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The table structures of the PPM Chemotherapy dataset have been presented in Figure 
5.1. The real year was available in two tables: ChemoCycles and Diagnosis. Chemo 
cycle years were recorded from 1996 to 2015. The experiment of the PPM 
Chemotherapy dataset description included the steps to identify elements of the event 
log from the PPM Chemotherapy dataset. The experiment documentation of the PPM 
Chemotherapy dataset description is presented in Appendix D.1. 
5.2.2 Stage 2: Extraction, transformation, and loading 
The extraction of the dataset for this experiment was done to select all events related 
to all eligible patients. Patients were included if they had (i) a diagnosis of metastatic 
breast cancer (ICD-10 C50) and received adjuvant epirubicin and cyclophosphamide 
(EC-90) chemotherapy or (ii) colorectal cancer (ICD-10 C18–C20) and received 
palliative oxaliplatin and infusional 5-fluorouracil chemotherapy. Those selection 
criteria followed the previous study. The selected cohort consists of 738 breast cancer 
patients and 418 colorectal cancer patients, a total of 1156 patients. 
The three basic elements of the dataset required for process mining are case id, activity 
name, and timestamp. A summary of those three basic elements in the PPM 
Chemotherapy dataset is as follows: 
• Case IDs are available in all tables: PID/KTPId, AdmissionId, or RegimenId. 
This study used PID/KTPId to analyse the pathways of patients. PID is the 
patient identification from the PPM database and KTPId is the patient 
identification from the Result database. 
• Activity name can be derived from each table except for Patients table. For 
example, the activity name from the Admissions table is admission, while the 
activity names from the ChemoCycles table are Cycle-[number of cycles]. 
• There is no timestamp identified, but there is the possibility to obtain the 
sequence based on Age (in the number of days) and Years in the tables. 
The event log can be created by combining all records in those identified in the event 
tables. The details of the allevents table are presented in Table 5.4. The allevents table 
contains more than 21 million records, with the three most frequent activities being 
TestResultsBlood (83.54%), Outpatients (4.56%), and Admissions (3.73%). As shown 
in Table 5.4, the database is dominated by TestResultsBlood due to the focus of the 
data collection for the previous research related to blood test results of patients 
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receiving chemotherapy. In this study, the focus is on analysing the pathways of 
patients receiving chemotherapy and not on the test results. 
Table 5.4 Details of the allevent table 
# Source Activity 
Class 
Patients Total Rows % 
1 Admissions 2 28,609 794,863 3.73 
2 AdmissionWardStayLocation 360 28,609 469,886 2.20 
3 ChemoCycles 93 29,009 198,096 0.93 
4 ChemoDrugs 301 31,421 706,670 3.31 
5 ChemoRegimens 2945 31,354 67,707 0.32 
6 Death 1 17,701 17,701 0.08 
7 Diagnosis 653 30,753 56,123 0.26 
8 Outpatients 69 28,878 973,177 4.56 
9 Radiotherapy 541 16,792 31,703 0.15 
10 Surgery 1345 21,395 74,889 0.35 
11 TestResultsBlood 34 29,151 17,814,931 83.54 
12 TestResultsMicrobiology 23 15,678 118,947 0.56 
Total   21,324,693 100 
 
A direct use of the allevents table to create process models would result in a spaghetti 
model and would not be understandable. Some alternatives to analyse the process are 
to select events of interest or to analyse specific cohorts of patients. This study focused 
on the first approach to select events of interest. 
Data transformation was done following the Process Mining Project Methodology 
(PM2) approach, which includes creating views, aggregating events, enriching logs, 
and filtering logs. These were done with ProM 6.7 plugins. A summary of the data 
processing is as follows: 
- Change the order of events having the same timestamp. This was important 
because the timestamp data are in days. The order of events was set to follow the 
logical order of the events based on a discussion with clinical experts. 
- Merge subsequent events. This was done to merge some routine test results, 
including neutropenia and bacteraemia. Only the first occurrence of the event was 
considered when an event repeated in sequence. 
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- Rename/merge events as required. For example, Elective admission (S2) à 
Chemotherapy (S1) = Chemotherapy (S1). This reflected the condition where the 
chemotherapy event was also recorded as an elective admission. 
- Add artificial START and END events. Each trace was added by a START before 
the first event and an END after the last event. This was needed because the 
current ProM plugins cannot deal with multiple start and end events, so that it is 
important to ensure that all traces have exactly one START and one END event. 
Additional work was done by following the activity coding done in the previous study 
[34]. The list of activity codes, names, and their descriptions is presented in Table 5.5. 
Table 5.5 Activity codes and descriptions of the allevent table 
Code Activity Description 
S1 Chemotherapy Chemotherapy was delivered 
D0 Home discharge Home discharge after chemotherapy 
S2 Elective admission Hospital attendance other than chemotherapy 
F1 Admission Other type of admissions 
D7 Neutropenic GP contact with neutropenia (neutrophil count <1.5x109/L) 
S6 Bacteraemia Bacteraemia (positive blood culture) during admission  
D3 Urgent outpatient Urgent review in outpatient 
D6 Death Death during hospital stay 
5.2.3 Stage 3: Mining and analysis 
This stage included process mining and process analytics. The process discovery was 
done to the selected events, using the Interactive Data-aware Heuristic Miner (iDHM) 
plugin in ProM. The iDHM plugin allows several representations to be chosen, 
including the directly-follows graph, dependency graph, causal net, or Petri Net. 
1) Process mining of the general events 
Process discovery resulted in a directly-follows graph as presented in Figure 5.2. A 
directly-follows graph describes what activities follow one another directly, based on 
the records in the event log. It was chosen because this graph provides important 
information visually, including START and END events, colours representing activity 
frequencies and arcs with the number of patients following the paths.  
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Figure 5.2 Directly-follows graph the PPM Chemotherapy dataset. This is a result from 
the interactive Data-aware Heuristics Miner (iDHM) plugin in ProM. 
 
 
Figure 5.2 shows that patient pathways are started with either an Elective admission, 
Admission, or an Urgent outpatient. Patients from an Elective admission or Urgent 
outpatient might go for a round of Chemotherapy and Home discharge repeatedly 
until this is followed by either a Neutropenia, Admission, Elective admission, or 
Urgent outpatient. Following an Admission, patients might also have a Neutropenia, 
Bacteraemia, Elective admission, Urgent outpatient, or Death. 
2) Process mining of the chemotherapy cycles 
Further analysis was done to focus on the events during the chemotherapy cycles of 
breast cancer patients receiving EC-90 chemotherapy (n= 738). This was done by 
analysing a lower-level event, which is the chemotherapy cycle number. The results 
were a process model, a trace variant, and a dotted chart shown in Figure 5.3-5.5. 
It is evidenced in the process model in Figure 5.3 that the number of patients from 
one cycle to the next is decreasing. The median duration between chemotherapy 
cycles is 21 days, which reflects the common duration in the treatment. 
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Figure 5.3 Process model showing 70% of the most common pathways. It was built in 
DISCO. The number below an activity name shows the number of patients undertaking that 
activity. The number on arc shows the detail of the flow [number of patients; median 
duration]. 
 
Figure 5.4 shows the six most common trace variants followed by more than ten 
patients. The most common trace variant is a sequence of Cycle 1 to Cycle 6 (n=120; 
16.3%), followed by a sequence of Cycle 1 to Cycle 3 (n=56; 7.6%), and a sequence 
of Cycle 1 to Cycle 3 followed by an Emergency admission (n=37; 5%). It is shown 
that Emergency was mostly happened after Cycle 3 (see Variant 3) or Cycle 6 (see 
Variant 4), while Neutropenia happened after Cycle 5 (see Variant 6). 
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Figure 5.4 The six most common trace variants of chemotherapy cycles. Activities 
included are Cycle 1 through Cycle 6, Neutropenia, and Emergency. 
 
Figure 5.5 shows a dotted chart of routine chemotherapy cycles of patients treatments 
of up to 7 years. The diagram shows groups of patients who had not completed six 
cycles of chemotherapy, who completed six cycles of chemotherapy, and who had 
more complicated courses of treatment. In total 51% (n=376) of patients did complete 
all six cycles,  with 21% of the total (n=158) without any acute event while 30% 
(n=218) had at least one acute event including emergency admission or neutropenic 
sepsis. Of the 49% (n=362) patients who did not complete six cycles, 28% (n=207) 
had acute events with the remainder 21% (n=155) not completing for other reasons. 
 
Figure 5.5 Dotted chart showing patient pathways over treatment duration. The x-axis 
shows duration from the first activity. The y-axis shows patient id, sorted from the shortest to 
the longest durations. 
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3) Process analytics: conformance-based process change over time 
Another analysis was done to identify process change over time. Conformance 
checking was done by analysing the conformance values of the process model. A 
reference process model has been presented in Figure 5.2 with a fitness of 0.826, a 
precision of 0.342, and a generalisation of 0.999, suggesting that the model did 
represent the traces in the event log, was generalisable, but not very precise. 
The analysis was enhanced to examine the process changes over time. It was done by 
checking the conformance of the event log per year to the reference process model.  
Table 5.6 Fitness, precision, and generalisation over years 
Year Events Cases Variants (%) Fitness Precision Generalisation 
2004 2,555 20 20 (100) 0.7828 0.3112 0.9500 
2005 4,363 32 31 (97) 0.8843 0.2784 0.9832 
2006 3,155 29 29 (100) 0.8745 0.3296 0.9755 
2007 4,083 44 43 (98) 0.8743 0.3029 0.9927 
2008 13,082 143 136 (95) 0.7484 0.3385 0.9986 
2009 14,889 173 154 (89) 0.7354 0.3459 0.9981 
2010 13,781 147 138 (94) 0.7447 0.3327 0.9986 
2011 14,255 168 138 (82) 0.7451 0.3669 0.9989 
2012 13,377 138 118 (86) 0.7568 0.3583 0.9963 
2013 14,302 149 125 (84) 0.7711 0.3719 0.9962 
2014 21,803 24 24 (100) 0.7622 0.3894 0.9632 
Average 0.78905 0.33869 0.98647 
 
The results are displayed in Table 5.6. It shows that the number of cases each year 
ranges from a minimum of 20 in 2004 to a maximum of 173 in 2009. The trend of the 
increasing number of cases from 2004 until 2013 was discussed with clinical experts 
and was said to conform the reality. This was related to the fact that the hospital is a 
large cancer centre with a growing capacity of cancer treatment. The fitness ranges 
from 0.7354 to 0.8843 (average = 0.7891). The precision ranges from 0.2784 to 
0.3894 (average = 0.3387). The generalisation ranges from 0.95 to 0.9989 (average = 
0.9865). The trend of those conformance values is presented in Figure 5.6.  
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Figure 5.6 Trend of trace fitness, precision, and generalisation over time. The 
generalisation was generally steady, while precision and fitness fluctuated over time. 
 
Figure 5.6 shows that the precision and fitness are not steady over time, suggesting 
there must be some changes. There is also a trade-off between fitness and precision 
where a more precise model would have lower fitness. There are two periods where 
the process had potentially changed, which are 2004-2005 and 2007-2008. 
5.2.4 Stage 4: Evaluation 
The evaluation was done through discussions with clinical experts. Those included a 
researcher of the previous study using the same dataset, a database administrator of 
the de-identified dataset, and a senior oncologist working with the PPM database. 
Discussions were done to get a description of the previous study, identify potential 
gaps in the research, and evaluate both intermediate and final results. 
Discussion on the early stages was done to plan and justify the experiment. It was also 
done to discuss the decisions on the extraction, transformation, and loading steps. 
Results of this early discussion include the order of the same timestamp and merging 
events. The clinical expert provided the logical order of events happened on the same 
day. Merging events were also decided based on a suggestion by the clinical expert to 
filter out duplicated records in the dataset. 
General comments of the intermediate and final results are that process mining is 
potentially useful to improve the previous study generating process model of 
chemotherapy treatment. The analysis is particularly helpful to visualise the variations 
from standard chemotherapy pathways, including incomplete treatment and adverse 
events. The conformance-based comparison was also useful for analysing process 
change over time, but the metrics need to be improved to identify change points 
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reliably. The detected change points were likely related to the introduction of the PPM 
EHR system in 2003 and the change from PPM1 to the current PPM in 2007. 
One limitation was that the preprocessing relied on the selection of the best set of 
events. It requires a good understanding of the dataset and a specific cohort of patients. 
This experiment was started by analysing the higher-level process as presented in 
Figure 5.2. It was then followed by examining the chemotherapy cycles including the 
adverse events, as shown in Figure 5.3- Figure 5.5. The decision to analyse the more 
specific pathway can be seen as a way to select the best set of events of interest. The 
more detailed analysis of the chemotherapy pathways is presented in Appendix D.2. 
 
5.3 Experiment 4: Trace clustering for similarity analysis 
The most obvious challenge of doing process mining in healthcare data is handling 
the high number of trace variants. One way to solve this is to apply trace clustering to 
cluster similar traces into one grouping. The experiment was done with hierarchical 
clustering using edit distance in the PPM Chemotherapy dataset. The complete step 
by step of this experiment is presented in this section. 
5.3.1 Stage 1: Planning and justification 
This stage was done to plan and justify the experiment. This experiment aims to 
improve the analysis of the variability of treatment in the PPM Chemotherapy dataset. 
The primary research question was “Is it possible to use trace clustering to analyse 
the variability of treatment in the PPM Chemotherapy dataset?”. This is an additional 
experiment to support the previous experiment with a specific focus on exploring the 
potential to use hierarchical trace clustering method. The hypothesis was that the 
hierarchical clustering could be used to group similar traces and create separated 
process models for each cluster. This experiment used Python and DISCO. 
5.3.2 Stage 2: Extraction, transformation, and loading 
General stages in this experiment followed those done in Experiment 3 as presented 
in Section 5.2. The additional steps were:  
(1) coding activity names,  
(2) creating an edit distance matrix,  
(3) hierarchical trace clustering,  
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(4) determining the optimal number of clusters,  
(5) retrieving clusters, and  
(6) describing process models of the clusters.  
Step (1) was part of Stage 2 and is described in the following paragraph. Step (2) to 
step (6) were parts of Stage 3 and are described in Section 5.3.3.  
Coding activity names was done to simplify the activity names into a character for the 
edit distance matrix creation. The coding step was done using pandas library in 
Python. Traces were hierarchically clustered using the scipy.cluster.hierarchy library. 
The optimal number of clusters was determined using the silhouette method. The 
activity names are presented in Table 5.7. The four most frequent activities are 
Chemotherapy (n=1,072 / 100%), Day case review (n=798/ 74.4%), Home discharge 
(700/ 65.3%), and Urgent outpatient (n=664/ 61.9%). 
Table 5.7 Coding activity name, the occurrence, and the number of patients 
Code Activity Name Occurrence (%) n (%) 
A Chemotherapy (S1) 5,910 (23.5) 1,072 (100) 
B Urgent outpatient (D3) 1,944 (7.7) 664 (61.9) 
C Non-neutropenic (S5) 1,192 (4.7) 603 (56.3) 
D Day case review (D4) 7,179 (28.6) 798 (74.4) 
E Death (D6) 388 (1.5) 388 (36.2) 
F Admission non-neutropenic (S4) 1,308 (5.2) 541 (50.5) 
G Home discharge (D0) 1,928 (7.7) 700 (65.3) 
H Neutropenic (D7) 1,107 (4.4) 511 (47.7) 
I Not bacteraemia (S8) 884 (3.5) 425 (39.6) 
J Elective admission (S2) 618 (2.5) 360 (33.6) 
K Admission progressing neutropenic (S9) 41 (0.2) 38 (3.5) 
L Bacteraemia (S6) 143 (0.6) 108 (10.1) 
M Admission neutropenic (S7) 324 (1.3) 218 (20.3) 
5.3.3 Stage 3: Mining and analysis 
The process mining step of the complete event log resulted in a process model, as 
presented in Figure 5.7. The fitness score was 0.826 and the precision score was 0.342. 
The median duration was 24.4 months and the mean duration was 28.9 months. The 
number of events per patient ranged from 1 to 220, with a mean of 21. There were 
1,042 variants out of 1,072 patients, suggesting that this process had high variability 
and there was a need to find groups of patients having similar traces to create simpler 
and more understandable process models. 
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Figure 5.7 General process model resulted from DISCO with 80% activities and 0% paths 
 
In the analysis step, the edit distance matrix was created using the Levenshtein 
distance [174]. It was originally used to measure the distance between two words as 
the minimum number of single-character edits (insertions, deletions, or substitutions) 
required to change one word into the other. This method is suitable for this experiment 
because the Levenshtein distance is a string metric for measuring the difference 
between two sequences. A trace with the coded activity names created a sequence of 
letters, thus comparing those sequences is the same as comparing words. The code to 
create a distance matrix is as follow. 
#create distance matrix 
import editdistance 
import numpy as np 
np.set_printoptions(threshold = np.inf) 
def f(x,y): 
    return editdistance.eval(x,y) 
     
def cartesian_product(*arrays): 
    la = len(arrays) 
    dtype = np.result_type(*arrays) 
    arr = np.empty([len(a) for a in arrays] + [la], dtype=dtype) 
    for i, a in enumerate(np.ix_(*arrays)): 
        arr[...,i] = a 
    return arr.reshape(-1, la) 
     
v=np.vectorize(f) 
arr = cartesian_product(cva.activity, cva.activity).T 
arr = v(arr[0, :], arr[1, :]) 
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dist_df = pd.DataFrame(arr.reshape(-1, cva.shape[0]), 
index=cva.index, columns=cva.index) 
dist_df 
The output is a distance matrix, as follow. 
trace  1    2    3    4    5    6    7    8    9    10  ...   1070  1071  1072  
trace                                                   ...                    
1          0    2    2    4    6    5    2    4   16   35 ...    88    8   26    
2          2    0    1    2    8    3    4    3   14   33 ...    87    6   24    
3          2    1    0    3    8    4    4    2   15   34 ...    86    6   25    
4          4    2    3    0   10    5    6    2   13   32 ...    86    5   22    
5          6    8    8   10    0    8    4   10   22   38 ...    94   14   32    
6          5    3    4    5    8    0    6    6   17   30 ...    87    8   25    
7          2    4    4    6    4    6    0    6   18   36 ...    90   10   28    
8          4    3    2    2   10    6    6    0   13   33 ...    84    6   24    
9         16   14   15   13   22   17   18   13    0   27 ...    73   12   17    
10        35   33   34   32   38   30   36   33   27    0 ...    63   29   21 
… 
[1072 rows x 1072 columns] 
The next step was to use the edit distance matrix to create a hierarchical clustering 
using scipy.cluster.hierarchy. This library clustered data based on agglomerative 
clustering [175], where objects are clustered based on their similarity. Pairs of objects 
with high similarity were merged iteratively until all objects are combined in one big 
cluster. The result can be presented as a tree-based representation of the objects, 
named a dendrogram.  
Traces were hierarchically clustered using the scipy.cluster.hierarchy library. The 
code of the hierarchical clustering is as follow. 
#hierarchical clustering 
import scipy.cluster.hierarchy as hcl 
from scipy.spatial.distance import squareform 
from scipy.cluster.hierarchy import dendrogram 
import matplotlib.pyplot as plt 
 
linkage = hcl.linkage(dist_df, method='ward') 
#ward minimises the sum squared distances within all clusters 
plt.figure(figsize=(20, 10)) 




    linkage, 
    truncate_mode='lastp',  # show only the last p merged clusters 
    p=10,  # show only the last p merged clusters 
    leaf_rotation=90.,  # rotates the x axis labels 
    leaf_font_size=8.,  # font size for the x axis labels 
    show_contracted=True  
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The resulting dendrogram from this experiment is shown in Figure 5.8, which groups 
1,072 traces hierarchically.   
 
Figure 5.8 Hierarchical clustering dendogram. X axis shows trace number grouped into 10 
clusters at the lowest level, Y axis shows distance based on the edit distance matrix. 
 
Based on the hierarchical clustering result, the next step was to determine the optimal 
number of clusters. There are two ways to do this, which are internal and external 
methods. Internal methods use the information of the clustering to evaluate the 
goodness of the clustering structure and can be used for estimating the number of 
clusters without any external data. Some methods to measure internal information of 
the clustering are Davies-Bouldin index, Dunn index, and Silhouette coefficient. 
External methods compare the clustering result to externally known labels, such as 
the provided class labels. In this experiment, the internal methods are suitable because 
there was no prior knowledge of the class labels.  
An internal method used in this experiment was the silhouette coefficient [176], which 
reflects the compactness/ cohesion (how close are the objects within the same cluster) 
and separation (how well-separated a cluster is from other clusters) of the cluster 
partitions. The silhouette coefficient measures how well an object is clustered and 
estimates the average distance between clusters. The formula is  
𝑺𝒊 = (𝒃𝒊 − 𝒂𝒊)/𝐦𝐚𝐱	(𝒂𝒊, 𝒃𝒊) 
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where bi is the dissimilarity between i and its neighbour cluster and ai is the average 
dissimilarity between i and all other points of the cluster where i belongs. Clustered 
items with a high average of silhouette value are considered well clustered. The 
summary of the silhouette coefficient for two to ten clusters is presented in Figure 5.9. 
 
Figure 5.9 Silhouette coefficient of k = 2 to k = 10. The silhouette coefficient decreases as 
the number of clusters (k) increases.  
 
Cluster 1 consist of traces of 839 patients (78%). The process model of cluster 1 (see 
Figure 5.10) is very similar to the general process model presented in Figure 5.7. The 
median duration is 24.4 months and the mean duration is 28.9 months. The most 
frequent variant consists of patients who received six cycles of Chemotherapy (S1) 
(n=21, 2.5%). The second variant consists of six S1 followed by an Urgent outpatient 
(D3) (n=20, 2.4%). The third variant consists of six S1 followed by a Not neutropenic 
(S4) (n=10, 1%). The average number of events per patient is 16 (min=1, max=46). 
Further analysis compared the trace frequency of each activity. The average difference 
is 5%. The highest difference is in the trace frequency of Admission not neutropenic 
(5%), where 50% of patients in the complete dataset had this activity but only 40% of 
patients in this cluster had this activity. The other activities had 7% or less difference 
on the trace frequency between this cluster and the complete dataset. The process 
model of cluster 1 is presented in Figure 5.10. 
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Figure 5.10 Process model of cluster 1. The process model is very similar to the general 
process model. 
 
The process model of cluster 2 in Figure 5.11 consists of patients having different/ 
exceptional traces. The median duration is 36.4 months and the mean duration 37.8 
months, both showing longer durations compared to cluster 1. Events per patient 
ranged from 4 to 220, with a mean of 41. There are three activities that are frequent 
in cluster 2 but not frequent in cluster 1 nor the complete log, which are Admission 
non-neutropenic (n=199/ 85%), Non-neutropenic (n=191/ 82%), and Not bacteraemia 
(n=156/ 66%).  The process model of cluster 2 is presented in Figure 5.11.  
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Figure 5.11 Process model of cluster 2. It shows process model of patients having 
exceptional care pathways (n=233/ 22%). 
5.3.4 Stage 4: Evaluation 
This experiment aimed to find an alternative way to group patients based on their 
similarities. The clustering method was separating the common traces from the 
exceptional ones. As presented hierarchically in Figure 5.8, two clusters were 
separating 838 traces (78%) from 233 traces (22%). The next level created three 
clusters of 839 traces (78%), 10 traces (1%), and 223 traces (21%). The final clusters 
were also not meaningful to separate patient groups in cancer treatment.  
An insight gained from this experiment is that there is an opportunity to create a new 
method or to improve the available methods for analysing process variants in cancer 
treatment. Another insight was that the differences between clusters could be 
characterised by the differences of activity frequency, as described in Section 5.3.3. 
Trace clustering would not be explored further in this thesis, but other approaches to 
characterised differences of process models based on trace duration and activity 
frequency will be used in the next case study. 
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5.4 Summary 
This chapter has described the analysis of the PPM Chemotherapy dataset. The PPM 
Chemotherapy dataset was used as an extract of the PPM database with a specific 
focus on records of patients receiving chemotherapy treatment within the LTHT. The 
analysis was initially done by reproducing the clinical pathway analysis in the 
previous study, with an improvement in the structured method proposed in this study. 
Discussions with clinical experts focused on how the visualisations resulting from the 
process mining approach can be useful to support understanding of the pathways.  
An additional analysis of the PPM Chemotherapy dataset was done to explore the 
possibility of using a trace clustering approach to find different patterns within a 
process. The results, as presented in Section 5.3, show two clusters with visual 
differences compared to the complete dataset. But it appears that the trace clustering 
was done to separate the outlier/ the infrequent traces from the main cluster. A lesson 
learned from this experiment was that trace clustering can be used to find different 
patterns within a process, but a better approach is needed for process change analysis. 
This case study can be seen from different perspectives, as described in Section 1.2. 
From the health service perspective, the process model in Figure 5.3, for example, are 
useful for the health service manager for understanding the pathway of patients 
receiving chemotherapy. From the process mining perspective, this case study has 
been shown how the dataset can be used for process mining in healthcare, despite 
some limitations due to the de-identification process. From the information system 
perspective, the conformance-based change detection in Section 5.2.3 shows that 
conformance values over the years are not constant. This finding implies that the 
process has been changed. It has been confirmed by a member of the PPM developer 
team that the detected changes were related to the introduction of the PPM software 
in 2003 and a major improvement in 2007.  
The analysis of the PPM Chemotherapy dataset can be seen as an exercise to get used 
to the complete data in the PPM Cancer dataset. Once the ethical access to the PPM 
Cancer dataset was granted, this study then used the dataset in the next experiments. 
  
 
Chapter 6  
Case study 3: Experiments using the PPM Cancer Data 
Analysis of the Patient Pathway Manager (PPM) Chemotherapy dataset produced a 
range of useful results that have been presented in Chapter 5. This chapter presents 
the analysis of the PPM Cancer dataset through four experiments. The PPM Cancer 
dataset also includes the patients selected in the Chemotherapy dataset. 
Section 6.2 has been presented in an invited joint presentation at the Public Health 
England National Cancer Registration and Analysis Service (PHE NCRAS) seminar 
in 2018. Section 6.3 was presented and published in the 2019 Process-Oriented Data 
Science for Health (PODS4H) entitled “A multi-level approach for identifying 
process change in cancer pathways” [177]. A journal paper is prepared to extend that 
paper into the International Journal of Environmental Research and Public Health 
(IJERPH) Special Issue of PODS4H19. Section 6.4 summarises another journal paper 
that is prepared for a jointly-authored publication entitled “Process mining to explore 
variations in the 62-day pathways of endometrial cancer” [178]. Section 6.5 presents 
additional work with process change analysis on the whole PPM Cancer dataset.  
6.1 Data description 
Overview of the PPM Cancer dataset has been presented in Section 1.4.2 and has been 
described in Section 3.4.3. More details of this dataset are presented in this section. 
6.1.1 Data provenance 
The PPM Cancer dataset was generated from direct access to the PPM Query 
database. This database is a copy of the live database of the PPM EHR system, which 
contains data on patient treatment in the LTHT from 1990 until the present. The 
characteristics of the PPM EHR system in the LTHT were presented in Section 5.1.1.  
The database contains information about all patients within the hospital, including 
cancer patients. Access to this database was made possible through the hospital 
infrastructure in the secure environment (UoL IRC). Along with the PPM Query 
database, other resources are also accessible. Those are the PPM Splunk, a web-based 
application management that captures real-time user access, and the PPM JIRA, a 
project management software used by the development team in the LTHT. 
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6.1.2 Representativeness 
The PPM Query database is an exact copy of the PPM live database, as used in the 
LTHT. PPM is a mature EHR that captures the comprehensive clinical data of all 
patients receiving treatment within the LTHT. The PPM Cancer dataset consists of 
the clinical data of more than 3 million patients, of which more than 270,000 patients 
have at least one cancer-related diagnosis (the number is growing). The system 
integrates data from multiple systems within the LTHT, including patient admissions, 
treatments (chemotherapy, surgery, and radiotherapy), pathology, investigations, 
Multidisciplinary Team (MDT) meetings, consultations, and outpatients. The PPM 
dataset is one of the largest EHRs in the UK, and this makes this data highly 
representative for cancer treatment analyses. 
6.1.3 Data characterisation 
The PPM Query database was accessed based on ethics approval. It contains 49 tables 
in the Leeds table schema (see Appendix E.1). Every table was checked to be used in 
process mining to analyse patient pathways during their cancer treatment. The main 
step was to check each column in those 49 tables to find potential columns to be a 
case id, an activity name, a resource name, and a timestamp that refer to an event in 
patient treatment. This step needed several iterations of a careful investigation of each 
table, documentation review, and discussion with clinical experts. 
One important challenge was that one table might contain more than one activity, and 
the activity names might need to be inferred from the recorded timestamp. For 
example, Admissions table has some potential columns: PatientID, AdmissionDate, 
ContactSpecialityLabel, DischargeDate, DischargeMethodLabel. There were two 
activities identified in this table, which were Admission and Discharge that was 
inferred from AdmissionDate and DischargeDate, respectively. The PatientID was 
identified as the case id. ContactSpecialityLabel was identified as the resource name 
of Admission and DischargeMethod Label was identified as the resource name of 
Discharge. The timestamps of Admission and Discharge were AdmissionDate and 
DischargeDate, respectively. 
Overall, 12 out of 49 tables had the minimum requirements for process mining and 
were selected to extract patient pathways. This selection is presented in Appendix E.2. 
The list of selected columns from each table for process mining is shown in Table 6.1. 
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Table 6.1 Detail of columns for process mining 
* if NULL, use cn_ContactTypeCode_CodeLabel from Contact reference table 
# Table case id resource timestamp 
1 Admission em_PatientID em_ContactTypeLabel em_AdmissionDate 
2 ChemoCycles ecc_PatientID ecc_CycleContactTypeLabel ecc_CycleStartDate 
3 Consultation eb_PatientID eb_ContactTypeLabel eb_ConsultationDate 
4 Diagnosis dx_PatientID dx_ContactTypeLabel dx_DiagnosisDate 
5 Investigation en_PatientID en_ContactTypeLabel* en_EventDate 
6 MDT Review ev_PatientID ev_ContactTypeLabel* ev_EventDate 
7 Outpatient op_PatientID op_ActualContactTypeLabel op_ClinicDate 
8 Pathology esp_PatientID esp_ContactTypeLabel* esp_PathologyDate 
9 Patients pt_PatientID NULL pt_DeathDate 
10 Radiotherapy er_PatientID er_ContactTypeLabel er_EventDate 
11 Referral ef_PatientID ef_SourceCodeLabel ef_ReferralDecisionDate 
12 Surgery es_PatientID es_ContactTypeLabel* es_SurgeryDate 
6.1.4 Data quality 
The data quality of the PPM Cancer dataset was assessed based on the data quality 
framework for process mining of EHR data [179]. This framework was built based on 
methods and dimensions of data quality assessment [133]. An important approach 
proposed in this framework was to register potential data quality dimensions and 
analyse them. The result is summarised in the following paragraphs. 
The completeness of the data was assessed with element presence, data element 
agreement, data source agreement, distribution comparison, and validity checking 
methods. The main concern was to find missing data in case, event, activity name, 
and timestamp. Completeness checking on the 49 tables in the PPM Cancer dataset 
was done by analysing the data and discussing the results with the clinical experts. 
One important finding was that the completeness of the data changes over time. This 
is because the PPM system is evolving. For example, Outpatient activity started to 
appear in patient records in 2006. This is not because patients before 2006 were never 
seen in any Outpatient activities, but because this activity just started to be recorded 
in the PPM system in 2006.   
The correctness of the data was assessed with element presence, data source 
agreement, and validity checking methods. The main focus was to analyse imprecise 
data in case, event, activity name, and timestamp. One important finding is that the 
Surgery table contains event data of all types of surgeries, including diagnostic 
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surgery and therapeutic surgery. A clinical expert categorised the main procedures of 
the surgeries to separate those two. As a result, there are two activities derived from 
the surgery events: Diagnostic Surgery and Surgery. Another issue found during the 
analysis is that some events were recorded with the date and 00:00:00 was added as 
the hour, minute and second. This led to a problem where those events seem to have 
occurred in the middle of the night, when they actually did not. 
The concordance of the data was assessed with element presence, data source 
agreement, and distribution comparison methods. The main focus was to analyse 
irrelevant data in case, event, activity name, and timestamp. This was done by 
examining columns in all tables within the PPM database to find relevant columns for 
process mining. There are 12 tables relevant for process mining of cancer treatment 
pathways, and some other tables used as reference tables. For example, the Contacts 
table was used as a reference table for defining the resource from the original table.  
The plausibility of the data was assessed with element presence and distribution 
comparison. The main focus was to find incorrect data in case, event, activity name, 
and timestamp. One example of an issue found in the plausibility of the PPM Cancer 
data was the surgery types. Early iterations on the pathway analysis found that the 
number of surgery records was too high, suggesting that the majority of patients had 
undergone surgery in their cancer treatment. Further discussions with clinical experts 
found that this was because surgery can be categorised into diagnostic surgery and 
[therapeutic] surgery. The issue of 00:00:00 as default time is also a critical problem 
in process mining. When the sequence of events is analysed, the events with 00:00:00 
time would be treated as the first event during the day and obstruct the real sequence 
of events. 
The currency of the data was assessed with a log review. The assessment was to check 
if they were recorded in the PPM EHR within a reasonable period of time following 
the activity. One issue found in the currency of PPM Cancer dataset was that there are 
records dated back to the 1990s, while the PPM EHR had only begun to be used in 
the LTHT in 2003. Discussions with the development team suggested that these data 
were manually recorded in the PPM database by the team in the early years of the 
PPM EHR system use. Another possible issue was data error, which might have 
occurred during data recording. To handle this issue, the analysis did not use any data 
before 2003. 
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The most crucial issue in the process mining of the PPM Cancer dataset is that the 
PPM database is supporting PPM software, an EHR system developed in the LTHT. 
The system was inevitably changed over time for many reasons. Some examples of 
the reasons are the changes needed when a clinician found an error in the system, the 
changing guidelines for the treatment of a specific type of disease, and the decision 
taken by the hospital to connect with other services outside the hospital. The naturally 
changing environment made it challenging to analyse the data with process mining. 
The process mining results for a subset of the data during a specific period might be 
different from those from another period. 
6.1.5 Data variety 
In the complete set of the PPM database, data variety is high. The PPM database was 
focused on recording data in cancer treatment since 2003 and has been underpinned 
to manage all data within the whole Trust since 2012. Further improvement was made 
in 2014 to join the Leeds Care Record (LCR), an integrated digital care record system 
across the Leeds city region. Those major changes are important as starting points to 
help understand the high complexity and high variety of the PPM dataset. For this 
research, data analysis focused on cancer patient records in the PPM database.  
The variety of cancer patients can be identified by the number of patients diagnosed 
with cancer during 2002–2017, as presented in Table 6.2. The most common cancer 
type in the PPM Cancer set is the C00–C75 (61.65%), followed by C81–C96 (55.55%) 
and D10–D36 (26.35%). One patient might have more than one type of cancer and 
can be included in more than one group. 
Table 6.2 The number of patients based on cancer types 
ICD code Cancer type Patients % 
C00-C75 Malignant neoplasms, stated or presumed to be 
primary, of specified sites, except of lymphoid, 
haematopoietic and related tissue 
236,244 61.65 
C76-C80 Malignant neoplasms of ill-defined, secondary and 
unspecified sites 
7,203 1.88 
C81-C96 Malignant neoplasms, stated or presumed to be 
primary, of lymphoid, haematopoietic and related 
tissue 
21,285 55.55 
D00-D09 In situ neoplasms 12,546 3.27 
D10-D36 Benign neoplasms 100,989 26.35 
D37-D48 Neoplasms of uncertain or unknown behaviour 4,930 1.29 
Total 383,197 100.00 
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6.1.6 Limitations of using PPM Cancer dataset in this study 
The limitations of using the PPM Cancer dataset in this research are closely related to 
the challenges of analysing real-life datasets. The PPM EHR system is a growing 
system, with a development team working continuously to improve and make changes 
as required by the hospital. This condition causes the quality of the PPM Cancer 
dataset varies over time. The long duration of data stored in the PPM Cancer dataset 
means it is not possible to assume that no changes happened to the process over that 
time. It is also not possible to understand the complete history of the changes that 
happened to the system based on the documentation only. 
One approach for change analysis is to separate one change and investigate the effects 
on the related process. Another approach is to analyse the process and detect the 
changes based on a specific pattern of interest (trend, seasonal, or residual patterns). 
 
6.2 Experiment 5: GP tab change analysis  
As mentioned in Section 6.1.6, the most critical issue in using the PPM database is 
that the system was changed over time. This study focused on the changes evidenced 
in the User Interface (UI) of the PPM EHR system, but the reasons for the UI changes 
are out of this discussion. This limitation was because the reason behind a change 
might not be evidenced in the data. 
All user interactions are recorded in the PPM Splunk, and every time a user views 
data in the PPM EHR system, the system automatically updates the data in the system. 
Whenever the PPM EHR system is changed, those changes are recorded in the PPM 
JIRA software. The PPM developer team uses the PPM JIRA software as a dashboard 
to track issues and changes to the PPM EHR system. From the PPM JIRA, detailed 
information about the change can be found in timely order, including the request for 
change, processing, and the release of the new updated version. 
In this research, UI changes in the PPM Cancer dataset were explored in two types of 
experiments. The first one was to analyse a process change when a change is known. 
For this purpose, the introduction of a General Practitioner (GP) Tab was chosen as a 
change of interest. The experiment using the GP Tab change is presented in this 
section. The second type of experiment was to detect changes without prior 
knowledge about any change and is presented in the next sections. 
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6.2.1 Stage 1: Planning and justification  
This stage was done to plan and justify the experiment. This experiment aims to 
examine the effects of GP tab introduction in cancer treatment. The primary research 
question is “Is it possible to analyse process changes from a given UI change?”. The 
GP Tab introduction is one example of a UI change in the PPM EHR system. The GP 
Tab allows clinicians to access patient records within the GP system required to 
support clinical decisions for patient treatment. This requires a change in the PPM 
EHR system, to provide access to the GP records.  
The GP Tab is a feature in the PPM EHR system presenting the GP information (such 
as diagnosis, allergies, and medications) recorded for patients registered with a Leeds 
GP taking part in the LCR. This GP Tab was introduced in July 2014. An illustration 
of the GP Tab in the PPM EHR system is presented in Figure 6.1. 
 
Figure 6.1 The GP tab in the PPM EHR system. This preview is from the official website 
of PPM support [180]. 
 
In this experiment, the usage of the GP Tab in the PPM EHR system is recorded in 
the PPM Splunk. The record of GP Tab usage was then analysed to explore the pattern 
of this usage over time. The record was also transformed into an event log and 
combined with the event log of the cancer treatment. The combined event log was 
used to explore the effect of the GP Tab access on the cancer treatment. For this 
experiment, the scope was breast cancer patients receiving chemotherapy from 2014 
to 2018. This experiment included clinical experts in every stage. 
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6.2.2 Stage 2: Extraction, transformation, and loading 
The extraction was done through a query in the PPM Splunk. The view of the query 
page in PPM Splunk is presented in Figure 6.2. This view contains detailed data on 
the date and time, page address, patient id and user id recording a time when a 
clinician had accessed the GP Tab page of a patient. There is also a bar chart 
visualising the number of records on a daily basis. The bar chart shows an obvious 
pattern of weekday- and weekend- usages. 
 
Figure 6.2 Records of user access in the PPM Splunk. Confidential information such as 
patient ID and dates are blocked in black. 
 
The result of the query was plotted in a bar chart representing the number of clicks on 
the GP Tab every day from July 2014 until December 2018. The plot is presented in 
Figure 6.3. 
 
Figure 6.3 GP tab clicks each day. It shows that the number of clicks generally increased 
over time, with steady fluctuations showing the pattern of weekday- and weekend- usages. 
 
In March 2018, there was an improvement of the Medical Interoperability Gateway 
(MIG) from MIG1 (GPv1) to MIG2 (GPv2). MIG is the gateway to integrate the GP 
SystmOne/EMIS into the LCR. The transition period from the GPv1 to GPv2 can be 
captured in the monthly usage from 2017 to 2018, as shown in Figure 6.4.   
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Figure 6.4 Monthly usage of GP tab during 2017-2018. The blue dots are monthly usage 
of the older version (GPv1) and the orange dots are those of the new version (GPv2). 
 
 
During September 2017 to February 2018, both versions were accessed by the 
clinicians. A small number of clinicians (7 to 14 users) clicked through the GPv2 from 
September 2017 to January 2018. The GPv2 was later tested by a larger number of 
clinicians (1,117 users) in February 2018 and fully replaced the GPv1 from March 
2018. The GPv1 was deprecated completely in March 2018. 
6.2.3 Stage 3: Mining and analysis 
Stage 3 of this experiment was undertaken to combine cancer patient events in the 
PPM Cancer dataset of the GP Tab access within the PPM Splunk. The initial analysis 
was done by checking the intersection of cancer patients in the PPM Splunk and the 
PPM Cancer records. The GP Tab access in the PPM Sclunk is from July 2014 to 
April 2018. The cancer patients included in the experiment were those diagnosed with 
C% or D% during 2002–2017. There were 46,547 out of 339,127 cancer patients 
(37%) who had their GP Tab clicked by clinicians. On the other hand, there are 46,547 
out of 171,468 GP Tab access (16%) are the GP Tab of cancer patients. 
Process mining was done to continue the analysis of the chemotherapy treatment of 
breast cancer patients, as presented in Section 5.2. This experiment analyses Leeds 
patients diagnosed with breast cancer (C50) who received EC-90 as adjuvant 
chemotherapy from 2014 to 2018, and whose GP Tab was clicked by clinicians. There 
were 733 patients included in this selection. The analysis was done to explore GP Tab 
access during chemotherapy cycles. The event log was a combination of patient events 
in the PPM Cancer dataset and the GP Tab access of those patients in the PPM Splunk.  
- 140 - 
Figure 6.5 shows the process map containing the flow from Cycle 1 of chemotherapy 
to the subsequent cycles up to Cycle 6. During the course of chemotherapy, the GP 
Tab might be accessed by clinicians. The most frequent sequence is that the GP Tab 
was accessed after Cycle 6 for 160 out of 339 GP Tab clicks (47%). This was 
discussed with clinical experts. The clinicians might need to check on patient records 
in the GP Tab after the sixth cycle to decide whether to discharge the patient or to 
suggest another treatment. The next most frequent one was after Cycle 3 for 110 clicks 
(32%). The possible case was that clinicians needed to check on patient records in the 
GP Tab after Cycle 3, to decide if the next cycles should be delivered as planned or 
not. Another interesting finding was that in 326 clicks (96%), the GP Tab click is the 
last activity in the pathway, or at the end of the treatment. 
 
Figure 6.5 Process model of GP tab access during chemotherapy cycles. This was built 
using bupaR. It shows that GP Tab was mostly accessed after Cycle 3, Cycle 6, or Cycle 4.  
 
 
6.2.4 Stage 4: Evaluation 
In this experiment, the evaluation was done in both statistical and clinical aspects. The 
results of the statistical evaluation were presented along with each result in Stage 3 
above. The clinical evaluation was done through discussion with clinical experts and 
is presented in the following paragraphs. 
In Stage 1, clinical experts suggested the scope of the study. Some known changes in 
the PPM EHR system were discussed with the clinical experts, the development team, 
and the software training team. The GP Tab change was chosen based on the 
availability of the related data to explore process change. One important insight from 
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the software training team was that for some new features introduced in the PPM 
software, there was a period when training was given to the clinicians to introduce the 
use of a new feature. This training period might affect the analysis of system usage. 
It was found that the training and testing period of the GP Tab introduction was from 
September 2017 to February 2018. 
In Stage 2, clinical experts evaluated the extraction step and suggested some changes. 
This included a change to focus on the effect of the GP tab introduction to the 
chemotherapy cycles. The decision to focus on one specific process and one change 
of UI was chosen to localise the change and the effects of that change to the treatment 
process. It was followed by a discussion with the programme manager of Leeds Care 
Record (LCR). LCR is the initiative to create integrated records of patients across 
providers and between different systems in Leeds. The GP tab introduction was part 
of the LCR program. The approach undertaken in this experiment was said to be 
promising to analyse the effect of the introduction of different functionality in the 
LCR program. The additional data from the PPM JIRA was also suggested by the 
development team to get complete records of the change. The PPM JIRA was useful 
to gather as many information as possible about a change being analysed. 
In Stage 3, the evaluation was done through a discussion of the results from the 
clinical perspective. The idea of combining user access records in PPM Splunk with 
the treatment records in the PPM Query database was good to analyse the effect of a 
system change to the treatment process. Another possibility discussed was to analyse 
PPM Splunk separately to be compared to the process model discovered from the 
patient record. Since PPM Splunk recorded all actions done by clinicians during 
patient treatment, the treatment process itself should be reflected in the records. 
 
6.3 Experiment 6: Endometrial cancer pathways from referral to 
diagnosis 
This experiment was done to explore process change over time without a prior known 
change. The endometrial cancer pathway was chosen in this experiment because of 
clinical expert availability. This was also because endometrial cancer is one of the 
most common cancers in the gynaecology department, and it was understood that the 
procedure for endometrial cancer had not been changed radically within the last 15 
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years. In this study, analysis of the endometrial cancer pathway was focused on the 
change process analysis, to detect and analyse change points over time. Based on a 
discussion with clinical experts, analysis can be done into two steps. The first step is 
the pathway from GP referral to diagnosis and is presented in this section. The second 
step is the pathway from GP referral to first treatment that represents the 62-day 
pathway and is presented in Section 6.4. 
This section explores the process change analysis of endometrial cancer treatment. 
This experiment followed the general methodology described in Chapter 3. The 
changes found were analysed to find process evolution within the system. The 
complete stages have been published [177] and the important findings are summarised 
in Sections 6.3.1 to 6.3.4. 
6.3.1 Stage 1: Planning and justification 
Stage 1 (planning and justification) in this experiment was done by understanding the 
data and additional resources of PPM development [21]. The scope of the experiment 
is the analysis of Leeds patients diagnosed with endometrial cancer during 2003–
2017. The analysis focused on the pathway from GP referral to the diagnosis of 
endometrial cancer. The research questions are: 
1)  What is the pathway of endometrial cancer from referral to diagnosis? 
2) Are there differences in care paths over time? 
The experiment involved clinical experts and a statistician during all stages of the 
study. This was done through regular discussions at the end of each stage. 
6.3.2 Stage 2: Extraction, transformation, and loading 
The extraction was done by obtaining all the events that happened to the selected 
cohort from GP referral to diagnosis. The criteria were to include: (1) all patients who 
have a legitimate care relationship with the LTHT, (2) those who have a 
definitive/primary diagnosis of endometrial cancer (C54 and C55), (3) those with a 
GP referral as the start event and the diagnosis as the end event, and (4) those having 
a maximum duration of 120 days. These selection criteria were applied in a database 
query to create an event log. The extraction was done by selecting columns for process 
mining: case_id, activity, resource, and timestamp. For this experiment, there were 
943 patients with a total of 96,067 events in the event log. 
- 143 - 
The transformation was done to filter the extracted event log as required. This 
included removing missing values, merging subsequent events, and adding artificial 
START and END events. Two additional filtering processes were performed to split 
Surgery and to handle the same-day events. Surgery was split based on two types of 
surgery (diagnostic and therapeutic surgeries) into Diagnostic Surgery and Surgery 
activities. Same-day events were ordered based on the logical sequence of the events 
as discussed with the clinical experts. The number of events and patients having those 
events for each activity in the final event log is presented in Table 6.3. 
Table 6.3 Detail of events in the event log 
# Activity Events n n (%) 
1 Admission 605 519 55% 
2 Chemotherapy 1 1 0.1% 
3 Consultation 357 152 16% 
4 Death 1 1 0.1% 
5 Diagnosis 943 943 100% 
6 Diagnostic Surgery 972 809 86% 
7 Discharge 284 256 27% 
8 Investigation 1,759 738 78% 
9 MDT Review 395 231 24% 
10 Outpatient 228 149 16% 
11 Pathology 1,239 860 91% 
12 Radiotherapy 1 1 0.1% 
13 Referral 1,854 943 100% 
14 Surgery 274 258 27% 
Total 8,915 943 100% 
* n = number of patients 
 
Table 6.3 shows that all patients have Referral and Diagnosis, as these are required 
as the start and end events of the process. The most infrequent activities are 
Chemotherapy, Radiotherapy, and Death. Along with Surgery, Chemotherapy and 
Radiotherapy are the treatment types for cancer. Those treatments commonly happen 
after diagnosis. In some cases, the diagnosis and the first treatment happened on the 
same day, hence they are extracted from this case study. 
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6.3.3 Stage 3: Mining and analysis 
The mining and analysis stage in this study was done through process mining and 
process analytics. Process mining includes process discovery and conformance 
checking. Process analytics was performed to analyse process change over time using 
a multi-level process comparison approach and is presented in Section 6.3.4. 
Process discovery was performed using iDHM, as a plugin in ProM that provides 
many options for process model abstraction. The input is an event log created as 
presented in Section 6.3.2. The directly-follows graph is shown in Figure 6.6 below. 
 
Figure 6.6 The directly-follows graph, showing process model of the pathway. 
 
Figure 6.6 shows the most frequent pathways from referral to diagnosis of endometrial 
cancer in the 943 patients. For simplicity, the process model shows the eight most 
frequent activities and the most frequent paths between them. The Outpatient, 
Consultation, and MDT Review activities were omitted to produce a simple diagram. 
The Outpatient activity appeared in 149 out of 943 patients (16%), Consultation 
appeared in 152 patients (16%), and MDT Review appeared in 231 patients (24%). 
Conformance checking was performed to check conformance of the reference model 
to the traces in the event log [86]. The reference model was discovered from the 
complete event log using iDHM plugin. The general process model was highly 
representative of the complete event log with a replay fitness of 0.809, a precision of 
0.83, and a generalisation of 0.996. This means that the process model can accurately 
reproduce the traces recorded in the log, allows behaviours that are not seen in the 
event log, and can reproduce predicted future behaviours of the process. 
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6.3.4 Process change analysis with a multi-level approach 
The analysis of process change over time was done by comparing the process in three 
levels of detail: process model, trace, and activity levels, as presented in Table 3.2 in 
Section 3.3.1. The idea was to explore process changes by comparing process 
execution over time within those three levels. The process-model level compares 
replay fitness, precision, and generalisation of the general process model to the traces 
over time. The trace level compares duration and variant proportion over time. The 
variant proportion compares the proportion of the general variants in the sub-logs. 
The activity level compares the frequency and percentage of the activities over time.  
A summary of the process-model comparison results is presented in Table 6.4. It 
shows that the general process model was representative of each year log.  
Table 6.4 Summary of multilevel comparisons 
 
The median [Interquartile Range (IQR)] of the replay fitness is 0.86 [0.10], the 
precision is 0.78 [0.03], and the generalisation is 0.93 [0.06]. All three conformance 
measures were similar across all years. The exceptions were in 2004 when the 
precision dropped, 2011 when the replay fitness dropped and the generalisation 
increased, and 2016 when both trace fitness and precision started to increase. 
Therefore, the three potentially significant change points are 2004, 2011, and 2016. 
The trace comparison was done by examining the trace duration and variant 
proportion for each yearly sub-log. There is no obvious qualitative pattern in the trace 
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duration, except on the IQR. The IQR generally decreases across the years, with the 
exception of the increasing IQR on 2005 from 42 to 71 days (68%), on 2008 from 32 
to 45 (39%), on 2010 from 34 to 49 days (44%), on 2011 from 49 to 50 days (2%), 
and on 2015 from 41 to 48 days (18%). Based on this analysis, five periods were 
detected as potential changes: 2005, 2008, 2010, 2011, and 2015. There is no obvious 
pattern in the variant proportion over time, except the waving trend of the first variant 
(Referral à Investigation à Pathology à Diagnostic Surgery à Diagnosis) and the 
decreasing trend of the other variants. 
The activity comparison was done by analysing the percentage of each activity for 
the number of patients each year. The activities were grouped into frequent activities 
(³ 60%), infrequent activities (< 60%), and high-varied activities in between. 
Qualitatively, the periods of 2004, 2011, and 2016 were marked by changes in the 
frequency of the activities. In 2004, all activities had a significant increase, except for 
the infrequent activities. In 2011, there are significant increases in the four infrequent 
activities, while Discharge decreased to be lower than the four infrequent activities. 
In 2016, the frequency of the infrequent activities was increased except for Outpatient. 
6.3.5 Stage 4: Evaluation 
In this experiment, statistical evaluation was presented along with the results 
described in Stage 3. The multilevel approach for process change analysis was found 
to be useful to support discussions with the statistical and clinical experts in this study. 
The clinical evaluation was done through discussions with the clinical experts and a 
member of the development team within the hospital. The discovered process model 
reflected the general pathway from referral to diagnosis of endometrial cancer. There 
was no significant change in the duration and sequence of the pathways that the 
clinical experts were aware of, which confirmed the trace-level comparison. A 
concern was raised about some trace variants having an Admission without a 
Discharge. This is the case where the Discharge happened after Diagnosis and was 
not included in this experiment. One important discussion in the activity-level 
comparison was that the EHR system is continually evolving. Some activities had 
only begun to be recorded in later years, such as Outpatient (2006) and Consultation 
(2008). The multilevel comparison was successfully captured the system changes. 
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6.4 Experiment 7: The 62-day pathways of endometrial cancer 
This section describes the analysis of the endometrial cancer pathway from GP 
referral to the first treatment. This reflects the 62-day wait pathway and is a 
continuation of the analysis in Section 6.3. The stages of the analysis followed the 
general methodology presented in Chapter 3 and are very similar to the stages of the 
analysis in Section 6.3. The specific steps for this experiment of the 62-day pathway 
are presented in this section. Those steps that are similar are not presented again in 
order to avoid duplication. 
6.4.1 Stage 1: Planning and justification 
This study expands the first experiment to answer two research questions: 
1) What is the general pathway of endometrial cancer from GP referral to the 
first treatment? 
2) Are there differences in care paths followed by different patient groups? 
The first research question was addressed by analysing all the events that happened 
to the patients during the period from GP referral to the first treatment. The second 
research question was explored by creating patient groups based on the types of first 
treatment they received for their cancer, their age at diagnosis, and the year of 
diagnosis. The three types of cancer treatment are surgery, chemotherapy, and 
radiotherapy. The age of patients was grouped into ten-year ranges. The year of 
diagnosis ranges from 2003 to 2018. These grouping criteria were selected based on 
the clinical expert suggestion that process change over time might be related to the 
treatment types and age range. 
6.4.2 Stage 2: Extraction, transformation, and loading 
Extraction was done from the PPM Query database in the Microsoft SQL Server 
database management system. Patient records were extracted using R codes with 
embedded SQL queries. The extracted records were then transformed into an event 
log containing case_id, event names, resource names, and timestamps. Patient data 
were carefully selected from 12 tables as identified in Section 6.1.3. Event names 
were derived directly from the table names with further adjustment based on 
discussions with clinical experts. There are timestamps (down to the day) in each of 
those 12 tables that are used directly in this study. 
- 148 - 
The selection criteria were similar to those in the experiment in Section 6.3. The 
criteria were to include: (1) all patients who have a legitimate care relationship with 
the LTHT, (2) those who have a definitive/primary diagnosis of endometrial cancer 
(C54 and C55), (3) those with a GP referral as the start event and first treatment 
(chemotherapy, radiotherapy, or surgery as the end event, and (4) those having a 
maximum duration of 240 days. 
The transformation was done to create an event log and adjust it to be used in process 
mining. The event log was filtered following the same approaches as mentioned in 
Section 6.3.2. There were 949 patients selected with a total of 17,413 events. The 
selected events were between July 2001 and May 2018. The duration of the traces 
ranged from 5 days to 238 days, with a median duration of 62 days and a mean of 79 
days. There were 921 trace variants out of those 949 patients, suggesting a high 
variability of the traces among patients. In this study, the variability was explored 
based on the first treatment, patient age at diagnosis, and the year of diagnosis. The 
proportion of patients in each group is presented in Table 6.5. 
Table 6.5 Proportion of patients in each group 
First treatment  Year of diagnosis 
Group N (%)  Group N (%) 
Surgery 877 (92%)  2003 29 (3%) 
Radiotherapy 49 (5%)  2004 38 (4%) 
Chemotherapy 24 (3%)  2005 44 (5%) 
   2006 51 (5%) 
Age at diagnosis  2007 54 (6%) 
Group N (%)  2008 57 (6%) 
20s (20-29) 3 (0.3%)  2009 48 (5%) 
30s (30-39) 10 (1%)  2010 64 (7%) 
40s (40-49) 54 (6%)  2011 94 (10%) 
50s (50-59) 205 (22%)  2012 94 (10%) 
60s (60-69) 318 (34%)  2013 105 (11%) 
70s (70-79) 245 (26%)  2014 87 (9%) 
80s (80-89) 105 (11%)  2015 80 (8%) 
90s (90-99) 9 (0.9%)  2016 52 (5%) 
   2017 52 (5%) 
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Table 6.5 shows the high variability of the cohort, based on the three grouping criteria. 
The first treatment groups show that the most frequent first treatment is surgery 
(92%), as confirmed by the clinical experts. The most frequent age groups at diagnosis 
are the 50s (22%), 60s (34%), and 70s (26%). There was an increasing trend of the 
number of patients over the years except in years 2009 and 2014–2017. Some groups 
had a small number of patients in them, for example patients who were diagnosed in 
their 20s. This has been confirmed with clinical experts to reflect the real proportion 
of endometrial cancer patients. The groups with a small number of patients were not 
analysed further to comply with the information governance and prevent re-
identification of the patients. 
6.4.3 Stage 3: Mining and analysis 
The process mining step was done through process discovery and conformance 
checking. The process model is presented in Figure 6.7. 
 
Figure 6.7 Process model of endometrial cancer 62-day pathways   
Figure 6.7 shows the simplified pathways with a minimum frequency of 0.1. 
Conformance checking was done in ProM and this showed conformance values as 
follows: a trace fitness score of 0.83, a precision score of 0.80, and a generalisation 
score of 0.995. These values show that the model is highly representative of the 
general pathway of endometrial cancer treatment. The three infrequent activities not 
presented in the process model are Chemotherapy (24 or 0.1%), Radiotherapy (49 or 
0.2%) and Death (1 or 0.006%). Other highly-frequent activities which are not 
presented in the process model, so might happen in many points within the sequence, 
are Consultation, MDT Review, and Outpatient. 
The variability can be presented as a dotted chart, or as the distribution of the pathway 
duration, as shown in Figure 6.8. This shows that the highest frequency is at 62 days. 
A long tail of duration > 62 days reflects the real circumstances of patients with more 
complicated conditions. 
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Figure 6.8 Histogram of the duration of endometrial cancer 62-day pathways 
 
The process model, trace variants, dotted chart, and the histogram of the pathway 
duration of the 62-day pathway of endometrial cancer are the supporting evidence of 
the complexity of the pathway. The variability is the focus of the process analytics. 
The process analytics step was done by analysing pathway variations based on the 
first treatment, the age at diagnosis, and the year of diagnosis. The groupings were 
shown in Table 6.5. For each grouping, a comparison was done to the pathway 
duration and the percentage of activity presence in the traces. 
Based on the first cancer treatment, there are three groups: Chemotherapy, 
Radiotherapy, and Surgery. Variability of the treatment duration in those three groups 
was compared. The shortest median duration is Chemotherapy (min 15 days, median 
60 days, max 228 days). This is followed by Surgery (min 5 days, med 62 days, and 
max 233 days). The Radiotherapy group (min 27 days, med 97 days, and max 238 
days) had the longest median duration among the three. Surgery is the most common 
treatment with a median duration similar to the target duration (62 days). 
The next comparison was done using the Process Comparator plugin in ProM. This 
plugin compares the percentage of trace frequencies having activities over all patients 
within a group. The alpha significant level is 5%. A summary of the differences 
between two groups is presented in Table 6.6. Based on the age at diagnosis, the 
patients were grouped into their 20s, 30s, 40s, 50s, 60, 70s, 80s, and 90s. The 
comparison was done by comparing the duration of treatment within the group of 
patients. The results show no specific trend on the treatment duration based on the age 
at diagnosis. The four most frequent groups have a very similar distribution of 
treatment duration, which are the 50s, 60s, 70s, and 80s groups.  
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Table 6.6 Process comparison based on the first treatment 
Group 1 Group 2 Difference Differences (Group 1 : Group 2) 
Surgery Chemotherapy 14.08% Outpatient (40% : 71%) 
Consultation (55% : 79%) 
Discharge (40% : 75%) 
Surgery Radiotherapy 11.11% Admission (93% : 71%) 
Outpatient (40% : 59%) 
Discharge (40% : 63%) 
Chemotherapy Radiotherapy 4.6% - 
The next comparison was using the Process Comparator plugin. A summary of the 
pair-wise differences is presented in Table 6.7. This shows that the differences 
between two groups range from 0% to 10% (average 3.6%). The group with the most 
significant difference is the 90s group (average 7.3%). Based on age at diagnosis, 
patients can be grouped into their 20s, 30s–40s, 50s–80s, and 90s. 
Table 6.7 Pair-wise differences (%) based on the age at diagnosis.  Percentage is color-
coded from red as the highest to green as the lowest difference. 
  20s 30s 40s 50s 60s 70s 80s 90s 
20s                 
30s 2.63               
40s 3.17 0             
50s 3.39 3.28 1.64           
60s 3.33 3.33 3.33 0         
70s 3.33 1.67 3.23 5.17 0       
80s 2.99 2.94 1.56 3.28 1.64 0     
90s 2.7 4.76 6.67 8.47 10 10 8.82   
Based on the year of diagnosis, the patients were grouped into 2003 to 2017. The 
comparison was done based on the treatment duration. The result shows the variability 
of the treatment duration based on the year of diagnosis. The trend of the median 
duration as shown in Figure 6.9 increased in 2003 (84 days) to 2005 (97 days). It 
decreased slightly in 2006 (66 days) to 2012 (57 days). It then increased in 2013 (72 
days) followed by a decrease in 2014 (61 days) to 2017 (60 days). 
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Figure 6.9 The treatment duration based on the year of diagnosis.  A box shows the first 
quartile, median, and the third quartile. The lines show the variability from the minimum to 
the maximum duration. The dashed line shows target duration (62 days). 
 
6.4.4 Stage 4: Evaluation 
In this experiment, the evaluation was done using both statistical and clinical 
evaluation. The results of the statistical evaluation were presented along with each 
result in Stage 3. The other detailed results of this experiment are presented in the 
paper prepared for a journal. The results of the clinical evaluation in each stage of this 
experiment are summarised in the following paragraphs. 
In Stage 1, planning and justification was done as discussed with clinical experts. 
They suggested grouping the patients to explore the variations in cancer treatment. 
The resulted patient groups were based on the first treatment, the age at diagnosis, and 
the year of diagnosis.  
In Stage 2, discussions with clinical experts were conducted to validate the 12 tables 
selected in this study. The clinical experts also suggested a limitation on the GP 
referrals as the start event to include only referrals from the GP to one of four 
oncology specialisms. Those four specialisms are gynaecology, gynaecology 
oncology, medical oncology, and clinical oncology. Another input from the clinical 
experts was to separate diagnostic and therapeutic surgeries. The last input from the 
clinical experts in this stage was to limit the pathway duration up to 240 days. This 
was based on the real practice that, when they need to diagnose a patient, they consider 
events up to eight months before the diagnosis only. A longer time period is too long 
for the events to be related. In the transformation step, because the database contained 
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timestamps in the granularity of days, some events seemed to happen in parallel when 
they were recorded on the same day. This was handled by setting an order based on 
the logical sequence provided by clinical experts. 
In Stage 3, clinical expert feedback was that the visualisations resulting from this 
experiment are interesting and useful for further analysis of the pathways. Some 
limitations raised for each visualisation type (process model, dotted chart, boxplot 
diagram) were focused on that fact that there is not one visualisation to fit all 
requirements within the analysis. This was reflected as an opportunity to improve the 
visualisation approaches in process mining. A potential future work is to list a set of 
process mining visualisation methods along with their features and a list of frequently-
posed questions in pathway analysis. Those two lists could then be mapped to build a 
guidance on the recommended visualisation methods for different questions of 
pathway analysis. 
This experiment provides evidence that the PPM Cancer dataset contains sufficient 
data for analysing cancer pathways from GP referral to the first treatment. The 
question-driven methodology has been applied and is suitable for an exploratory study 
to analyse variants in a treatment pathway. 
 
6.5 Experiment 8: Cancer treatment change analysis  
This experiment was done to detect change points in the monthly records of events 
related to cancer treatments. The experiment was to show a change pattern in the 
system usage and aims to find change points where the system has been potentially 
changed. It is important to note that this experiment was conducted only for the larger 
cohort of all cancer patients. This was done to get a larger dataset that can be flexibly 
partitioned into subsets based on the monthly records. It is not possible to do this 
experiment in a cohort of patients having a specific type of cancer without breaching 
the rule of small number limitations. For example, as presented in Table 6.5, the 
number of endometrial cancer patients over the years ranged from 29 to 105 patients. 
If that number of patients were then partitioned into months, there would only be 2 to 
9 patients per month. Those numbers are too small and patients might be identified. 
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6.5.1 Stage 1: Planning and justification 
The data for this experiment included all events of cancer patients in the PPM Cancer 
dataset. The analysis was done to examine the number of monthly records of each 
activity of interest and to detect change points based on the pattern of the monthly 
records. The monthly duration was chosen to get a smaller size of sub-logs without 
breaching the information governance requirement to work on small size samples. 
The research question was “Is it possible to detect change points based on the monthly 
records over time?”. This experiment included a team of computer scientists, clinical 
experts, and statisticians. 
6.5.2 Stage 2: Extraction, transformation, and loading 
The extraction was done by a query to get the number of monthly records of each 
activity related to cancer treatment in the PPM Cancer dataset from 2003 to 2018. The 
events were recorded in 12 tables, as identified in Section 6.1.3.  
The transformation was done to transform the number of monthly records of each 
activity from 2003 to 2018 into a time-series object in R. This section presents the 
step-by-step analysis of the Diagnosis events and summarises the findings of the other 
events. Diagnosis is the baseline in this experiment because it was used in the 
selection criteria. Patients were included in this experiment if they have been 
diagnosed with cancer. The complete result of each event is shown in Appendix E.3. 
6.5.3 Stage 3: Mining and analysis 
The process mining step in this stage was done by creating a process model of cancer 
treatment in the PPM Cancer dataset. The process model was very complicated and, 
as such, is usually called a spaghetti model.  
The process analytics was done to analyse process change over time. The time-series 
object was then decomposed using the signal decomposition method for additive time 
series. This method resulted in four plots mapping:  
(1) the observed signal showing the monthly records of an activity in the event log,  
(2) the trend signal showing the increasing/ decreasing pattern of the observed plot,  
(3) the seasonal signal showing the monthly average of the observed signal, and  
(4) the random/ residual signal showing the residual signal from the observed signal 
minus the trend and the seasonal pattern.  
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For example, the result of the Diagnosis event is presented in Figure 6.10. 
 
Figure 6.10 Decomposition of monthly records of diagnosis.  It consists of four plots 
mapping the observed, trend, seasonal, and random/ residual plots over time. 
 
 
The first plot in Figure 6.10 represents the observed signal as the monthly records of 
diagnosis with minimum 807, median 3,641, mean 3,512, and maximum 7,568. The 
trend is presented in the second plot and was based on 12-moving average. The trend 
can also be explained by fitting a linear model on the observed signal. The fitted linear 
model for monthly records of diagnosis is presented in Figure 6.11. 
 
Figure 6.11 Fitted linear model of monthly records of diagnosis. The monthly records 
increased over the years with a coefficient of 33.6. 
 
The seasonal pattern as shown in the third plot of Figure 6.9 is the monthly average 
of the observed signal. It presents the variability of the number of diagnosis records 
in a year. The minimum is in December (-296) and the maximum is in July (186). 
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The residual/ random signal is presented in the fourth plot. The residual signal was 
analysed using a Statistical Process Control (SPC) approach. The idea is to plot the 
variability of the monthly diagnosis records after subtracting the trend and seasonal 
patterns. The change points were detected as the residual signal varied outside the 
control lines. Figure 6.12 shows the SPC chart of the monthly diagnosis records.  
 
Figure 6.12 The SPC of residual signal of monthly diagnosis records. The blue signal 
shows the variance over means of the monthly records. One detected change point is in May 
2018 where the signal is over the upper control line. 
  
 
The steps of analysing monthly records with the signal decomposition and SPC 
methods were performed on each of the 12 activities. Details of the steps in those 12 
activities are presented in Appendix E.3. The results were summarised in the statistical 
evaluation and discussed with clinical and technical experts. 
6.5.4 Stage 4: Evaluation 
The evaluation was done in two steps: statistical evaluation and clinical evaluation. 
The statistical evaluation was done by summarising the results of the steps in Stage 3 
for each activity. The clinical evaluation summarises the feedback from the clinical 
experts about the findings. 
The statistical evaluation started with a summary of the fitted linear model and is 
presented in Table 6.8. The p-value of the fitted linear model indicates the relationship 
between the number of monthly records and time. A small p-value means it is unlikely 
that the relationship is due to chance. The coefficients are colour coded to easily spot 
the activities having the highest coefficient to the lowest. The activity with the highest 
coefficient is Outpatient, and the lowest is Radiotherapy. All activities have a small 
p-value, except Radiotherapy. The p-value of Radiotherapy is more than 0.05, which 
means that there is not enough evidence to declare a relationship between the number 
of Radiotherapy records and time. 
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Table 6.8 Summary of the fitted linear model of the trend pattern 
activity coef adjusted R2 p-value 
Discharge 113.6616 0.8146 < 2.2e-16 
Consultation 72.78571 0.7631 < 2.2e-16 
Chemotherapy 12.6943 0.9111 < 2.2e-16 
Diagnosis 33.59295 0.9566 < 2.2e-16 
Investigation 376.0788 0.9156 < 2.2e-16 
MDT Review 39.9816 0.9678 < 2.2e-16 
Outpatient 791.9042 0.7555 < 2.2e-16 
Pathology 24.8572 0.6626 < 2.2e-16 
Radiotherapy 0.1599 0.002322 0.2317 
Referral 222.2942 0.8401 < 2.2e-16 
Surgery 41.24259 0.8681 < 2.2e-16 
A summary of the seasonal pattern is presented in Table 6.9. Based on this table, 
activities are mostly at their minimum average in December, except for Consultation 
and Chemotherapy. Consultation was at the minimum average in August while 
Chemotherapy was at the minimum average in February. 
Table 6.9 Summary of the seasonal pattern 
 
Activity Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Admissions 525 -1052 1131 -728 287 194 621 -266 63 429 147 -1350 
Discharge 237 -1048 1130 -631 304 181 690 -215 -54 491 72 -1157 
Consultation 4 134 354 -100 -28 415 98 -650 275 -425 91 -167 
Chemotherapy 19 -161 48 -41 -4 4 54 40 26 45 17 -47 
Diagnosis -93 -214 147 -68 92 163 186 -44 -15 56 86 -296 
Investigation 2468 -1266 2452 -688 463 179 1405 -1490 -140 1131 120 -4634 
MDT Review 101 -177 50 -146 -67 162 224 -128 45 135 107 -306 
Outpatient 3200 -8416 1939 -2370 770 5126 4956 -5704 3862 5730 4474 -13567 
Pathology 10 -253 222 -172 8 128 51 -232 147 212 320 -440 
Radiotherapy 4 -48 2 -42 -30 8 12 -22 5 101 76 -66 
Referral 802 -1348 2154 -377 601 1438 1262 -1739 204 1155 -88 -4064 
Surgery 26 -318 270 -279 -56 215 170 -241 177 284 346 -594 
Key: Red = Maximum, Yellow = Minimum 
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Statistics of the seasonal pattern is presented in Table 6.10. The variability of the 
seasonal pattern can be described based on the interquartile range (IQR) value. An 
IQR represents the middle 50% of values ordered from the lowest to the highest. The 
activity with the highest IQR is Outpatient with 7,798 and the lowest IQR is 
Radiotherapy with 38.1. 
Table 6.10 Statistics of the seasonal pattern 
Activity Min. Q1 Med. Q3 Max. IQR 
Admissions -1349.8 -381.6 170.4 452.7 1130.8 834.3 
Discharge -1157.3 -319.4 126.4 351.0 1130.0 670.4 
Consultation -650.4 -116.8 47.5 169.0 415.1 285.8 
Chemotherapy -161.1 -13.1 18.0 41.2 53.8 54.3 
Diagnosis -295.9 -74.4 20.5 106.0 186.3 180.4 
Investigation -4633.6 -832.5 149.6 1199.5 2467.7 2032 
MDT Review -305.5 -132.5 47.2 113.8 223.9 246.3 
Outpatient -13567.0 -3203.6 2569.5 4594.4 5729.6 7798 
Pathology -440.3 -187.2 30.6 163.1 319.9 350.3 
Radiotherapy -65.7 -30.1 3.4 8.0 101.0 38.1 
Referral -4064.1 -376.6 600.5 1235.3 2153.7 1611.9 
Surgery -593.8 -241.4 98.4 214.8 345.8 456.2 
A summary of the detected change points based on the random/residual pattern is 
presented in Figure 6.13. January 2004 was detected as a change point based on five 
activities (Admission, Discharge, Investigation, Outpatient, and Referral). It was 
followed by February 2004 based on four activities (Admission, Discharge, 
Investigation, and Outpatient), October–November 2003 based on three activities 
(Admission, Discharge, and Investigation) and October 2014 based on three activities 
(Admission, Discharge, and Radiotherapy). 
 
Figure 6.13 Number of activity change points by month. It shows the number of activities 
where change points were detected, over time.  
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The clinical evaluation was done through a discussion of the findings of this 
experiment. Some comments from the clinical experts were related to each finding 
and were mostly on the change points detected from the residual analysis using SPC. 
The details of the analysis of each event are presented in Appendix E.3. Some 
important comments are summarised as follow. 
The Admission and Discharge are two related activities which record the hospital 
admission and discharge of a patient. The pattern of detected change points based on 
the admission and discharge are very similar. Both suggesting three change points in 
2004, 2011, and 2014. Discussion with the clinical experts revealed that admissions 
were recorded as a copy from another system in the early years of the PPM system 
(2003–2004) and those had been completely migrated in later years. 
The Consultation shows change points detected in March–June 2018. This was 
discussed with the clinical experts and was apparently related to the fact that 
Consultation was moved into another system recently and was in the process of 
migration during 2018. 
The Chemotherapy shows a change point detected in July 2014. Based on discussion 
with the clinical experts, this is likely due to the change when clinicians in the 
haematology department started to do chemotherapy, whereas previously this could 
only be done by clinicians in the gynaecology and gynaecology oncology 
departments. 
Across activities, there are two periods where changes had potentially happened: 
October 2003-January 2004 and October 2014. October 2003-January 2004 was the 
early period of PPM implementation. Further discussions revealed that the change in 
October 2014 was due to the launching of the Leeds Care Record initiative. 
 
6.6 Summary 
This chapter has presented four experiments using the PPM Cancer dataset. The first 
one analysed the pathway from referral to the diagnosis of endometrial cancer. This 
has been published in a conference journal in 2019 [177]. The second one analysed 
the 62-day pathway of endometrial cancer, which is the pathway from referral to the 
first treatment of cancer. This is prepared for a journal paper [178]. The third one 
presented the analysis of a GP Tab as a feature in the PPM EHR system. The GP Tab 
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was treated as a known change in the system and was analysed to explore how this 
feature had been used during chemotherapy cycles. The fourth one explored the 
records in the PPM EHR system to detect change points down to the month. The case 
study of PPM Cancer dataset can also be seen from a different perspective, as 
described in the following paragraphs.  
From the health service perspective, process models discovered using process mining 
approaches are useful to visualise the pathways and further analysis. For example, 
experiment 6 and 7 in this case study can express process models in several 
visualisations, such as directly-follows graph in Figure 6.6. Future analysis was done 
following multi-level approach to analyse pathways in process-model, trace, and 
activity levels.  
From the process mining perspective, this case study has been shown that the PPM 
Cancer data can be used for process mining in healthcare. As a representative of real-
life healthcare data, the PPM Cancer dataset has been shown to provide sufficient data 
needed in process mining. The limitation of using process mining has been presented 
in Section 6.1.6. Due to the high number of data and variations of those data, a 
straight-forward approach to use process mining has not resulted in useful insight 
about the process. This has been addressed by proposing a combined approach of 
signal decomposition and SPC chart.  
From the information system perspective, this case study has been shown two 
experiments to analyse process change over time, which are experiment 5 and 
experiment 8. Experiment 5 shows how GP tab change has been used as an example 
of a known change in the system. The analysis has been done by creating an event log 
by combining user access log in the PPM Splunk and patient log in the PPM Query 
database. Experiment 8 proposed a new approach to analyse process change over time 
based on signal decomposition and SPC chart. The detected change points were then 
being discussed with experts to find the potential reasons behind those changes. 
The next chapter summarises discussions based on Chapters 1–6 of this thesis. It 
serves as a critical exploration of the literature review and method development 
explored in this study and as a reflection on the experiments conducted in the three 
case studies described in Chapters 4–6. 
  
 
Chapter 7  
Discussion 
Chapters 4 to 6 presented the analysis of the case studies based on the methodology 
described in Chapter 3. In this chapter, a discussion on the findings and lessons 
learned in this study is presented. This includes a reflection on the method, the 
challenges with healthcare process mining, the process change analysis, and the effect 
of system change on the healthcare process. This chapter is concluded by a discussion 
on the contributions of this thesis. 
7.1 Reflection on the method 
The standard method presented in Chapter 3 has been applied to the three case studies. 
The method evolved and was refined, as presented in Figure 7.1.  
 
Figure 7.1 Reflection on the method. The final method (right) has been put into the context 
of the key inputs and outputs in the healthcare environment (left). 
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As presented in Figure 7.1, the healthcare process in reality is complicated by the 
multifaceted nature of the organisational structure, process, people, and technology. 
These are also known as four forces in Leavitt’s diamond, as discussed in Section 
2.2.4.2. All of these facets are captured by the Electronic Healthcare System (EHR) 
through its User Interface (UI). They are then processed by the application and 
recorded in the database of the EHR. The data in the database was extracted, 
transformed, loaded (ETL), mined and analysed in this study, and later reviewed 
based on both a statistical and clinical evaluation. 
The benefit of process-oriented data analysis is that it uses the routinely collected data 
within the EHR. In terms of research, it means that there is no additional process or 
effort required for data collection. Another advantage is that the analysis can be done 
in a relatively short time over a relatively long duration of the data. By using the 
routinely collected data within the EHR, the process model discovered reflects the 
real execution of the treatment process. 
7.2 Answering research questions 
The six Research Questions (RQs) as presented in Section 1.3 have been broken down 
and answered through experiments using three datasets. The summary is as follow. 
(RQ-1) It is possible to analyse changes in care processes in EHR using process 
mining. This has been answered through experiment 2 as presented in Section 4.3, 
experiment 3 in Section 5.2, and all four experiments using the PPM Cancer dataset 
in Sections 6.2 – 6.5. This research questions covered RQ-2 and RQ-3. 
(RQ-2) It is possible to analyse process changes from a given UI change. This has 
been answered in experiment 2 in Section 4.3 and experiment 5 in Section 6.2. The 
MIMIC-III dataset provides a case where the EHR system was changed from a version 
to another. Process changes have been analysed by comparing the trace of the process 
before and after the system change. The analysis of a UI change in the PPM Cancer 
dataset is represented by an introduction of GP tab as a new feature in the PPM EHR 
system. Process mining approach has been used to analyse the usage of the new 
feature within the care pathway of chemotherapy cycles. 
(RQ-3) It is possible to detect a time point when a care process changed and this has 
been shown through experiment 6 – 8 in Sections 6.3 – 6.5. Experiment 6 analysed 
process changes in the pathways from GP referral to the diagnosis of endometrial 
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cancer. The multi-level approach applied in this experiment found several change 
points in the pathway. Experiment 7 explored the variability of the pathway from GP 
referral to the first treatment of endometrial cancer and the 62-day target. The 
variability of the pathway was explored based on the type of the first treatment, the 
age at diagnosis, and the year of diagnosis. Experiment 8 analysed the process change 
in the dataset of all cancer patients in the PPM system. Some change points were 
detected and reflected different causes of process change, including the early stage of 
EHR system implementation, the introduction of a new system to record an event in 
the EHR system, and the change in the structural organisation to the upgraded capacity 
of the care service in the hospital. 
(RQ-4) A process change is characterised by many parameters. This has been 
explored in experiment 4 in Section 5.3 and in experiment 6 through the multi-level 
approach in Section 6.3. Those parameters include replay fitness, precision and 
generalisation in the process-model level; trace duration and variant proportion in the 
trace-level; and frequency and percentage of activities in the activity level. 
(RQ-5) The best representation of care pathways depends on different perspectives 
for analysing care pathways and the properties of different options have been explored 
in Section 3.2.3.1. The options are to visualise the care pathway as a process model, 
a trace variant diagram, a dotted chart, or a process comparison diagram, among 
others. All experiments in this research explored those options and presented the best 
ones to support the visualisation of the experiment results. 
(RQ-6) The extraction of the dataset of patient pathways from the EHR system can be 
done by identifying events related to the patient pathways, extracting those events and 
transform them into an event log with minimum components of case id, activity name, 
and timestamp. Those steps represented stage 1 (planning and justification) and stage 
2 (extraction, transformation, and loading) in the study method. 
Some challenges in working with healthcare data have been reviewed in Section 
2.2.4.2 and are described in more detail in Section 7.3. The analysis in this research 
was heavily dependent on the data quality, which is dependent on many aspects of the 
collection, design, structure, management, and policy of the data. The quality of the 
analysis results was also dependent on the ETL, tools, method, and clinical experts. 
Another limitation is that the discovered process models can only represent what has 
been recorded in the data. 
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7.3 Challenges on working with healthcare data 
During this study, there were some challenges identified in performing process mining 
using healthcare data. The main challenges were related to data access and ethics 
approval, data quality, data understanding, and data visualisation. These will be 
discussed in the following sections. 
7.3.1 Data access and ethics approval 
Healthcare data are personal and sensitive. The procedures to gain access to the data 
varied based on the institutions managing the data. In this study, three datasets were 
used, and three different approaches were undertaken to gain access to the data. 
The MIMIC-III database is accessible after completing the National Institutes of 
Health (NIH) Protecting Human Research Participants training course. Upon 
completion, the certificate (as presented in Appendix B.1) had to be uploaded along 
with the MIMIC-III access request through a PhysioNetWorks login account. Another 
requirement was the need to sign a data use agreement. When access is granted, the 
MIMIC-III database can be downloaded as comma-separated (.csv) files. Those files 
can be imported to any major database frameworks such as MySQL, PostgreSQL, and 
Oracle. In this study, PostgreSQL was used.  
The PPM Chemotherapy dataset was used in two previous studies as described in 
Section 3.4.2. The front page of the IRAS application is presented in Appendix B.2. 
Access to the PPM Chemotherapy dataset was gained by joining the research team 
working on this dataset. This process was accompanied by a series of discussions with 
the PPM developer team to support connectivity setting and data understanding. Some 
challenges were solved through those discussions, for example, we had to decide 
whether data would be accessed from a University-networked PC or a hospital-based 
PC. We also submitted a request to create a Virtual Research Environment (VRE) in 
the Leeds Institute of Data Analytics (LIDA), but that was not successful. Once the 
decision was made, i.e. to enable access using a remote desktop connection from a 
University-networked PC, the process was completed within a week. 
The PPM Cancer dataset is an extract of the PPM live database, as described in 
Section 3.4.3. In this study, access to the database was through a hospital-networked 
PC in a LIDA secure room. The access arrangement to the PPM Cancer dataset was 
made through two approaches which were the LTHT Honorary Contract and the 
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Integrated Research Application System (IRAS) application. The LTHT Honorary 
Contract was first submitted in July 2016 and access granted in December 2016 (a 
five-month processing time). The IRAS application took longer. It was first created 
in April 2016, progressed and finally submitted on November 2017, and the approval 
outcome was granted in April 2018 (a two year processing time). Access to the PPM 
Cancer dataset began in January 2017, and access to the complete data was given in 
March 2018. The processing time of the ethics approval delayed the progress of the 
experiments with the PPM Cancer dataset. 
7.3.2 Data quality 
Data quality is a critical challenge in data analytics, including healthcare process 
mining. The EHR data were collected for clinical purposes to support clinicians 
providing treatment for their patients. When those EHR data are used for research 
purposes, the suitability of the data may be compromised. This condition may result 
in an extensive amount of data cleaning and filtering needed for the research. 
In this study, the data quality of each dataset was assessed following the Weiskopf & 
Weng framework [133]. This framework specifies five data quality dimensions: 
completeness, correctness, concordance, plausibility, and currency. Those five 
dimensions were assessed using seven methods: element presence, data element 
agreement, data source agreement, distribution comparison, validity check, gold 
standard, and log review. The main purpose of the data quality assessment in this 
research was to assess its suitability for process mining. Data quality of the datasets 
for process mining has been discussed in Sections 4.1.3 (MIMIC-III), 5.1.3 (PPM 
Chemotherapy), and 6.1.4 (PPM Cancer).  
The main data quality issues for process mining in healthcare can be identified as 
incompleteness, incorrectness, impreciseness, or irrelevancy [104]. These can happen 
in different levels of the event log: case, event, attribute, activity names, timestamp, 
or resource. The general approach to handle data quality issues was to identify the 
issues and exclude the unsolved issues. The advantage is that this approach resulted 
in high-quality data for further analysis. The disadvantage is that the resulting data 
was relatively small and might not representative of the complete dataset. This is the 
only possible approach within the MIMIC-III data analysis because access to the 
hospital is not possible. In the PPM Chemotherapy and PPM Cancer datasets, this 
approach can be minimised through frequent discussions with the clinical experts. 
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Another lesson learned from analysing the three datasets in this study was that the 
data quality was continually changing over time, due to many changes happening 
within the system. In the MIMIC-III dataset, the system change from CareVue (CV) 
to MetaVision (MV) was the system change of interest. Process comparison in the 
CV and MV systems has been discussed in Section 4.3. In the PPM Chemotherapy 
and PPM Cancer datasets, the data quality changes were found when comparing the 
process execution over time. Conformance-based change detection in PPM 
Chemotherapy dataset has been presented in Section 5.2.3. In the PPM Cancer dataset, 
process change has been analysed based on a known change in Section 6.2 and 
without a known change in Section 6.3 – 6.5.  
7.3.3 Data understanding 
Data understanding is another challenge in analysing healthcare data. This challenge 
is related to many factors, such as coding standards, semantic meaning, and also data 
quality. Understanding the nature of the EHR system, coding standards, process 
guidelines, the nature of cancer as a complicated disease, and UK standard for cancer 
waiting times have been effected by reviewing the related literature, as presented in 
Section 2.1. The nature of healthcare data as ‘big data’ [181] increased the challenge 
to understand the data completely. Big data can be described in the five Vs. The 
Volume of big healthcare data refers to the vast amount of data recorded in the system. 
The Velocity refers to the speed at which new data is generated and the speed at which 
data moves around. The Variety refers to the different types of data in the HIS, which 
includes among others administrative data, clinical data, radiology, and imaging. The 
Veracity refers to the messiness or trustworthiness of the data. The Value refers to the 
usefulness of the data in the specific domain. 
Based on the analysis of the three datasets in this study, this challenge was related to 
the different conditions within the three different datasets. The understanding of the 
MIMIC-III dataset was done completely based on the available documentation, both 
from the website of the MIMIC-III dataset and published papers analysing the 
MIMIC-III dataset for many other purposes. This understanding was limited because 
there was no direct access to the hospital that provides the data. Another limitation 
was due to the anonymisation approach undertaken by the data curator of the MIMIC-
III dataset, where times were shifted to the future dates. Some analysis was not 
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possible, such as the analysis of busy days, the impact of a bottleneck, etc. This has 
been presented in Section 4.1.6. 
The understanding of the PPM Chemotherapy and PPM Cancer datasets was done 
based on the available documentation, data exploration, and through discussion with 
the clinical experts and the development team. The documentation of the data 
structure of the PPM Chemotherapy and PPM Cancer datasets is limited. Direct 
exploration of the data is therefore required and this, in turn, requires a significant 
amount of time. The documentation of the system change in the PPM Cancer dataset 
was provided through access to PPM JIRA. In the PPM JIRA, all records of system 
changes can be found, including the change request, steps undertaken in the execution 
of the change, and the release notes. Further discussion with the clinical experts and 
the development team were found to be useful to complete the understanding. 
7.3.4 Data and process visualisation 
This study involved both computer science and clinical insights. Knowledge transfers 
between those two disciplines were completed through several discussions. Thus, a 
good visualisation approach to support the discussion was required. Basic data 
visualisations to describe different perspectives of the dataset have been used in this 
study, such as bar charts, line charts, histograms, box-and-whisker plots. 
During the analysis, some visualisation approaches were used to facilitate discussions 
with the clinical experts. The results of the process mining have been presented in 
several complementary ways. The challenge was to decide which one of the 
visualisations can be used to present the results in the best way. As discussed in 
Section 3.2.3.1, the main visualisations are process models, trace variants, dotted 
charts, and comparison diagrams.  
A process model is the main output of process discovery in process mining. A process 
model can be presented in several diagrams, such as a transition system, a UML 
activity diagram, a BPMN model, or a Petri Net as described in Section 2.2.2. In 
general, a process model is a diagram showing the sequence and the flow from one 
activity to another. Additional information can be presented in a process model such 
as the number of traces and the median or average time between events. Colouring 
and thickness can also be used to show the frequency or importance of the event and 
the path from one event to another. 
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A trace variant diagram shows the sequence of events happening to traces, grouped 
by the trace variants. An example of a trace variant diagram is shown in Figure 4.5 in 
Section 4.2.4. It is normally sorted in descending order of the frequency of the traces 
in the trace variants. This visualisation is useful to see the variability of the pathways. 
Limitations of a trace variant diagram are that it is not representing the duration of 
activities in the process and that one variant is represented as one sequence without 
representing the volume/ proportion of the variant relative to the population. 
A dotted chart shows the spread of activities over time. An example of a dotted chart 
is shown in Figure 5.5 in Section 5.2.3. The most common setting is to have a dotted 
chart with time on the x-axis and patients on the y-axis. One line in the dotted chart 
shows the pathway of a patient over time. A dotted chart is useful to gain insight on 
the pathways from the time perspective. A limitation of a dotted chart is the difficulty 
to represent the general pathway of a group of patients. This limitation is because one 
dot in the dotted chart represents one event happening to one patient, giving a fine-
grained level of pathway. 
A comparison diagram is a state transition diagram showing activities as boxes and 
the paths between activities as directed arcs from one box to another. In these terms, 
a comparison diagram can also be seen as a process model. The difference is that a 
comparison diagram represents a process model from the comparison of two event 
logs. It is then annotated and colour-coded to visualise the differences in those two 
event logs. The advantage of using a comparison diagram is that it combines process 
models from two event logs being compared as one diagram. The limitation is that the 
combined process model increases complexity. 
7.3.5 Process change over time 
The main challenge discussed in this study is the healthcare process changes over 
time. Any analysis done in healthcare should consider those changes and how they 
affect the process of interest. This was also the case in the healthcare process mining 
projects. It is important to collect and analyse a large amount of data to get a better 
result for process mining. The trade-off is that a large amount of data are mostly 
collected during a long period of time. The EHR system collecting those data might 
have been changed. If the data is assumed to be static, the process model and the 
analysis of it would be invalid. The conformance of the discovered process model 
needs to be measured over time. In the first and second experiments of the PPM 
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Cancer dataset case study, it was evidenced that the process has been changed over 
time. This change was analysed with the multilevel approach proposed in this study. 
Data in an EHR system is an output of a complex combination of organisational 
structure, task, people, and technology [135]. A change in an EHR system could be a 
change in organisational structure, task, people technology, or a combination of those 
aspects. The specific cause of a change was not discussed in this study. A change in 
the EHR system is an interplay between those aspects. For example, when there is a 
change in the organisational structure, the system will need to change the task, people, 
and technology. The detected changes were discussed with the clinical experts to 
reveal the possible reasons behind those changes, but there was no specific method to 
differentiate change in the organisational structure or the task, people, or technology.  
The process change analysis in the MIMIC-III was effected based on a system change 
documented in the MIMIC-III data descriptor. This change could be seen as a change 
in technology. The findings showed that the organisational structure, task, and people 
were also changed. This has been discussed further in Section 4.3.5. 
The analysis in the PPM Chemotherapy dataset was done by comparing process 
models over years, based on the value of trace fitness, precision, and generalisation. 
This analysis found differences in the process models, that could be used to represent 
processes or task. This has been discussed further in Section 5.2.4. 
The analysis in the PPM Cancer dataset was achieved in two ways: with or without a 
known change prior to the analysis. With a known change, analysis of the effect of 
GP tab change showed an example of a technology change. The finding showed the 
evidence of organisational-, task-, and people- changes. Without a known change, the 
findings showed evidence of changes in all four aspects. As discussed in Section 6.5.4, 
it revealed that the technology has changed over time, from a software focused on 
supporting cancer data collection to an EHR system in the whole hospital trust, from 
a software coded in Basic to a web-based application. The EHR system is also 
evolving, with some organisational-, task- and people- changes found where the 
activities were started to be recorded in the system at different years, additional task 
was given to a department, and organisational change to join a larger initiative 
combining the EHR system with those of other institutions. 
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7.4 Process change analysis 
In this thesis, one of the main tasks was process change analysis. This analysis was 
done by partitioning an event log to create subsets over time and performing a process 
comparison between two consecutive time windows. The partitioning approach was 
applied, as illustrated in Figure 3.8. The general method of using process mining to 
analyse process changes has been built upon the available approaches in the literature 
including concept drift analysis, as described in Section 2.2.5. The problem 
dimensions of process change analysis are illustrated in Figure 7.2 below. 
 
Figure 7.2 Problem dimensions of process change analysis. Each dimension needs to be 
analysed in the initial stage of process change analysis. 
 
It is important to understand as many dimensions as possible in the initial stage of 
process change analysis, to plan and justify the method correctly. Each of the problem 
dimensions in Figure 7.2 is described in the following paragraphs. 
In term of the modes of handling, a process change analysis can be done in an online 
or offline mode. This study was in the offline mode, which means that the process 
change analysis was not performed on the real-life/real-time data but was performed 
on the extracted data. An unusual condition on the three datasets used in this study 
was that access to the datasets was provided to the full database. This condition is 
advantageous in that it enabled further extractions as required in each experiment. 
Based on the duration of change, this study analysed both the momentary and 
permanent changes. In the MIMIC-III dataset, the system was changed permanently 
from CV to MV in 2008 with a clear separation of hospital admissions. In the PPM 
Chemotherapy dataset, no specific system change was analysed, but the data 
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partitioning technique was used to analyse process change over time. A conformance-
based comparison was undertaken to compare the conformance of two consecutive 
years, which reflect the momentary change in the process. In the PPM Cancer dataset, 
the GP Tab implementation was an example of a permanent change. On the other 
hand, a momentary change was also explored using the data partitioning technique 
combined with a multilevel approach of consecutive years comparisons. 
Based on the perspectives, this study focused on the control-flow perspective, but also 
analysed the data and time perspectives. The control-flow perspective was used to 
analyse changes in the sequence and flow of events. The data and time perspectives 
were used to provide supporting details of the control-flow perspective. 
The pattern of change analysed in this study was a sudden/abrupt change. The 
sudden/abrupt change is the basic type of change which might also support the finding 
of other patterns of changes. When a sudden change happened several times with a 
repeating pattern, a recurring change is potentially identified. When a sudden change 
occurred several times with a non-repeating pattern, an incremental change or a 
gradual change is potentially identified. 
The sub-problems of the process change explored in this study were the detection, 
localisation, characterisation, and enhancement/unravelling of the process change. 
When a change is known, change detection is straightforward. For example, in the 
MIMIC-III dataset (CV to MV) and in the PPM Cancer dataset when the GP Tab 
introduction was being analysed. When a change was unknown, change detection was 
done by uniformly partitioning the data over time and comparing the process 
execution within each time window. Change localisation and characterisation were 
done by digging deeper into the process based on the identified change. The 
enhancement was done through discussions with the clinical experts and the 
development team to reveal the possible reasons for the process change. 
The nature of the change revealed that the enhanced sub-problem ranged from the 
real change of process execution to the change within the EHR system. The change 
in the MIMIC-III dataset was known to be caused by the change of the EHR system. 
The changes in the PPM EHR system were more complicated because they were a 
combination of many changes in the system. Process changes were found through 
process comparison over time. An example of system changes was that some activities 
were not found in the early years because they were not recorded yet in the system.  
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7.5 The effect of system change on healthcare processes 
A system change in an EHR system could happen any time and for many different 
reasons. This research explored some reasons behind a system change. In the MIMIC-
III dataset case study, a system change happened in 2008 when the hospital replaced 
the EHR system with a new one. In the PPM Chemotherapy dataset case study, there 
were no system changes known initially. The analysis of the process revealed that 
there were differences in the conformance values over time. This finding suggested 
that there were process changes. The more complicated condition happened in the 
PPM Cancer dataset case study. The dataset contains clinical data of the patients over 
16 years (2003 to 2018). The PPM EHR systems had begun to be used in the hospital 
in 2003. Some changes had taken place in those 16 years. In 2010, the PPM1 that was 
focused on cancer treatment records only was expanded to the PPM that covered the 
whole Trust. In 2014, there was an introduction of a GP Tab that enabled clinicians 
in the hospital to check on patient records in the GP system during consultations. 
Among the three case studies, the PPM Cancer dataset was the best fit for this study. 
It was because this dataset was a copy of a real-time database, complete with the real 
advantages and real limitations. The main benefits were that it represented actual 
healthcare processes in a busy hospital and that it came with an excellent connection 
to clinical experts and the development team. The limitations were that the dataset 
was raw and had not been curated. The PPM Cancer dataset case study was also 
suitable for this study because there were some documentations of system changes 
over time, which was used by the developer team to record the progress of system 
changes and communicate within the team. The access to the complete data of patient 
treatments, the clinical experts, and the development team of the EHR system were 
three success factors in analysing process change within a healthcare setting. 
There were four experiments to analyse the effect of system change in the healthcare 
process in the PPM Cancer dataset case study. They were experiments 5-8 in Section 
6.2 - 6.5. The experiment on the GP Tab change analysis was to test the effect of a UI 
change on the process. The process mining approach was a suitable approach to reveal 
the use of the GP Tab during chemotherapy cycles. This experiment was 
representative of the process change analysis based on a known system change. On 
the other hand, experiments 6-7 worked on analysing process change over time on the 
endometrial cancer pathways, guided by the UK cancer waiting time standard, as 
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described in Section 2.1.7. Experiment 8 was done to detect process change without 
any prior information of a possible system change. The experiment explored the 
system usage to detect change point(s) that had possibly occurred within the system. 
 
7.6 Contributions of this thesis 
The motivation of this research is to contribute to the community, specifically the 
Process-Oriented Data Science for Health (PODS4H) community [8]. There are four 
contributions of this thesis: the case studies for healthcare process mining, the 
multilevel approach for identifying process change, the signal decomposition 
approach for change analysis, and the time window selection for process analysis. 
Each of them will be described in the sections below. 
7.6.1 Case studies for healthcare process mining 
The first contribution of this study was to apply process mining approaches in three 
different datasets, i.e. the MIMIC-III, the PPM Chemotherapy, and the PPM Cancer 
datasets. All three datasets did not come from process-aware information systems. A 
process-aware information system is a software system that manages and executes 
processes based on process models. Process mining in process-aware information 
systems is straightforward, which means that analysis can be done based on the 
process models referred to in the information system development. Because that was 
not what happened in the three datasets used in this study, additional steps were 
needed to assess if the quality of the datasets were sufficient for process mining. These 
additional steps included the data quality assessments focusing on the completeness 
and validity of the data for process mining. This assessment was done in the data 
understanding steps, which led to different challenges within the three different 
datasets. 
The MIMIC-III dataset is representative of a typical database in an EHR system. This 
dataset is publicly accessible and has been curated following the good practice of 
sharing sensitive healthcare data. Those are why the MIMIC-III dataset is suitable for 
data analytics projects focused on method development. In this study, the MIMIC-III 
dataset was used in the first year of study to focus on the exploration of the process 
mining techniques available in ProM plugins, the DISCO tool, and R libraries. The 
MIMIC-III dataset was first used in a process mining project in our research group, 
- 174 - 
including in this study. There is still a wide range of possibilities to use the MIMIC-
III dataset for many other studies in process mining. 
The PPM Chemotherapy dataset was initially extracted for a study focused on 
analysing the effect of adverse events in cancer treatments, especially chemotherapy. 
The previous study was done using specifically developed software and a Markov 
model to produce a schematic diagram of patient pathways during chemotherapy. This 
current study improved the method used in the previous study by applying process 
mining as a structured approach to analyse patient pathways during chemotherapy as 
a cancer treatment. This dataset is rich with clinical details and is potentially useful 
for future work with different focuses. 
The PPM Cancer dataset is the third dataset in this study. This study is the first study 
implementing process mining in this data. The complexity of the data served as an 
additional challenge in this study. Unlike the other two datasets, the PPM Cancer 
dataset is the complete database and a duplicate of the live database recording the 
clinical data of the patients in the PPM system at the LTHT. The issues of data quality 
and data understanding in this data were different. In the PPM Cancer dataset, data 
understanding was gained through frequent discussions with the development team 
and the clinical experts.  
Apart from the patient records, the analysis in the PPM Cancer dataset was also 
supported by PPM Splunk recording real-time user access. The web-log provided in 
the PPM Splunk is also potentially useful for future work. The web-log in the PPM 
Splunk could be useful to reveal patient treatment and further analysis in the 
organisational perspective, such as to find if a specific clinician or a group of 
clinicians might have developed a best practice in doing their tasks. 
The PPM EHR system was initially developed to support data collection of the 
national reporting on cancer treatment within the LTHT. This EHR system was then 
adopted to cover all services within the hospitals. It means that the data structure was 
changed from serving the needs of cancer reporting to supporting the day-to-day 
operations in the hospitals. Another aspect of the PPM Cancer dataset was that the 
PPM EHR system is an in-house software system. Discussions with the development 
team of the PPM revealed that the system had been through many changes over time. 
Apart from those changes, cancer treatment has also been changed over time. 
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7.6.2 The multi-level approach for identifying process change 
The second contribution of this study was the multilevel approach for identifying 
process change. This approach resulted in a jointly-authored publication and was 
presented at the PODS4H 2019 in Vienna, Austria. The case study used in the paper 
was the analysis of the pathway from referral to the diagnosis of endometrial cancer, 
as described in Section 6.3. Some details of the approach were presented in Section 
3.3.1.1. A summary and reflection of this approach are discussed in this section. 
The general methods followed in the proposed approach are the L* Lifecycle Model 
and the Process Mining Project Methodology (PM2); both have been described in 
Section 2.2.3.4. The general methodology was extended with a focus on the process 
analytics stage to analyse process changes over time. This approach allowed the 
detection of changes by comparing process execution from one year to another. 
Process change detection, localisation, and characterisation were performed at the 
model, trace, and activity levels. This was based on the understanding that a process 
can be represented as a process model, a set of traces, or a set of activity sequences. 
Those three levels have different levels of granularity. Comparison in those three 
levels revealed differences in three levels of granularity. 
This approach was developed based on the available tools and plugins. The process 
discovery was done using the interactive Data-aware Heuristics Miner (iDHM) plugin 
in ProM. The conformance checking was done using the available plugins to calculate 
trace fitness, precision, and generalisation values. The process comparison was done 
on three different levels. The comparison in the process model level was performed 
using the same plugins as for the conformance checking. In the trace level, the 
duration and variant proportion were compared using bupaR in R. The comparison in 
the activity level was done based on the frequency and percentage of patients having 
a specific activity within a year. 
This approach supports the exploration of process change analysis when the change 
is not known in advance. The graphical data visualisations were used to support 
discussions with the clinical experts about process evolutions. Future work could 
perhaps review the partitioning method, the comparison metrics, and the reference 
model discovery. The partitioning method carried out in the experiment was by 
partitioning the log into sub-logs based on the calendar year of diagnosis. Potential 
improvements could be to work on more detailed levels based on, for example, a 
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monthly or weekly basis. The comparison metrics could be examined further to 
improve the process comparison. The reference model was discovered using iDHM, 
but other options could include using an inductive miner, fuzzy miner, or manually 
drawing the process model based on clinical guidance. 
7.6.3 The signal decomposition approach for change analysis 
The third contribution was the combination approach of signal decomposition and the 
Statistical Process Control (SPC) for process change analysis. This approach was 
applied to analyse a cohort of cancer patients in the PPM Cancer dataset, as presented 
in Section 6.5. This section provides a summary and reflection of this approach. 
This approach was initially planned to improve the experiment of endometrial cancer 
pathways. The problem was that the number of patients in each sub-log based on the 
year of diagnosis was too small. It was a significant limitation because a small sample 
is not representative of the population. A small sample also breaches the information 
governance rule to exclude the granular information of fewer than six cases. 
The input was the number of monthly records in each activity of interest. The central 
part of the approach was the signal decomposition that was done using an R library. 
The results are separated plots of the trend, seasonal, and random signals. It means 
that the number of monthly records was analysed to see the trend over time, the 
seasonal/monthly pattern, and the random/residual signal. The seasonal pattern was 
explained to see the months when the average number of records was at a minimum 
or a maximum value. The residual signal was analysed using SPC to detect change 
points outside the control lines. 
This approach successfully revealed several types of system changes, as referred to as 
the dimensions of Leavitt’s diamond. Some technology changes were in 2003 when 
the PPM EHR system started to record cancer treatment events only and 2018 when 
consultation started to be recorded in another system. One organisational structure 
change was in 2010 when the PPM EHR system was underpinned to be used 
throughout the whole hospital. One task change was evidenced in 2014 when the 
haematology department started to deliver chemotherapy that previously could only 
be done by clinicians in the gynaecology and gynaecological oncology departments. 
This approach is potentially useful to be applied to other case studies with large 
datasets. 
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7.6.4 The time window selection to analyse process 
The fourth and final contribution of this thesis was the time window selection to 
analyse the process. Process analysis studies generally work with a relatively long 
duration of data. The duration of the MIMIC-III dataset is 12 years (2001–2012), the 
PPM Chemotherapy dataset is nine years (2004–2012), and the PPM Cancer dataset 
is 16 years (2003–2018). The longer the duration, the more likely the data is prone to 
changes in the system and/or the process. 
A common method in data analysis is to assume that the data is static, and the large 
volume of data is analysed at the same time. This study revealed the possibility that 
many changes had happened in the process, and those changes were evidenced in the 
data. The proposed multilevel approach for process change analysis could be used to 
analyse those changes. Some changes identified using this approach were the 
evolution of data collection within an EHR system, the increasing capacity of the 
service, the introduction of a new feature in the EHR system, and the additional 
assignment of a particular role. 
One important issue in the process change analysis is the time window selection. In 
the PPM Cancer dataset case study, the event log was split into yearly sub-logs based 
on the calendar year of diagnosis. Further partitioning of the log into months, weeks, 
days, or hours could be considered in order to detect changes in a smaller window. 
The important points to consider are the expected duration of the process of interest 
and the size of the data within each time window. The window size should not be 
smaller than the expected process duration and the number of data points in each time 
window should not be smaller than the number required for an accurate analysis. For 
example, in the PPM Cancer dataset case study, the experiments were done to analyse 
the pathway from referral to diagnosis of endometrial cancer. The clinical experts 
suggested the inclusion of pathways of a maximum of 120 days. In this case, the 
window size should not be smaller than 120 days (4 months). If the window size is 
smaller than four months, many of the traces would be excluded in the study. The 
information governance rule of this study prevented the revealing of the information 
of six patients or less. This limitation made it not possible to make partitions of the 
event log into smaller sizes. 
 
- 178 - 
7.7 Summary 
This chapter discussed the findings and reflections on the method and experiments of 
this research. Process change analysis as the main part of this research has been done 
using process mining. This approach has been applied to the three datasets. The 
challenges on working with healthcare data for process mining are related to many 
factors, including the data access and ethics approval, data quality, data 
understanding, data and process visualisations, and process change analysis. Despite 
those challenges, the method proposed in this research has been successfully applied 
to the three datasets to analyse process change over time. Contributions of this thesis 
include the three case studies for healthcare process mining, the multi-level approach 
for identifying process change, the signal decomposition approach for change 
analysis, and the time window selection to analyse the process.  
  
 
Chapter 8  
Summary 
This thesis has presented a literature review, a methodology development, three case 
studies analysed using the methodology, and a discussion. The research objective was 
to use process mining approaches to detect and analyse process changes in the EHR 
systems. This chapter summarises the thesis by providing the conclusions and future 
work of this study. 
 
8.1 Conclusions 
This study has explored process mining methods for analysing data that were routinely 
collected within hospital information systems. Three case studies were presented: the 
MIMIC-III dataset, the Patient Pathway Manager (PPM) Chemotherapy dataset, and 
the PPM Cancer dataset. The conclusions of this research are summarised below 
following the thesis structure. 
8.1.1 Conclusion from the literature review 
A literature review of process mining in oncology was conducted in the early phase 
of this study. The important findings are as follows: 
1) The most common case study in healthcare process mining is in cancer, more 
specifically in gynaecology. Process mining in gynaecology was found in 24 
of the 37 papers (65%) reviewed in the early stages of this study. Even though 
cancer is the most common, a limited number of case studies are available. 
Previous studies have mostly used a dataset in the Business Process 
Intelligence Challenge (BPIC) 2011. 
2) The most common analysis in healthcare process mining is from the process 
discovery and the control-flow perspective. Most studies worked in process 
discovery, as found in 35 of the 37 papers (95%) reviewed. Process discovery 
was commonly followed by a control-flow analysis to examine the 
relationship between one activity and the others. 
3) The most commonly used tool for process mining in healthcare is the ProM 
framework. The ProM framework is a de facto standard in the process mining 
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research community and can be combined with other tools. ProM is also the 
primary tool used in this study, along with some additional tools, such as 
DISCO and bupaR. 
4) Limitations in healthcare process mining projects include data, technique, and 
team limitations. Data limitation is related to the sensitivity and confidential 
nature of healthcare data. Technique limitation revealed an opportunity for 
method development. Team limitation is a reminder to include 
multidisciplinary experts in the team. 
A further literature review was done during the research to explore publications in 
healthcare and technical backgrounds. Literature in the healthcare background 
includes healthcare systems in the US and the UK, EHR research, coding standards, 
process guidelines, and cancer. Literature in the technical background includes 
workflow technology, process modelling notations, process mining, process mining 
in healthcare, process mining for process change analysis, and statistical approach. 
One important point is that process change analysis is an understudied area in process 
mining projects. Most process mining projects worked with an assumption that the 
dataset is static. This research shows that this assumption is not reasonable for studies 
with long-duration datasets. 
8.1.2 Conclusion from the methodology development 
The main stages of the general methodology in this study were built based on the L* 
life-cycle model and the Process Mining Project Methodology (PM2) as the two well-
known process mining methods. Additional methods adopted in this study were the 
question-based methodology, the ClearPath method, concept drift analysis, signal 
decomposition, and SPC methods. The four main stages are: (1) planning and 
justification, (2) extraction, transformation, and loading (ETL), (3) mining and 
analysis, and (4) evaluation. 
The main part of this study is the process analytics in the third stage. Process analytics 
in this study was done for process change analysis. The main steps in process change 
analysis are: change detection, change characterisation and localisation, and the 
unravelling of the process evolution. The general change detection was to split the 
event log into sub-logs based on time. Those sub-logs were then compared to see the 
variance over time. Change characterisation was done through a more in-depth 
analysis of the variability over time. The unravelling process evolution was done 
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through discussions with clinical experts. There are two types of process change 
analysis based on the initial condition, which are with and without a known process 
change. Both types were explored in this research. 
8.1.3 Conclusion from the experiments on the MIMIC-III dataset 
The MIMIC-III dataset was the first dataset used in this study. It was suitable for this 
study because it is a publicly available healthcare dataset so that the study using this 
dataset is reproducible by other studies. There is no event log provided directly in the 
MIMIC-III database, but there are 16 event tables recording timestamped clinical 
events relating to patient treatments. Those tables can be easily transformed into an 
event log suitable for process mining. The database has been through a de-
identification process and is available for research through ethical clearance. It is 
another advantage for a study to have a curated dataset that makes it ready for many 
types of analysis.  
An assessment of the data quality found that, despite some limitations, the MIMIC-
III dataset can be analysed with process mining and is useful for method development 
in the studies. For this study, the MIMIC-III dataset is specifically suitable to test the 
effect of system change. The documentation of the MIMIC-III dataset explained that 
the system from which the clinical data in MIMIC-III came was changed in 2008 from 
the CareVue (CV) system (2001–2008) to the MetaVision (MV) system (2008–2012). 
The limitation of using the MIMIC-III dataset was due to its de-identification 
procedures. All dates recorded in the MIMIC-III database had been shifted, consistent 
for the same patient but randomly distributed in the future. It is mainly an issue in 
process mining that limits cross-patient analysis, such as workload and bottleneck 
analysis. Another obvious limitation was that there was no direct access to clinical 
experts from the hospital. 
8.1.4 Conclusion from the experiments on PPM Chemotherapy dataset 
The PPM Chemotherapy dataset was an extract from the PPM database with a specific 
focus on the clinical records of patients receiving chemotherapy treatment in the 
Leeds Teaching Hospitals NHS Trust (LTHT). This dataset had been used in a 
previous study and had been curated for that study.  
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In this study, the PPM Chemotherapy dataset was analysed by reproducing the 
previous study and improving it with a structured methodology for pathway analysis 
using process mining. The result was presented in a process model and dotted chart 
to show the flow of the activities during chemotherapy cycles. One important finding 
from the clinical perspective is that patients who underwent chemotherapy fell into 
three categories: those who stopped before the sixth cycle of chemotherapy, those 
who completed six cycles of chemotherapy without any complications, and those who 
had more complicated treatment over the years. The dotted chart presented those three 
groups of patients in a clear visualisation. 
This dataset has also been used to analyse process change over time. It is evidenced 
that the conformance values of the process had been changed over the years. An 
additional analysis was done to explore the possibility of using a trace clustering 
approach to find different patterns within a process. For this cohort, there were 
changes in 2004–2005 and 2007–2008. The conformance-based comparison was the 
only comparison performed on the PPM Chemotherapy dataset and is a primary 
method to compare processes over time. 
8.1.5 Conclusion from the experiments on the PPM Cancer dataset 
The third case study was done using the PPM Cancer dataset. Among the three 
datasets used in this study, the PPM Cancer dataset was the most complex. Access 
was given to the complete database, which is a copy of the original raw version of the 
live database in the PPM Electronic Health Record (EHR) system. The advantage of 
using this dataset was that it represented the real data in a large hospital in the UK. 
The PPM dataset also came with a direct connection to the clinical experts and the 
development team within the hospital. 
Four experiments were conducted in this case study. The first experiment was done 
to analyse a known change in the EHR system and its effect on the cancer treatment. 
The change of interest is the GP tab introduction, which was a part of the Leeds Care 
Record (LCR) initiative to integrated care records from many providers including GP 
and hospital. In this experiment, the GP tab introduction was related to the 
chemotherapy cycles of breast cancer patients. The records of user access in the PPM 
Splunk was combined with the records of patient treatment in the PPM Cancer dataset. 
The findings showed potentially useful insights to examine the effects of the 
introduction of a feature in the EHR system to the cancer treatment. The second and 
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third experiments were done to analyse the pathways of endometrial cancer patients. 
Those two experiments resulted in two methods to investigate process change over 
time, when there was no prior information about any change in the system. The fourth 
experiment was done to explore all events related to cancer treatment in the PPM 
database for process change analysis. 
8.1.6 Conclusion from the discussion 
This study is a process-oriented data analytics study using process mining and process 
change analysis approaches. The datasets analysed in this study were the routinely 
collected clinical data from the EHR system. The advantages were that those datasets 
recorded the real execution of treatment processes within the hospital and that no 
further effort was required for data creation. The limitations were that the data quality 
was dependent on many factors, including the data collection, data recording, and the 
data management of the EHR system. A specific characteristic of the datasets is the 
high veracity of the data, which leads to high variability over time due to many 
possible changes that happened in the system. 
The challenges on the healthcare process mining included data access and ethics 
approval, data quality, data understanding, data and process visualisation, and process 
change over time. The process change over time was the main challenge explored in 
this study. The dimensions of process change analysis are the modes of handling, 
change duration, perspective, the pattern of change, sub-problems, and the nature of 
change. One crucial aspect is the time window selection to analyse the process. This 
aspect has been explored in different experiments in this research, especially using 
the PPM Cancer dataset with the monthly and yearly record analysis. 
 
8.2 Presentation and feedback  
The contributions of this thesis as described in Section 7.5.4 are the case studies for 
healthcare process mining, the multi-level approach for identifying process change, 
the signal decomposition approach for change analysis, and the time window selection 
to analyse the process. These contributions can be seen as a way to contribute to the 
community of healthcare process mining, more specifically to the alliance of Process-
Oriented Data Science for Healthcare (PODS4H), and in the broader communities of 
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related studies. This study contributes to the technical and clinical aspects of the 
healthcare process mining studies. 
Published contributions of this study included three posters presented at international 
conferences, four paper presented at international conferences, and one paper 
published in an international journal, as listed in the front pages of this study. Other 
than those eight publications, some parts of this study have been presented in seven 
further events to gather feedback from a range of communities. Those events are: 
1) Guest lecture in the MSc class of data mining (5 May 2016) 
This was an hour-long joint-presentation with Owen Johnson on an introduction to 
process mining. There were around 30 students who attended the lecture. I presented 
an illustrative example of analysing healthcare data using process mining. The dataset 
for this presentation was a fictional data from Leeds Accident and Emergency (A&E). 
The students were actively trying to find patterns in the small event log. This 
presentation is not explicitly presented in this thesis but has developed the foundation 
of understanding process mining as the fundamental approach in this study. 
2) LIDA Seminar: health informatics and data analytics (10 November 2016) 
This is one of the Leeds Institute of Data Analytics (LIDA) seminar series. I presented 
the idea of this study to test the effect of UI design on the healthcare process. Other 
presenters in this seminar were Owen Johnson and Professor John Fox. Owen 
presented a general introduction to mining, modelling, and improving care pathways 
with big data. I presented my work as a case study of process mining in oncology. 
Professor John Fox is the main speaker presented Artificial Intelligence (AI) in 
medicine: data science meets knowledge management. He is a professor at Oxford 
University and the Chairman and Co-founder of OpenClinical. 
One insight gained from the presentations was that organisations are complex systems 
where task, technology, people, and structure are interrelated and mutually adjusting. 
One important piece of feedback given by a data scientist after the seminar was that 
healthcare data are naturally messy, and that might provide a real challenge for my 
study. This has been addressed by applying a quality assessment of the datasets. 
3) School of Computing PhD symposium (17 January 2017) 
This is an annual PhD symposium within the School of Computing, University of 
Leeds. There were around 20 people attended the presentation. I introduced myself 
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and my study plan for this thesis. The material presented was based on the literature 
review of process mining in oncology, as published in the conference in 2016. 
An interesting piece of feedback from this symposium was that I would need to define 
the characteristics of the UI change and not confuse it with other types of changes. 
This has been reflected in the fourth research question in this study, where a process 
change is characterised by a significant change in one or more metrics of the multi-
level approach. 
4) WUN Data Science Thematic Workshop (1 May 2017) 
This was the World University Network (WUN) data science thematic workshop: 
wellness data for healthy societies. The workshop was presented in New York, as part 
of the annual WUN Conference and AGM. Eric Rojas (Pontifical Catholic University 
of Chile) and I joined in Owen Johnson (the main supervisor of this research) 
presentation. I presented the method and progress of our studies in the comparative 
analytics of patient pathways data.  
One interesting insight from this workshop was that there were several groups in other 
countries working on pathway analysis closely related to my study. Their concern 
during the workshop was on finding a general method to be applied to different 
countries. A follow-up discussion occurred in Cambridge to explore the possibility of 
joint research between Leeds and Cambridge hospitals. The publication on the data 
quality assessment of the MIMIC-III is written in collaboration with Eric Rojas as a 
follow-up result of this workshop [168]. 
5) PHE NCRAS seminar (23 May 2018) 
This is one of the routine seminars hosted by Public Health England National Cancer 
Registration and Analysis Service (PHE NCRAS). This event was held in London and 
was broadcast throughout the PHE network. It was a joint-presentation with Owen 
Johnson entitled “Process mining of cancer pathways using Electronic Health 
Records”. Owen presented some challenges understanding real pathways of care and 
how EHR can help. I presented some of the progress made in the analysis of the PPM 
Chemotherapy and the PPM Full datasets. 
One interesting insight from this seminar was that PHE NCRAS has a team dedicated 
to pathway analysis, but they have not used any process mining approach in their 
work. Further exploration on the official website of PHE NCRAS found information 
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about cancer treatment, cancer statistics, routes to diagnosis, cancer outcome metrics, 
and other topics related to this study. 
6) School of Computing PhD Symposium (14 February 2019) 
This was an annual PhD symposium within the School of Computing, University of 
Leeds. I presented the method and progress of my study in this thesis. The main focus 
of the presentation was on the analysis of process change over time. The material 
presented in this event was the interim result as later published in the PODS4H 2019. 
One interesting discussion was about how best to present the results of this study to 
the clinical experts. This discussion is addressed in Section 7.3.4 on data and process 
visualisation. The outstanding discussion is that there is a range of options to visualise 
the results. The choice should be taken by considering what the most important 
message to relay to the clinical experts is. 
7) Manchester healthcare analytics group seminar (14 June 2019) 
This was an internal seminar held by the healthcare analytics group, University of 
Manchester. Eric Rojas (Chile), Frank Fox (Ireland; a member of our healthcare 
process mining research group), and I presented our studies in healthcare process 
mining. I presented some results from my experiments with the PPM Chemotherapy 
and the PPM Cancer datasets. 
One interesting discussion in this seminar was about the meaningfulness of the results 
from the clinical perspective. This can be seen as a potential to use the question-driven 
approach, and this has been addressed in the general method of this research. An 
engagement with the clinical experts is needed during the research. 
 
8.3 Future work 
This study shows some potentials to be used and improved in future work in 
healthcare process mining studies. Future work could improve this study in five 
directions, as described in the following paragraphs. 
The first direction could be to improve the method to capture patient characteristics 
in the analysis. This improvement would enhance the usefulness of the study for the 
clinical experts. This is also based on the feedback that this study could be more useful 
for epidemiology study. By improving the method to capture patient characteristics 
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and relating those characteristics to the process mining results, process mining can be 
more useful in an epidemiology study. 
The second direction is the potential to use process mining to create event log by 
combining software usage log with patient treatment records. Experiment 5 with the 
GP tab analysis shown that this approach is potentially useful to add another 
perspective in the typical process mining approach. Software usage log could be 
included in the process discovery step to enhance the process model representing the 
patient treatment pathways with other actions done by the users during patient 
treatment. 
The third direction could be to support the interpretation of the results by statistical 
analysis. Regular complaints by clinical and statistical experts are that this research 
lack of statistical evidence. Interpreting process mining results using statistical 
analysis could demonstrate stronger evidence of the significance of the results. Some 
statistical approaches have been applied in this study, but there are still opportunities 
to improve this analysis with a more sophisticated statistical approach. 
The fourth direction could be to widen the use of the proposed methods in healthcare 
case studies. This could include many different cohorts of patients and the exploration 
of many other guidelines and expected pathways within the guidelines. This thesis 
provides evidence that the general method can be applied in two different data sources 
and three different datasets. The multi-level approach to detect process change over 
time is relatable to many real-life settings in the hospitals. Understanding the change 
over time provides a valuable insight to get a better understanding of the dynamic 
nature of the healthcare processes. 
The fifth and the last direction could be to improve the method for international 
comparison of healthcare processes. The datasets included in this study were from the 
USA, a country with a non-universal healthcare system dominated by private 
providers, and from the UK, a country with a universal government-funded healthcare 
system. Other countries have healthcare systems similar to either one of these or a 
combination of both. The successful implementation of this method in the datasets 
from the USA and the UK open up an opportunity for international comparison of 
healthcare processes. 
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8.4 Final remark 
Process mining has been applied to many studies in the healthcare domain. One 
understudied area is the analysis of process change. When process mining is applied 
to a dataset over the years, the process might have changed, and the change might 
evidence in the data. This thesis explores the opportunity to use process mining 
approach to analyse process change over time. The method proposed in this study has 
been applied to three different datasets. It is shown that process mining can be used 
to analyse process change over time. When a change is known in the initial stage of 
the study, process mining can be used to analyse the process before and after the 
change point. When a change is unknown, process mining can be used to detect 
change points by creating partitions of the data over time and comparing the process 
characteristics in the subsequent partitions.  
On the other side, EHR systems are generally evolving. The EHR systems might be 
changed because of four factors affecting process and data, which are the structure, 
process, technology, and people. This thesis focused on the impact of UI change on 
clinical pathways, but those four factors of change are inseparable in the discussions 
during the research. Process mining studies need to consider the interplay between 
those four factors when analysing the impact of changes in the EHR systems.
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Appendix A 
Training summary 
Summary of the planned training, courses, conferences and workshops undertaken 
during this study are as follow. 
Domain A. Knowledge intellectual abilities 
A1. Coursera and FutureLearn online courses 
# Course Host Grade Hours 
1 Interprofessional Health Informatics University of Minnesota 100%   8 
2 Process Mining: Data Science in Action Eindhoven Univ of Technology 91% 24 
3 Java Programming: Solving Problems 
with Software 
Duke University 92.9% 16 
4 Programming Foundations with 
JavaScript, HTML and CSS 
Duke University 81.4% 16 
5 Intro to Process Mining with ProM Eindhoven Univ of Technology 96% 16 
6 Process Mining in Healthcare Eindhoven Univ of Technology 94% 16 
7 The Data Scientist's Toolbox John Hopkins University 96% 16 
8 R Programming John Hopkins University 95% 16 
9 Getting and Cleaning Data John Hopkins University 94% 16 
10 Exploratory Data Analysis John Hopkins University 98% 16 
11 Reproducible Research John Hopkins University 94.9% 16 
12 Statistical Inference John Hopkins University 97.5% 16 
13 Regression Models John Hopkins University 96% 16 
14 Applied Plotting, Charting and Data 
Representation in Python 
University of Michigan 98.3% 16 
15 Intro to Data Science in Python University of Michigan 93.8% 16  
  Total hours 260 
A2. YCHI/ LIHS courses 
# Code Course Hours 
1 YCHI5010m Informatics in Health Care 40 
2 YCHI5015m The Legal, Ethical and Professional Considerations in Healthcare  40 
3 YCHI5030m Process Modelling, Benefits and Change 40 
4 YCHI5045m Statistics for Health Sciences 40 
5 YCHI5055m Health Data Analytics and Visualisation 40 
 
       
  Total hours 200 
A3. Conferences, workshops, and seminars 
# Conference Year Hours 
1 Process Mining Camp 2016 8 
2 Cancer Data and Outcomes Conference 2016: Using data to drive services 2016 16 
3 Health Insights – Regional One Day Event 2016 8 
4 The Ideas in Practice Conference – Big Data: Turning Data into Value 2016 8 
5 The First Leeds Precision Oncology Symposium 2016 8 
6 The 6th Int. Conf. on Information Communication and Management 2016 16 
7 2016 NCRI Cancer Conference 2016 16 
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# Conference Year Hours 
8 LIDA Seminar: Process Analytics in Healthcare 2016 4 
9 UK Health Data Analytics Network Workshop 2017 16 
10 Informatics for Health 2017 2017 24 
11 LIDA Seminar: Big Data and Ethics and Pre-seminar Ethics Workshop 2017 2 
12 Tableau Workshop  2017 8 
13 The WUN Data Science Thematic Workshop 2017 16 
14 Cancer Data and Outcomes Conference 2017: Using data to drive services 2017 16 
15 Data in Applied Health Research Seminar 2017 2 
16 International Conference on Data and Information Science 2017 16 
17 LIDA seminar: Introduction to big data in public health 2018 3 
18 PHE NCRAS Seminar: Process mining of cancer pathways using EHRs 2018 2 
18 The 2018 NCRI Cancer Conference 2018 18 
19 UK launch of the International Society for Digital Health 2019 2 
20 PODS4H – Workshop Process-Oriented Data Science for Healthcare 2019 8 
21 The 2019 Business Process Management Conference  2019 24 
 
       
 Total hours   239 
Domain B. Personal effectiveness 
# Course Host Hours 
1 A balancing act – dealing with the stress of doing a research degree SDDU 3 
2 Time management during your research degree SDDU 3 
3 Preparing for your transfer engineering SDDU 3 
4 Project managing your research degree SDDU 3 
5 Health and Safety Training for DSE Users UoL 4 
6 Fire Safety Training UoL 4 
7 Manual Handling Training UoL 4 




Domain C. Research governance and organisation 
# Course Host Hours 
1 Ethics & ethical review SDDU 2 
2 Ownership, confidentiality and secrecy in research SDDU 2 
3 Research Conduct on VLE UoL 4 
4 CIEH Health & Safety course UoL 4 
5 NIH web-based training on “Protecting Human Research Participants” MIMIC 8 
6 The finishing thesis writer OD&PL 2 




Domain D. Engagement influence and impact 
# Course Host Hours 
1 Introduction to research impact SDDU 3 
2 Working effectively with your supervisor SDDU 3 
3 Reading critically to write critically PGR workshop Language 3 
4 Foundational Level: Writing purposely workshop Language 3 
5 Giving effective seminar and conference presentations (Science, 
Engineering and Maths) 
SDDU 3 
6 Giving effective poster presentations (online) SDDU 3 
7 An Introduction to Effective Research Writing SDDU 2 
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Appendix B 
Ethical approvals 
Following are the ethical approvals to access the data used in this study. 
B.1 The MIMIC-III Database Access  
To access the MIMIC-III database, it is required to complete a web-based training 
course from the National Institutes of Health (NIH) entitled “Protecting Human 
Research Participants”. The certificate for completing this course is presented below. 
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B.2 The PPM Chemotherapy Extract Access  
To access the PPM Chemotherapy extract of the PPM database, I was included in the 
research team working on this dataset. The study title was “The use of routine clinical 
datasets to develop decision support rules and risk algorithms in cancer patients on 
treatment”. The first page of the ethical approval for this project is presented below. 
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B.3 The PPM Cancer dataset access  
To access the PPM Cancer Dataset, I went through two ethical approvals: 
1) Get NHS LTHT Honorary Contract 
An Honorary Contract is a clinical interaction or period of education or 
observation which involves Trust employees or patients. The first page of the 
Honorary Contract for this study is presented below. 
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2) IRAS application 
The Integrated Research Application System (IRAS) is a single system for 
applying for the permissions and approvals for health, social and community care 
research in the UK. This study falls under the requirement to gain the Health 
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Appendix C 
Experiments of the MIMIC-III dataset 









Date of experiment 
01/05/2017 Experiment title: 
Data quality assessment of process 
mining using MIMIC-III database Experiment code 
M3-DQ-ALL001 Researcher's name:   
Angelina Kurniati 
Area of investigation 
This experiment is a data quality assessment of MIMIC-III dataset for process mining.  The 
complete report of this experiment has been published in a paper in the Health Informatics 
Journal. 
Data source 
The MIMIC-III dataset is analysed per table. 
Research questions 
(1) Can the MIMIC-III database be used to better understand data quality issues for 
process mining in healthcare? 
(2) What are the data quality issues for process mining with MIMIC-III? 
(3) How might the change in the EHR system in 2008 affect the data quality? 
Hypothesis 
Weiskopf &Weng (W&W) framework can be used to identify data quality issues for 
process mining with MIMIC-III. 
Method 
The general method used in this experiment is an adaptation of the L* lifecycle model, 
which includes data quality assessment. The methodology consists of Plan and justify 
(Stage 0), Database reconstruction (new stage), Extract (Stage 1), Create a control-flow 
model (Stage 2), Create integrated process model (Stage 3), and Data quality assessment 
(new stage). Database reconstruction was added to support Data quality assessment and 
trigger the next iterations. 
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Result and Discussion 
1) Planning and justification have been done by specifying three research questions. 
Q1 was addressed through a cancer-specific example, Q2 was addressed by 
applying the Weiskopf& Weng framework, and Q3 was addressed by investigating 
the differences of processes in CV and MV systems. 
2) Database reconstruction was needed as a foundation to support iterative 
experiments on data quality assessment. The downloaded data were in .csv files (26 
files, more than 6 GB in total) and were imported to a PostgreSQL database. The 
concept level Entity-Relationship Diagram (ERD) is presented in the following 
Figure. 
 
The entities in bold contain timestamped information which can be used to construct 
an event log for process mining. 
3) Extraction, transformation, and loading (ETL). Extraction was done multiple 
times from the reconstructed database. For example, the admission table in the 
MIMIC-III database was extracted by selecting [admittime, dischtime, 
edregtime, edouttime, deathtime] of cancer patient admissions 
[icd9_codes 140x-239x]. Process discovery was done using three plugins in ProM: 
(1) Convert CSV into XES, (2) Add artificial events >> START and END events, 
and (3) BPMN Analysis using Heuristics Miner. The Q1 (Can the MIMIC-III 
database be used to better understand data quality issues for process mining in 
healthcare?) was addressed to find the most followed admission paths of cancer 
patients. The five most common variants and BPMN process model of admissions 
are presented in the following Figure. 
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4) Process analytics was done by extending with time and resource perspective. In 
this experiment, it was done to study the effect of EHR change, which addressed 
Q3 (How does the change in the EHR system in 2008 affect the data quality?). The 
approach was to work backwards from the inputevents_cv and inputevents_mv 
tables to identify which hospital admissions has been recorded on which EHR. We 
also identified the differences through four tables: chartevents, datetimeevents, 
inputevents, and outputevents. Each admission was marked with CV, MV, or both; 
then we created separate event logs from each data sources. We then compared the 
models using DifferenceGraph plugin in ProM.  
5) Data quality assessment was done based on the W&W framework, which has been 
summarised in Table 4.1 in Section 4.1.3. 
Conclusion 
Despite some limitations found in this data quality assessment, the MIMIC-III database was 
found to be sufficient for process mining projects. The three minimum components required 
for process mining are available in 16 tables in the MIMIC-III database. Process miners can 
also specify different levels of details needed in the analysis.  
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Date of experiment 
07/03/2018 Experiment title: 
Data profiling of MIMIC-III dataset for 
CV-MV comparison Experiment code 
M3-CVMV-PRF001 Researcher's name:   
Angelina Kurniati 
Area of investigation 
This experiment is data profiling of MIMIC-III dataset as an initial step for CV-MV 
comparison.  
Data source 
The MIMIC-III dataset is analysed per table. 
Research question 
Is analysing each table in the MIMIC-III dataset provides initial information for CV-MV 
comparison? 
Hypothesis 
Data profiling would give initial information for CV-MV comparison. 
Method 
1) Extraction has been done by database reconstruction process in PostgreSQL. 
2) Create event logs of each event tables with [case_id, activity, timestamp, tsource] 
format, with: 
     case_id = subject_id/ hadm_id/ icustay_id 
     activity = {identified in Table 4.5} 
     timestamp = {column named -time in each table} 
2) Save as .csv files 
3) Load into DISCO and ProM (if possible), and analyse the result. 
Result and Discussion 
Data profiling was done to analyse the similarities and differences of patient data in CV and 
MV systems. This analysis was done per table in the MIMIC-III database. Only data profiles 
that potentially related to process mining are presented here. 
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1. Admissions 
This table sourced from hospital databases, to define a patient’s hospital admission, 
HADM_ID. 
o NEWBORN admissions only happened in CV (7,863 admissions/ 23.46%). It has 
also been described in the data descriptor that NEWBORN admissions were not 
included in the MV extracts. It was due to the limitation of the de-identification 
procedure to maintain confidentiality. 
EHR System Admission type Admissions % 
CV Elective 3,983 11.88 
Emergency 20,649 61.61 
Newborn 7,683 23.46 
Urgent 1,020 3.04 
MV Elective 2,960 15.33 
Emergency 16,130 83.51 
Urgent 224 1.16 
o There were data quality issues detected in CV where ED duration < 0 (98 
admissions). After non-valid data excluded, the average ED durations in MV 
(0.212 days) are shorter than CV (0.238 days). It means that ED duration has been 
shortened in the new system. 
     
o There are 204 records without admission location in CV, but there is none in MV.  
It means that data quality is improved in the new system, in term of recording 
admission location. 
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2. callout 
Provides information when a patient was READY for discharge from the ICU, and 
when the patient was actually discharged from the ICU. 
o Acknowledge status are mostly Acknowledged both in CV (8,078/ 91.61%) and 
in MV (15,560/ 99.01%). 
 
o Both in CV and MV, the three most common callout units are MICU, SICU, and 
CSRU. In both systems, callout units were rarely recorded, with Null value of 
8,208 (93.08%) in CV and 14,914 (94.90%) in MV. 
 
3. caregivers 
Defines the roles of caregivers in CV and MV databases. Some caregiver types are 
only available in MV, which are: attending, pastoral care, rehabilitation, research 
assistant, and social worker. There are a significant number of NULL values in CV 
(43.25%), but none in MV.  
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4. chartevents 
Contains all charted data for all patients in CV and MV databases. 
Characteristic CV MV 
Distinct subject_id 25,505 16,116 
Distinct hadm_id 29,541 19,248 
Distinct icustay_id 31,329 20,582 
Distinct itemid 5,100 1,868 
Distinct cgid 1,177 1,358 
5. cptevents 
Contains current procedural terminology (CPT) codes, which facilitate billing for 
procedures performed on patients. 
Characteristic CV MV 
Distinct subject_id 16,279 15,856 
Distinct hadm_id 19,588 19,250 




Distinct cpt_cd 971 1786 
Distinct cpt_number 970 1780 
Distinct cpt_suffix 0 1 
Distinct ticket_id_seq 550 531 
Distinct description 4 4 
 
6. d_items 
This is the reference table to separate CV and MV records in the other tables. 
Information available in the d_items table are: 
Characteristic CV MV 
Distinct itemid 9059 2992 
Distinct 
abbreviation 
0 (all NULL) 2907 





Distinct category 23 68 
Distinct unitname 0 (all NULL) 53 
Parameter types in MV system: checkbox (c), datetime (d), numeric (n), numeric with 
tag (nt), process (p), solution (s), and text (t). 
Linksto c d n nt p s t 
chartevents v  v v   v 
datetimeevents  v      
inputevents_mv      v  
outputevents  v v    v 
procedureevents_mv     v   
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7. d_labitems 
This is the reference table to separate CV and MV records in the labevents table. 
Information available in the d_labitems table are: 
Characteristic CV MV 
Distinct itemid 705 675 
Distinct label 557 534 
Distinct fluid 13 12 
Distinct category 6 6 
Distinct loinc_code 572 552 
8. datetimeevents 
Contains all date formatted data in the CV and MV databases. Column ‘resultstatus’ is 
Null in all rows. Columns ‘warning’ and ‘error’ are mostly Null in CV, but not in MV. 
Characteristic CV MV 
Distinct subject_id 11395 16116 
Distinct hadm_id 12759 19242 
Distinct icustay_id 13495 20559 
Distinct itemid 28 131 
9. diagnosis_icd 
This table contains ICD diagnoses for patients in ICD-9 codes, which were generated 
for billing purposes at the end of the hospital stay. 
 
10. drgcodes: contains diagnosis-related groups (DRG) codes for patients. *per admission 
DRGs are used to categorise inpatient hospital visits severity of illness, risk of 
mortality, prognosis, treatment difficulty, need for intervention, and resource intensity. 
The DRG system was developed for statistical classification of hospital cases. 
(icd.codes/articles/what-is-drg) 
Characteristic CV MV 
Distinct drg_code 1515 1512 
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11. icustays 
This table defines each ICUSTAY_ID in the database. The ICUSTAYS table is 
derived from the TRANSFERS table, grouped based on ICUSTAY_ID, and excluded 
rows without ICUSTAY_ID. 
Characteristic CV MV 
First_careunit 
 
Unit #sid #hid #iid 
CCU 4024 4328 4455 
CSRU 5040 5260 5478 
MICU 7555 9025 9452 
NICU 4795 4914 4984 
SICU 3610 3875 4082 
TSICU 3133 3205 3298 
 
 
Unit #sid #hid #iid 
CCU 2165 2320 2373 
CSRU 2909 3053 3189 
MICU 6793 8121 8521 
SICU 3504 3775 3975 





Unit #sid #hid #iid 
CCU 4024 4328 4455 
CSRU 5040 5260 5478 
MICU 7555 9025 9452 
NICU 4795 4914 4984 
SICU 3610 3875 4082 




Inputevents in the CV system is in inputevents_cv table and inputevents in the MV 
system is in inputevents_mv table. Observations in those two tables are not duplicated 
and can be unioned to create complete inputevents when needed. Only the 
CHARTTIME is available in CV, while STARTTIME and ENDTIME are available in 
MV. The CHARTTIME in CV is correspond with starttime. 
Characteristic CV MV 
Distinct subject_id 25,450 16,012 
Distinct hadm_id 29,353 19,111 
Distinct icustay_id 31,011 20,393 
Distinct itemid 2,794 274 
Distinct cgid 1,078 500 
   
13. labevents 
This table contains all laboratory measurements for a given patient, including 
outpatient data. Lab measurements for outpatients do not have a HADM_ID. The item 
identifiers can be explained with reference to d_labitems table.  
Characteristic CV MV 
Distinct itemid 705 675 
Distinct subject_id 25404 16087 
Distinct hadm_id 30040 19581 
Additional columns are value, valuenum, valueuom, and flag. Value contains the value 
measured for the itemid. If the value is numeric, valuenum contains the same data in 
numeric format, otherwise valuenum is null. Valueuom is the unit measurement for the 
value. Flag indicates whether the value is abnormal or not. 
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14. microbiologyevents 
This table contains microbiology information, including tests performed and 
sensitivities.  
Characteristic CV MV 
Distinct subject_id 19,454 16,420 
Distinct hadm_id 22,840 18,574 
Distinct spec_itemid 89 81 
Distinct org_itemid 282 215 
Distinct spec_itemid 30 29 
15. noteevents 
This table contains all notes for patients. There is no HADM_ID for outpatients and 
for inpatients who was not admitted to the ICU for that particular hospital admission. 
The main part of this table is the text, which contains all notes for patients and is 
potential to be analysed with text analytics. 
Characteristic CV MV 
Distinct subject_id 25,532 15,867 
Distinct hadm_id 30,376 19,445 
Distinct category 13 15 
Distinct description 2,025 2,812 
Distinct cgid 1,215 1,087 
Distinct text 1,175,306 634,789 
16. outputevents 
This table contains output data for patients. Metavision ITEMID values are all above 
220000, while a subset of commonly used medications in CareVue data have ITEMID 
30000-39999. ISERROR is a Metavision checkbox where a caregiver can specify that 
an observation is an error. 
Characteristic CV MV 
Distinct subject_id 24,251 15,932 
Distinct hadm_id 27,951 18,951 
Distinct icustay_id 29,405 20,200 
Distinct itemid 1,035 70 
Distinct cgid 1,038 837 
17. patients 
This table contains all charted data for all patients. DOB has been shifted for patients 
older than 89. The median age for the patients whose date of birth was shifted is 91.4. 
DOD is the date of death for the given patient, merged from DOD_HOSP (from the 
hospital database) and DOD_SSN (from the social security database), giving priority 
to DOD_HOSP if both were recorded. Patients table contains 25,534 CV patients and 
16,116 MV patients. 
Gender CV MV  Expire flag CV MV 
M 14,491 9,040  0 15,358 11,397 
F 11,043 7,075  1 10,176 4,718 
- 205 - 
18. prescriptions 
This table contains medication related to prescriptions, sourced from the hospital 
provider order entry database. DRUG_TYPE provides the type of drug prescribed. 
DRUG, DRUG_NAME_POE, DRUG_NAME_GENERIC are various representations 
of the drug prescribed to the patient. FORMULARY_DRUG_CD, GSN, NDC provide 
a representation of the drug in different coding systems. GSN is the Generic Sequence 
Number, NDC is the National Drug Code. ROUTE is the route prescribed for the drug. 
Characteristic CV MV 
Distinct subject_id 20,801 16,096 
Distinct hadm_id 24,574 19,587 
Distinct icustay_id 25,393 20,544 
Distinct drug 3,253 2,700 
Distinct prod_strength 3,245 2,139 
Distinct route 67 71 
 
19. procedureevents 
Contains procedures for patients in MV database.  









This table contains ICD procedures for patients in ICD-9 procedure codes. The ICD 
codes are generated for billing purposes at the end of the hospital stay. Seq_num 
provides the order of the performed procedures. ICD9_code can be joined to the 
d_icd_procedures table to get the descriptions. 
Characteristic CV MV 
Distinct subject_id 23,601 14,122 
Distinct hadm_id 27,832 16,898 
Seq_num 1-40 1-40 
Distinct icd9_code 1,719 1,557 
21. services 
This table lists services under which a patient was admitted/ transferred under. While 
a patient can be physically located at a given ICU type, they are not necessarily being 
cared for by the team which staffs that ICU. 
Characteristic CV MV 
Distinct subject_id 25,520 16,110 
Distinct hadm_id 30,484 19,736 
Distinct prev_service 17 17 
Distinct curr_service 20 
*Not in MV: NB (Newborn at hospital), 
TRAUM (trauma), NBB (newborn baby), 
PSYCH (psychiatric)  
17 
*Not in CV: - 
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22. transfers 
This table records physical locations for patients throughout their hospital stay. The 
ICUSTAYS table is derived from this table. ICUs have moved throughout the years, 
same WARDID may be an ICU for patient A but not an ICU for patient B. 
EVENTTYPE describes what transfer event occurred, which includes transfer, admit, 
and discharge. There are 15 events in CV with eventtypes = NULL, but none in MV. 
Characteristic CV MV 
Distinct subject_id 25,534 16,115 
Distinct hadm_id 30,514 19,748 
Distinct icustay_id 31,749 20,759 
Distinct prev_wardid 53 45 
Distinct curr_wardid 53 45 




The log-based comparison reveals some important information to consider in the next step 
in process mining to analyse process changes in CV and MV systems in the MIMIC-III 
database. Differences in columns and data details recorded in the CV and MV systems 
should be considered when comparing process in those two systems. For example, newborn 
admissions were only included in the CV system and not in MV. The consequence is when 
the comparison is done to all records in the CV and MV systems, they will not be 
comparable. Calculation of the average age at admission will also include newborn 
admissions in the CV system and not in the MV system.  
Another insight gained from this experiment is that it is not valid to analyse all data in the 
MIMIC-III database without considering two different systems from which the admissions 
were recorded. Data profiling of those two EHR systems revealed many differences in the 
data level that affected the process analysis. 
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 School of Computing 




Model comparison of MIMIC-III for 
CV-MV Experiment code 
M3-CVMV-
MDL001 
Researcher's name:   
Angelina Kurniati 
Area of investigation 
This experiment is model comparison of MIMIC-III tables as a part of CV-MV 
comparison.  
Data source 
The MIMIC-III dataset is analysed per table. 
Research question 
Is comparing process models of each table in the MIMIC-III dataset provides initial 
information for CV-MV comparison? 
Hypothesis 
Model comparison would give control-flow change information for CV-MV comparison. 
Method 
1) Extraction has been done in database reconstruction process in PostgreSQL. 
3) Create event logs of each event tables with [case_id, activity, timestamp, tsource] 
format, with: 
     case_id = subject_id/ hadm_id/ icustay_id 
     activity = {identified in M3-TRS-DES001} 
     timestamp = {identified in M3-TRS-DES001} 
2) Save as .csv files 
3) Load into DISCO and ProM (if possible) 
 - Merge subsequent events 
 - Add artificial START and END events 
 - Create PN with Heuristics Miner 
4) Analyse the results 
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Result and Discussion 
Model comparisons were done by creating a process model for each table in CV and MV. 







- In CV, ED out can happen before or after admission. In MV, admission 







- There are four activities in CV and five activities in MV. The one additional 
activity in MV is first reservation. This additional activity happens after callout 
acknowledge and before callout outcome.  
- In CV, callout update is an optional activity happened after callout create and 
before callout acknowledge. In MV, callout update happened in the backward 
path after callout outcome and before callout acknowledge. 
 
Conclusion 
The model comparison reveals some important information to consider in the next step in 
process mining to analyse process changes in CV and MV systems in the MIMIC-III 
database. The limitation of this approach is that it is heavily dependent on the visual 
differences of the process models. There was an opportunity to find a more structural/ 
quantitative way to analyse the differences in the properties of two process models. 
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Appendix D 
Experiments of the PPM Chemotherapy dataset 










13/02/2017   Experiment title: 
PPM Chemotherapy Data Description Experiment code 
CHE-ALL000 Researcher's name:   
Angelina Kurniati 
Area of investigation 
This experiment is for understanding PPM Chemotherapy dataset through building data 
description, which include creating an event log from each table in the database, with the 
minimum format is [case_id, activity, timestamp]. 
Data source 
The dataset is a copy of DB2-2016 database, which is an anonymous dataset of cancer 
patient treatment in Leeds Cancer Centre during 1996-2015. This database was originally 
created to develop decision support rules and risk algorithms in cancer patients on treatment. 
Research question 
Is the PPM Chemotherapy database can be used for process mining? 
Hypothesis 
The tables in the PPM Chemotherapy database can be used as it provides at least minimum 
requirements for process mining. 
Method 
1) Extract by copying the DB2-2016 database in SQL Server from all potentially useful 
tables. 
2) Describe each table for understanding each attribute and the relations between attributes. 
This includes identifying columns needed for process mining (especially activities) and 
identifying splitting attributes for next experiments. 
3) Transform to create event log with [case_id, activity, timestamp] format. For example, 
admissions table has been transformed into an event log with: 
     case_id = PID/ KTPId 
     activity = {admission, discharge} 
     timestamp = {GenDateAtAdmission, GenDateAtDischarge} 
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* all timestamp attributes are created by generating dates based on ages (in number of 
days) with ’01-01-2020’ as the date of birth for all patients. 
4) Save as .csv files 
5) Load into DISCO and ProM (if possible), and analyse the result. 
Result and Discussion 
1) Admissions 
The ADMISSIONS table gives information regarding the patient’s admission to the 
hospital. It is linked to other tables through PID and AdmissionId. 
Table columns: 
Column Data type Distinct Missing Description 
PID unique id 28,609 0 Case id 
AdmissionId int 397,444 0  
AgeAtAdmission int 33,388 0 Activity  
ContactSpecialityCode int 80 910  
ContactSpecialityLabel nvarchar(100) 80 910  
AdmissionMethod varchar(9) 3 0  
MethodCode Int 17 0  
MethodLabel nvarchar(100) 17 0  
AgeAtDischarge int 33,365 25 0 – 36,649 
Number of rows 397,444 
Notes:  
(1) Potential case_id = PID;  
(2) AgeAtDischarge=0 in 25 admissions;  
(3) Potential activities: ‘Admission’ and ‘Discharge’ or AdmissionMethod/ MethodLabel 
Details: 
Cases  : 28,609 
Events  : 794,863 
Events per case : min 2, mean 28, max 1020 
Mean case duration : 35.3 months 
Median case duration: 17.1 months 
Case duration : 0 days – 12 years 11 months 23 days 
Variants  : 500 
Variance checking shows that 80% of cases can be represented by 4% of variants: 
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The admission table can be used for process mining, providing that this table contains the 
minimum requirements for process mining. 
2) AdmissionWardStayLocation 
The AdmissionWardStayLocation table gives detailed information regarding the patient’s 
admission to the hospital, ward stays location, start and end of staying. It is linked to other 
tables through PID and AdmissionId. 
Column Data type Distinct Missing Description 
PID unique id 28,609 0 Case id 
AdmissionId int 397,423 0  
AgeAtAdmissionDischarge int 33,365 37 0-36,649 
AgeAtWardStayStart int 33,730 0 0-36,642 
AgeAtWardStayEnd int 33,748 7 0-36,649 
ew_WardLabel nvarchar(100) 360 0  
Number of rows 469,886 
Two important points are:  
(1) AgeAtAdmissionDischarge is identical with AgeAtDischarge in the Admissions table. 
(2) Potential activitiy is WardLabel. 
Details: 
Events    : 469,886 
Cases   : 28,609 
Events per case  : min 1, mean 16.5, max 517 
Activities   : 360 
Mean case duration : 35.3 months 
Median case duration : 17.1 months 
Case duration  : 0 days - 12 years 11 months 23 days 
Variants  : 24,460 
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Fuzzy model: 
 
(1.7% activities, 0% paths, showing case frequency) 
The fuzzy model above shows the most frequently assigned ward is ward 80 (n=12,336), 
followed by ward 96 (n=8,045) and ward 97 (n=4,687). A further search has been done and 
found that ward 80 is the oncology ward, ward 96 is an acute assessment ward, and ward 97 
is an oncology ward for patients with different types of cancer. 
3) ChemoCycles 
The ChemoCycles table provides detail information regarding chemotherapy cycles of the 
patient. This is linked to other tables through PID and RegimenID. 
Column Data type Distinct Missing Description 
PID unique id 29,009 0 PID-Cycle = 1-m 
CycleID int 198,096 0 RegimenID-CycleID = 1-m 
RegimenID int 56,624 0 PID-RegimenID = m-m 
AgeWhenCycleStarted int 28,399 0 2-36,626 
YearCycleStarted int 20 0 1996-2015 
CycleNumber int 93 0 1-93 
CycleMaxDays int 131 0 -7 – 547 
CycleCalculatedLength int 131 0 -7 – 547 
Number of rows 198,096 
Notes: (1) Potential case_id: PID, CycleID, RegimenID 
 (2) Potential activities: CycleNumber 
- 213 - 
Number of cycles started per year: 
 
The diagram above shows that the number of cycle started is generally increasing over the 
years, but the number of subsequent cycles is decreasing. It has been further analysed in the 
experiment 3 using the PPM Chemotherapy dataset as presented in Section 5.2. 
Fuzzy models: 
 
(8% activities, 1.7% paths) 
(case frequency) 
(caseID = PID) 
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* The left model shows model with caseID = PID, which is not fair, because a patient 
might have more than one RegimenID and the ChemoCycles might represent cycles of 
different regimen. This setting would be needed to combine this event log with event 
logs from other tables. 
* The right model shows model with caseID = PID+RegimenID, which represent 
ChemoCycles for each regimen of each patient. It shows that patients are generally 
followed subsequent cycles, with 61 patients (0.12%) repeated cycle 1 and 20 patients 
(0.04%) had to go back to cycle 1 from cycle 4.  
Details: 
Events    : 198,096 
Cases   : 56,624 
Events per case  : min 1, mean 3, max 91 
Activities   : 93 
Mean case duration : 78.3 days 
Median case duration : 42 days 
Case duration  : 0 days - 6 years 6 months 17 days 
Variants   : 1,105 
4) ChemoDrugs 
The ChemoDrugs table provides detail information regarding chemotherapy drugs given to 
the patients. This is linked to other tables through PID and RegimenID. 
Column Data type Distinct Missing Description 
PID unique id 31,421 0 > PID in Admissions table 
DrugID int 706,670 0 unique 
RegimenID int 59,639 32,683 High missing values 
AgeWhenDrugGiven int 34,184 0 2 – 36,720 
DrugLabel varchar(max) 301 0 Count:[ 1- 81,501] 
DrugDose float 435 3 Explaining DrugLabel 
DoseUnit varchar(max) 12 3 Explaining DrugDose 
DrugLabelMapped varchar(max) 291 11,971 Mapped 1-1 to DrugLabel 
DrugTherapyType varchar(max) 19 11,971 High missing values 
Number of rows 706,670 
Notes: 
(1) Some missing RegimenID can be replaced by:  
a. referencing to ChemoRegimen table, when AgeAtRegimenStartDate = 
AgeWhenDrugGiven, leaving with 9,799 missing values 
b. referencing to ChemoCycles table, when AgeWhenCycleStarted = 
AgeWhenDrugGiven, leaving with 5,151 missing values 
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(3) There are 11 DrugLabel that are not mapped to DrugLabelMapped  and 
DrugTherapyType 
(4) Potential activities: DrugLabel / DrugLabelMapped 





Calcium folinate 44148 
Biological Modifier 37140 






Kinase Inhibitor 7536 












(1.7% activities, 8.4% paths, showing case frequency) 
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Details: 
Events    : 706,670 
Cases   : 76,995 
Events per case  : min 1, mean 9, max 448 
Activities   : 301 
Mean case duration : 81.7 days 
Median case duration : 27 days 
Case duration  : 0 days - 17 years, 2 months, 13 days 
Variants  : 12,791 
5) ChemoRegimens 
The ChemoRegimens table provides detail information regarding chemotherapy regimens 
of the patient. This is linked to other tables through PID and RegimenID. 
Column Data type Distinct Missing Description 
PID unique id 31,354 0 Count:[1-33] 
RegimenID int 67,707 0 unique 
AgeAtRegimenStartDate int 22,744 0 Relative 
RegimenLabel varchar(max) 2,945 0 Count:[1-1389] 
Intent varchar(max) 7 12,687  
RegimenLabelMapped varchar(max) 547 8,972  
LinkedDiagnosisId int 32,490 4,360  
LinkedDiagnosisICD varchar(max) 68 4,360  
DiagnosisLinkMethod varchar(max) 3 4,360  
CourseOfSameChemo int 14 0  
Number of rows 67,707 
Notes:  
(1) Potential activities: RegimenLabel,  
(2) Potential splitting attributes: Intent, LinkedDiagnosisICD, DiagnosisLinkMethod. 
Details: 
Events    : 67,707 
Cases   : 31,354 
Events per case  : min 1, mean 2, max 33 
Activities   : 2,951 
Mean case duration : 37.7 weeks 
Median case duration : 0 milliseconds 
Case duration  : 0 days – 18 Years, 5 Months, 24 Days 
Variants  : 2,951 
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Fuzzy model: 
 
(0.3% activities, 0% paths) (showing case frequency) 
The above fuzzy model shows a model where a case consists only of a small number of 
activities. Based on the following details, each case consists of 1 to 33 activities, with an 
average of 2. 
6) Death 
The Death table provides information about the AgeAtDeath and LastCycleBefore Death. 
It is linked to other tables through PID. 
Column Data type Distinct Missing Description 
PID unique id 17,701 0  
AgeAtDeath int 11,214 0 28 - 36,649 
LastCycleBeforeDeath int 10,504 1,317 (in age- days) 2 – 36,089 
Number of rows 17,701 
Notes: 
(1) Potential activity: Death 
(2) There is no attributes potentially useful as splitting attribute in this table. 
(3) Because this table consists of only one activity, it wouldn’t be useful to use this table 
alone in process mining, and will be combined with the other tables. 
 
7) Diagnosis 
The Diagnosis table provides information about the patient diagnosis. It is linked to other 
tables through PID. 
Notes:  
- Potential activities: dx_ICD10Label. 
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Column Data type Distinct Missing Description 
PID unique id       30,753  0  
AgeAtDiagnosis int       20,132  0 0 - 36609 
YearOfDiagnosis int             63  0 1921-2015 
dx_DiagnosisID int       56,123  0 unique 
dx_ICD10CDS nvarchar(50)           507  7,892  
dx_ICD10Label nvarchar(100)           518  6,422  
TStage nvarchar(100)             32  44,387  
NStage nvarchar(100)             19  44,905  
MStage nvarchar(100)             12  45,634  
StageLabel nvarchar(100)             74  45,147  
dx_DiseasePhase int               3  421  
dx_DiseasePhaseLabel nvarchar(100)               3  421  
dx_CancerStatus int               7  77  
dx_CancerStatusLabel nvarchar(100)               7  77  
dx_MorphologyCDS nvarchar(50)           471  8,464  
dx_MorphologyCode int           521  8,261  
dx_MorphologyLabel nvarchar(100)           521  8,261  
dx_SiteCDS nvarchar(50)           265  614  
dx_SiteLabel nvarchar(100)           278  0  
dx_Her2Status int               8  54,774  
HER2Status_Label varchar(35)               6  54,784  
dx_EstrogenReceptorStatus int             11  54,540  
OestrogenReceptorStatus_Label varchar(16)             10  54,545  
dx_ProgesteroneReceptorStatus int             10  54,762  
ProgesteroneReceptorStatus_Label varchar(16)               9  54,775  
DistrictLevelPostcodeAtDiagnosis (if 
known) 
varchar(8000) 166 51,108  
DrivingDistanceFromLTHT_Miles float 1,065 54,570  
Number of rows 56,123 
Details: 
Events    : 56,123 
Cases   : 30,753 
Events per case  : min 1, mean 2, max 21 
Activities   : 278 
Mean case duration : 22.9 months 
Median case duration : 0 millis 
Case duration  : 0 days – 18 Years, 5 Months, 24 Days 
Variants   : 6,063 
 
 
- 219 - 
Fuzzy model: 
 
(4.8% activities, 0% paths, showing case frequency) 
 
8) Outpatients 
The Outpatients table provides information about the outpatient visits. It is linked to other 
tables through PID. 
Column Data type Distinct Missing Description 
PID unique id 28,878 0  
AgeAtTimeOfOPClinic int 34,438 0  
op_AppointmentTypeCode int 166 28,580  
AppointmentTypeDescription nvarchar(255) 69 47,564 NULL=‘Not Known’ 
Number of rows 973,177 
Notes:  
(1) Potential activities: AppointmentType Description (‘Not Known’ treated as an 
activity).  
(2) Potential splitting attribute: none. 
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Fuzzy model: 
 
(7% activities, 7% paths, showing case frequency) 
Details: 
Events    : 926,797 
Cases   : 28,878 
Events per case  : min 1, mean 32, max 399 
Activities   : 69 
Mean case duration : 54.7 months 
Median case duration : 42.8 months 
Case duration  : 0 days – 14 Years, 6 Months, 19 Days 
Variants  : 23,868 
9) Patients 
The Patients table provides information about the outpatient visits. It is linked to other 
tables through PID. 
Column Data type Distinct Missing Desc 
PID unique id 31,511 0  
Gender nvarchar(100) 2 27  
EthnicCategory nvarchar(100) 20 1514   
AgeAtDeath int 11,214 13,810  
DistrictLevelPostcode nvarchar(4) 693 45  
DrivingDistanceFromLTHT_Miles float 4,341 3,655  
DayOfWeekOfBirth nvarchar(30) 7 1  
Number of rows 31,511 
Notes:  (1) Potential activities: death (duplicate with Death table). (2) Missing ethnic 
categories: NULL=1514, Not given – 4881, Not collected – 234, Not stated – 192. (3) 
Potential splitting attributes: Gender, EthnicCategory, DistrictLevelPostcode, and 
DistrictLevelPostcode. (4) The Patients table is potentially useful for patient 
characterisation, such as proportion of male versus female patients and proportion of patient 
ethnicity. 
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10) Radiotherapy 
The Radiotherapy table provides information about the radiotherapy treatment. It is linked 
to other tables through PID. Radiotherapy is one of three possible treatment for cancer, 
along with chemotherapy and surgery.  
Column Data type Distinct Missing Description 
PID unique id 16,792 0  
AgeAtRadiotherapy int 15,212 0 one invalid (-13959) 
IntentCode  nvarchar(50) 4 4,495  
IntentLabel nvarchar(100) 5 3,298  
SiteCode nvarchar(50) 232 5,361  
SiteLabel nvarchar(100) 236 4,720  
Number of rows 31,703 
Notes: (1) Potential activity: ‘Radiotherapy’,  
 (2) Potential splitting attributes: IntentLabel, SiteLabel 
Fuzzy model: 
 
(4.7% activities, 0% paths) (showing case frequency) 
The above fuzzy model shows a possibility to use SiteLabel as the activity name. It 
resulted in a model of site progression of cancer. The model shows that the most frequent 
activity is ‘Unknown’, which should be excluded from the model, with a risk of losing 
information of the most common site label. 
Details: 
Cases   : 16,792 
Events   : 31,160 
Events per case  : min 1, mean 2, max 30 
Mean case duration : 45.3 weeks 
Case duration  : 0 millis – 12 years 7 months 6 days 
Variants   : 3,361 
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11) Surgery 
The Surgery table provides information about the surgery treatment. It is linked to other 
tables through PID. Surgery is one of three possible treatment for cancer, along with 
chemotherapy and radiotherapy. 
Column Data type Distinct Missing Description 
PID unique id 21,395 0 Case id 
AgeAtSurgery int 22,199 0 Activity 
ProcedureCode nvarchar(50) 1,237 26,134  
ProcedureLabel nvarchar(100) 1,345 6 23,389 Unknown 
Number of rows 74,889 
Notes: Potential activity: ‘Surgery’ / ProcedureLabel 
Fuzzy model: 
 
(1% activities, 0% paths, showing case frequency) 
The above fuzzy model shows that the most frequent activity is ‘Unknown procedure 
created by Pathology import’. A discussion with clinical expert confirmed that this activity 
can be further analysed from the Pathology table, which unfortunately was not included in 
the PPM Chemotherapy dataset. 
Details: 
Cases   : 21,395 
Events   : 74,695 
Events per case  : min 1, mean 3, max 50 
Mean case duration : 22.5 months 
Median case duration : 22.6 weeks 
Case duration  : 0 millis – 12 years 7 months 6 days 
Variants   : 3,361 
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12) TestResultsBlood 
The TestResultsBoold table provides information about the results of blood tests. It is 
linked to other tables through PID. 
Column Data type Distinct Missing Description 
PID unique id 29,151 0 KTPId 
AgeAtOrderDate int 34,971 0 0 – 36,751 
Value varchar(50) 21,063 577 Numbers, some started with < 
or > 
Units varchar(50) 16 1,037,211  
Term varchar(256) 34 0  
Number of rows 17,814,931 
Notes: (1) Potential activities: Term; (2) Potential splitting attribute: Term+Value 
(3) A possible data quality issue is that some values started with < or > when they 
are expected to be in a numeric format. 
(4) TestResultsBlood table contains most of the data in the PPM Chemotherapy 
dataset (71 million/ 83%) 
13) TestResultsMicrobiology 
The TestResultsMicrobiology table provides information about the results of microbiology 
tests. It is linked to other tables through PID. 
Column Data type Distinct Missing Description 
PID unique id 15,678 0 KTPId 
AgeAtOrderDate int 27,823 0  
Source varchar(max) 23 0  
Positive bit 2 0 0/1 
PossibleContaminant bit 2 0 0/1 
Number of rows 118,947 
Notes: (1) Possible activities: Source 
 (2) Possible splitting attributes: Source+Positive 
Details: 
Cases   : 15,678 
Events   : 88,049 
Events per case  : min 1, mean 6, max 187 
Mean case duration : 12.9 months 
Median case duration : 29 days 
Case duration  : 0 millis – 11 years 9 months 28 days 
 Variants  : 3,093 
 




(43% activities, 0% paths) (showing case frequency) 
 
Conclusion 
This experiment shows that all tables except Patients table are potentially useful for process 
mining. Patients table contains no timestamped event, but is useful for patient 
characterisation. Some tables can be used for process mining combined with other tables 
(Death, Radiotherapy, Surgery), some tables cannot be used as event log but will be useful 
as a reference table (Patients), while the other 9 tables can analysed using process mining 
by themselves. Some data quality issues are identified and has been described for each table 
in this experiment. 
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Date of experiment 
05/10/2018 
Experiment title: 
Process mining of EC-90 chemotherapy 
pathways of breast cancer patients  
Experiment code 
PPMC-SBRI-BC001 
Researcher's name:   
Angelina Kurniati 
Area of investigation 
This experiment is for using process mining to explore variations in chemotherapy 
pathways for breast cancer patients. 
Data source 
The dataset is a subset of SBRI dataset from PPM Chemotherapy data (712 variants of 
738 patients).  
Research question 
Can process mining be used to explore variations in chemotherapy pathways for breast 
cancer patients? 
Hypothesis 
Process mining can be used to explore variations in chemotherapy pathways for breast 
cancer patients. 
Method 
1) Extraction and transformation has been done in CHE-ALL000. Patients were 
included if they had a diagnosis of metastatic breast cancer (ICD-10 C50) and received 
adjuvant epirubicin and cyclophosphamide (EC-90) chemotherapy. 
3) Create event log of all events with [case_id, activity, timestamp, tsource] format, 
with: 
     case_id = PID/ KTPId 
     activity = {identified in CHE-ALL000} 
     timestamp = {identified in CHE-ALL000} 
2) Save as .csv files 
3) Load into DISCO and ProM (if possible), and analyse the result. 
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Results and Discussion 
1) Extraction and transformation has been done by selecting events of interest. 
Event name Occurence Percentage 
Neutropenic 836 17.2% 
Cycle 1 732 15.0% 
Cycle 2 725 14.8% 
Cycle 3 699 14.3% 
Emergency 611 12.5% 
Cycle 4 487 9.9% 
Cycle 5 402 8.3% 
Cycle 6 380 7.8% 
2) The event log is illustrated below. 
 
3) The event log above has been loaded to ProM and DISCO for further analysis. The 
resulted process model, trace variant diagram, and dotted chart presented in Figure 
5.3 – Figure 5.5 in Section 5.2.3.  
4) Further analysis has been done to examine the cycles leading to an emergency 
admission or a neutropenic condition. The following table shows that most patients 
who had emergency admission got it after Cycle 3, Cycle 6, or Cycle 1; while most 
patients who had Neutropenic condition got it after Cycle 3, Cycle 2, or Cycle 1. 
Cycle 
number 
Cycle leads to Emergency Cycle leads to Neutropenic 
N (%) med; mean  N (%)  med; mean 
Cycle 1 81 (11) 8 d; 18.4 d 94 (13) 19 d; 23.1 d 
Cycle 2 52 (7) 8 d; 43.9 d 123 (17) 19 d; 20.6 d 
Cycle 3 117 (16) 28 d; 27.3 w 142 (19) 18 d; 61.1 d 
Cycle 4 64 (9) 14d; 27.3 w 84 (11) 19 d; 16 d 
Cycle 5 22 (3) 13.5 d; 19.2 w 70 (9) 19 d; 33.5 d 
Cycle 6 90 (12) 13.5 m; 20.8 m 57 (8) 14 d; 26.4 w 
5) Another discussion with clinical experts was that it seems that a lot of patients stopped 
chemotherapy after Cycle 3. This is presented in Figure 5.4 as the second (n=56; 
7.6%)  and third trace variant (n=37; 5%). The clinical expert explained that this was 
because the analysis was done in only one regimen (EC-90). The regimen might have 
changed in the subsequent cycles. This condition is out of the scope of the experiment. 
Conclusion 
This experiment shows that process mining of routine data can show extensive variations 
from standard chemotherapy pathways including incomplete treatment and adverse 
events. Future work is needed to explore potential causal links and understand changes in 
the pathways over time. 
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Appendix E 
Analysis of the PPM Cancer dataset 
E.1 Table description of the PPM Cancer dataset 
The following table contains list of table and the details of PPM Cancer dataset. 
# table name # columns 
data type* 
id char num time 
1 Admissions 63 1 36 22 4 
2 Annotations 71 1 29 36 5 
3 AssessmentActivities 8 2 0 2 4 
4 AssessmentResults 5 2 1 2 0 
5 Assessments 3 2 0 1 0 
6 COSDInvestigations 24 0 14 6 4 
7 COSDPathology 39 0 25 9 5 
8 COSDRegistration 84 0 68 9 7 
9 COSDSurgery 32 0 18 8 6 
10 CWTReferralTreatmentComplete 52 0 26 22 4 
11 CancerWaitingTimes 142 1 58 62 21 
12 CareEpisodes 56 1 30 19 6 
13 ChemoCycles 94 1 43 42 8 
14 ChemoDrugs 153 1 75 67 10 
15 ChemoRegimens 77 1 34 35 7 
16 Consultations 77 1 38 35 3 
17 DataForIBMPOC 4 0 3 1 0 
18 Diagnosis 318 1 153 155 9 
19 Event 23 1 2 15 5 
20 EventAdmission 13 1 0 12 0 
21 EventBloodTest 59 1 1 56 1 
22 EventMetadata 69 5 12 41 11 
23 EventMetadataSummaries 6 1 2 2 1 
24 EventWardStay 22 1 16 5 0 
25 InvestigationEx 50 1 20 26 3 
26 Investigations 85 1 47 32 5 
27 LastContacts 55 0 35 18 2 
28 MDTReview 82 1 45 29 7 
29 Organisation 10 1 6 3 6 
30 Outpatients 99 1 52 40 3 
31 Pathology 335 1 160 171 3 
32 PatientOrganisation 8 1 4 3 0 
33 PatientOrganisationVersion 37 1 25 8 3 
34 PatientPCT 3 0 2 1 0 
35 Patients 90 1 55 29 5 
36 Radiotherapy 103 1 47 48 7 
37 RadiotherapyEx 76 1 33 37 5 
38 Referrals 99 1 53 36 9 
39 StratifiedMedicineResultsBase 10 0 7 3 0 
40 StratifiedMedicine_TabulatedResultsXML 233 0 203 3 27 
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# table name # columns 
data type* 
id char num time 
41 Surgery 160 1 97 55 7 
42 TrialActivityContactOrg 105 1 56 35 14 
43 TrialConsultationActions 22 1 9 10 3 
44 TrialRecruitmentInstitution 57 1 20 28 8 
45 TwoWeekWaitReferrals 25 1 17 6 2 
46 WardStays 81 1 45 29 6 
47 Watch 2 1 2 2 2 
48 WatchDefinition 12 1 97 8 7 
Total 3,333 40 1,724 1,324 245 
*id includes uniqueidentifier 
*char includes char, nchar, nvarchar, varchar 
*num includes bit, float, int, numeric, real, tinyint, varbinary 
*time includes date, datetime 
E.2 Data selection of the PPM Cancer dataset 
The following table contains description of table name, columns, and data types in the 
database which was used in this study. 
*Code: C=case_id, A=activity_id, R=resource, T=timestamp 





em_AdmissionDate datetime T, A 
em_ContactSpecialityLabel nvarchar R 
em_DischargeDate datetime T 
em_DischargeMethodLabel nvarchar A 





ecc_CycleContactSpecialityLabel nvarchar R 
ecc_CycleNumber int A 
Ecc.PatientID int C 





ecd_DrugEndDate datetime T 
ecd_DrugLabel nvarchar A 
ecd_DrugStartDate datetime T 
Ecd_CycleCOntactSpecLabel nvarchart R 




ec_ContactSpecialityLabel nvarchar R 
ec_RegimenEndDate datetime T 
ec_RegimenLabel nvarchar A 
ec_RegimenStartDate datetime T 




eb_ConsultationDate datetime T 
eb_ContactMethodLabel nvarchar A 
eb_ContactSpecialityLabel nvarchar R 




en_PatientID int C 
en_InvestigationLabel nvarchar A 
en_ContactSpecLabel nvarchar R 
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#) TABLE_NAME COLUMN_NAME DATA_TYPE CODE 




dx_ContactSpecLabel nvarchar R 
dx_DiagnosisDate datetime T 
dx_ICD10CDS3 nvarchar A 
dx_ContactTypeLabel nvarchar R 




ev_EventDate datetime T 
ev_EventDetail nvarchar A 
ev_PatientID int C 






op_AppointmentDate datetime T 
op_AppointmentTypeCodeLabel nvarchar A 
op_ClinicConsultantContactSpecialityLabel nvarchar R 
op_ClinicDate datetime T 
op_ClinicType nvarchar A 








esp_ContactSpecialityLabel nvarchar R 
esp_HistologyReportDate datetime T 
esp_PathologyDate datetime T 
esp_PatientID int C 
esp_ReceivedDate datetime T 
esp_SiteCodeLabel nvarchar A 
esp_SpecimenTypeLabel nvarchar A 
11) Patients  pt_BirthDate datetime T 
pt_CauseOfDeathCode int A 
Pt_DeathPlace nvarchar A 






er_BookedDate datetime T 
er_ContactTypeLabel nvarchar R 
er_EndDate datetime T 
er_EventDate datetime T 
er_PatientID int C 








ef_AcceptedDate datetime T 
ef_FirstAppointmentDate datetime T 
ef_PatientID int C 
ef_ReceivedDate datetime T 
ef_ReferralDecisionDate datetime T 
ef_ReferralTypeLabel nvarchar A 
ef_ReferredByContactSpecLabel nvarchar R 








es_DecisionDate datetime T 
es_MainProcedureLabel nvarchar A 
es_MethodLabel nvarchar A 
es_PatientID int C 
es_ProcedureText nvarchar A 
es_SurgeonSpecialityLabel nvarchar R 
es_SurgeryDate datetime T 
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 School of Computing 
EXPERIMENT 
DOCUMENTATION 
Date of experiment 
25/06/2019   
Experiment title: 
PPM Cancer data change points Experiment code 
PPMQ-CH0002 Researcher's name:   
Angelina Kurniati 
Area of investigation 
This experiment is the detection of the change points of the data. The findings in the 
previous experiment show a change pattern in the system usage. This experiment focused 
on finding change points where the system has been potentially changed. 
Data source 
The dataset is all events of cancer patients in the PPM Cancer data, which was accessed in 
the secure room in LIDA. Specifically, the data of monthly records is analysed. Details of 
the R libraries used in this experiment is in Appendix F.2. 
Research question 
Is it possible to detect change points where system is potentially changed? 
Hypothesis 
It is possible to detect change points based on the system usage over time. 
Method 
For each event:  
1) Query to calculate monthly frequency of each activity from 2003 to 2018. 
2) Create a time-series (ts) object using R library stats. Frequency = 12. 
3) Signal decomposition to subtract trend and seasonal pattern from the observed 
pattern. Time series patterns are trend (based on 12-moving average), seasonal 
(monthly average), and random. R library used in this experiment is fpp2. 
4) Fit a linear model to analyse the trend, using R library stats. This is analysed based 
on the coefficient, adjusted R2, and p-value. The coefficient represents the intercept 
and slope in the linear model. The adjusted R2 shows how well the model is fitting 
the actual data. The p-value shows the significance of the relationship. 
5) SPC chart to detect time points with significant change of activity frequency over 
time. R library used in this experiment is qicharts2. 
6) Analyse the results. 
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Results 
Admission (Min 7761; Med 26102; Mean 24467; Max 35669) 
 
Fitted trend: (coef = 115.0181, adjusted R2 = 0.8144, p-value < 2.2e-16) 
 
SPC to detect change points: 
 
Change points: 
Month 10-2003 11-2003 1-2004 2-2004 3-2004 3-2011 10-2014 
value -2600.5 -3323.6 3316.4 2979.1 2522.8 2771.4 2456.9 
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Change points mapped into bar chart of monthly records: 
 
The trend of Admission shows an increasing pattern by 115 records per month and is higher 
than the trend of Diagnosis. The change points detected in October-November 2003, 
January – March 2004, March 2011, and October 2014.  
The changes in October – November 2003 reflected the early stage of PPM EHR system 
implementation. The change in March 2011 and Oct 2014 were likely related to the major 
changes in the PPM EHR system. In 2011, PPM EHR system were started to be adopted to 
manage data in the whole hospital, where previously used only to record events related to 
cancer treatment. In 2014, PPM EHR system has been improved to join the Leeds Care 
Records (LCR) and connected to other providers such as General Practitioners (GPs), 
community and adult social care. 
Discharge (Min 7754; Med 26025; Mean 24338; Max 35564) 
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Fitted trend: (coef = 113.6, adjusted R2 = 0.8146, p-value < 2.2e-16) 
 
 




Month 10-2003 11-2003 12-2003 1-2004 2-2004 3-2011 10-2014 
value -2474.9 -3317.6 -2448.4 3456.5 3063.8 2431.5 2583.8 
 
The number of Discharge records by month is very similar to those of admissions.  
The trend is that there is an increase of 113.6 per month and is higher than the trend of 
Diagnosis. The trend shows that Discharge records increased by 113.66 per month. Three 
periods where change potentially happened are in October 2003 to February 2004, March 
2011, and Oct 2014.  
The change in Oct-2003 to Feb-2004 were most likely related to the fact that PPM EHR 
system were just started to be used in the LTHT. The change in March 2011 is when the 
PPM EHR system was started to be adopted to manage data in the whole hospital. In October 
2014, PPM EHR system has been improved to join the Leeds Care Records (LCR) and 
connected to other providers such as General Practitioners (GPs), mental health, community 
and adult social care. 
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Consultations (Min 1; Med 5788; Mean 6459; Max 15025) 
 
Fitted trend: (coef = 72.78571, adjusted R2 = 0.7631, p-value < 2.2e-16) 
 
SPC to detect change points: 
 
Change points: 
Month 3-2018 4-2018 5-2018 6-2018 
value 1714.8 2182.6 2218.8 2418.6 
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Change points mapped into bar chart of monthly records: 
 
The trend of Consultation shows an increasing pattern by 72.78 records per month and is 
higher than the trend of Diagnosis. The change points detected in March–June 2018 were 
because Consultation was in the process of migration into a new system during 2018. 
Chemotherapy (Min 615; Med 1818; Mean 1971; Max 3559) 
 
Fitted trend: (coef = 12.6943, adjusted R2 = 0.9111, p-value < 2.2e-16) 
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Change points mapped into bar chart of monthly records: 
 
Chemotherapy is one of three cancer treatment types, along with surgery and radiotherapy. 
The trend of monthly records of chemotherapy in the PPM EHR system is increasing. One 
change point is detected in Jul-2014. This was discussed with clinical expert and was 
apparently because of a change in people authorized to do chemotherapy. Previously, it can 
only be done by clinicians in the gynaecology and gynaecology oncology departments. In 
2014, clinicians in the haematology department was started to be authorized to do 
chemotherapy. 
Diagnosis (Min 807; Med 3641; Mean 3512; Max 7568) 
Diagnosis can be said as the baseline in this experiment. This is because diagnosis was used 
in the selection criteria. More detailed results of the analysis of the monthly Diagnosis 
records are presented as an example in Section 6.6.3. 
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Investigation (Min 38; Med 48662; Mean 45835; Max 94323) 
 
Fitted trend: (coef = 376.0788, adjusted R2 = 0.9156, p-value < 2.2e-16) 
 
SPC to detect change points: 
 
Change points: 
Month 10-2003 11-2003 1-2004 2-2004 4-2017 6-2017 8-2017 
value -7072.8 -7504.5 6716.1 6852.2 -9932.0 -8249.7 9058.2 
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Change points mapped into bar chart of monthly records: 
 
MDT review (Min 183; Med 3658; Mean 3744; Max 8135) 
 
Fitted trend: (coef = 39.9816, adjusted R2 = 0.9678, p-value < 2.2e-16) 
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SPC to detect change points: 
 
There is no change point detected based on the MDT review records. In the other word, 
the increasing trend is stable. 
Outpatient (Min 1977; Med 140584; Mean 133371; Max 205905) 
 
Fitted trend: (coef = 791.9042, adjusted R2 = 0.7555, p-value < 2.2e-16) 
 
- 240 - 
SPC to detect change points: 
 
Change points: 
Month 1-2004 2-2004 3-2004 4-2004 5-2004 6-2004 
value -28878,6 -24813 -42320.3 41464.8 28405.8 24579.7 
Change points mapped into bar chart of monthly records: 
 
Pathology (Min 8; Med 5126; Mean 4571; Max 6740) 
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Fitted trend: (coef = 24.8572, adjusted R2 = 0.6626, p-value < 2.2e-16) 
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Radiotherapy (Min 474; Med 633; Mean 647.1; Max 1229) 
 
Fitted trend: (coef = 0.1599, adjusted R2 = 0.00232, p-value = 0.2317) 
 
SPC to detect change points: 
 
Change points: 
Month 10-2007 10-2013 10-2014 11-2014 4-2015 6-2015 11-2015 11-2017 
value 424.4 276.8 248.6 155.9 272.9 277.2 202.7 253.0 
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Change points mapped into bar chart of monthly records: 
 
Referral (Min 14223; Med 36088; Mean 39371; Max 63584) 
 
Fitted trend: (coef = 222.2942, adjusted R2 = 0.8401, p-value < 2.2e-16) 
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SPC to detect change points: 
 
Change points: 
Month 12-2003 1-2004 
value 8397.9 9329.3 
Change points mapped into bar chart of monthly records: 
 
Surgery (Min 56; Med 6480; Mean 5745; Max 9214) 
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Fitted trend: (coef = 41.24259, adjusted R2 = 0.8681, p-value < 2.2e-16) 
 





Change points mapped into bar chart of monthly records: 
 
Conclusion 
Each activity has different pattern of trend, seasonal, and change point(s) detected based on 
this method. Further evaluation of the results have been presented in Section 6.6.4. 
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Appendix F 
Overview of Plugins and Library 
F.1 Log Skeletons: A Classification Approach to Process Discovery 
Overview 
This is a rule-based approach to visualize log skeleton model. This model is related to the 
Declare constraint model with a way to classify traces. The better the discovered model can 
classify trace conformance to the event log, the better the discovery algorithm is supposed 
to be. 
Description 
An event log can be seen as a bag (or multi-set) of sequences of activities (or activity 
traces). Every activity trace can be extended with an artificial start activity and an end 
activity (called as an extended log), to explicitly gives a better picture of the activity log in 
the end. 
 
From the extended log, some relations can be defined, i.e. always after, always before, often 
next, often previous, never together, and next (one way or both ways). For example, the 
event log from experiment 1 in case study 1 as discussed in Section 4.3 can be visualised 
as the following log skeleton showing the ‘always after’ and ‘always before’ relations. 
Some important information visualised is that edout is not always after edreg, and discharge 
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is not always after admissions. This indicates data quality issues of the completeness of 
edout and discharge. 
 
Conclusion 
This plugin is one of the analytics plugins in ProM. This plugin visualises relations of 
activities in the event log as a log skeleton.  
F.2 bupaR 
Overview 
This is a package of functionalities for process analysis in R. This package is related to the 
other packages, including edeaR (exploratory and descriptive event-data analysis), 
processmapR, and processmonitR. 
Description 
The bupaR package is the core package of the framework that provides functions to create 
the objects and to support transformations such as mutate, filter, group_by, and mutate. The 
minimum required attributes to create an event log are case identifier, activity label, and 
timestamp. For example, the event log from experiment 2 in case study 3 as discussed in 
Section 6.4 can be created in bupaR with the following sintax. 
-- input: a dataframe endcancer of PatientID, Activity, Actor, Dated 
evlog <- endcancer %>%  
 mutate(status=”complete”, activity_instance = 1:nrow(.))%>% 
 mutate(Dated=as.Date(Dated, format=’%Y-%m-%d’))%>% 
 eventlog(case_id=”PatientID”,activity_id=”Activity”, 
 activity_instance_id = “activity_instance”,  
 lifecycle_id = ”status”, timestamp = “Dated”,  
 resource_id = “Actor”) 
The edeaR package provides methods for describing and selecting process data, and for 
preparing event log data for process mining. Event data can be explored based on the time, 
organisational, and structuredness perspectives. Time perspective includes three metrics, 
i.e. throughput time, processing time,  and idle time. Organisational perspective includes 
resource frequency, resource involvement, and resource specialisation metrics. For 
example, to analyse throughput time of processes in an event log, the following sintax can 
be used. 
evlog %>% throughput_time (“activity”) %>% plot 
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The processmapR package provides several visualisations of the data, such as process 
maps and dotted chart. The visualisations are customisable to support different needs in the 
study. This includes options to present the absolute/ relative frequency or performance 
profile in term of mean, median, or custom profile in the process model. For example, the 
pathways of endometrial cancer from referral to diagnosis can be visualised using a process 
map presenting median durations. This can also be combined with a filtering function in 
edeaR to include only top 30% of the most frequent traces. The complete syntax is as 
follow. 
evlog %>% filter_trace_frequency(percentage=0.3)  
 %>% process_map(type=performance(median, units=”days”)) 
Output: 
 
The processmonitR package provides a set of process dashboards. Some predefined 
dashboard are performance dashboard, activity dashboard, rework dashboard, and resource 
dashboard. Those dashboards combined some functions in the bupaR packages to provide 
more interactive visualisation of data and process of interest. 
Conclusion 
This package has been useful in the PPM Cancer case study in this thesis. Data description 
of event log has been made easy by bupaR with summary() sintax. The process discovery 
used in this package is visualised in state transition diagram. The analysis has been 
combined with many other basic packages in R such as stats, ggplot, and sqldf. 
 
 
